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CHAPTER I 
INTRODUCTION 
1.1 Rationale for the study 
In humans, transplantation of haemopoietic cells has shown to be an effective treat-
ment for certain disorders originating in the haemopoietic stem cell (HSC) compart-
ment: severe combined immunodeficiency disease (CID) [Buckley, 1971; Van Bekkum, 
1972] and aplastic anaemia [Thomas et al., 1972; Storb et al., 1974; Floersheim and 
Storb, 1974]. The bone marrow aplasia induced by a radical chemotherapeutic treat-
ment of acute leukaemia is also amenable to bone marrow transplantation (Graw et 
al., 1971; Fefer et al., 1973; Floersheim and Storb, 1974]. 
The rationale for bone marrow transplantation is that an injection of haemopoietic 
cells derived from a healthy donor can restore the damaged or depleted HSC com-
partment in the recipient, provided that the inductive microenvironment is not 
defective [Van Bekkum and De Vries, 1967]. In transplantation practice, bone marrow 
has been used most extensively as the source of haemopoietic cells. Bone marrow 
contains, along with cells of the erythroid, myeloid, thromboid, and lymphoid cell 
lines in all stages of differentiation, a small minority of HSC [Metcalf and Moore, 
197la]. During the last decade, it has been shown that this cell type is responsible for 
the extensive repopulation of the haemopoietic sites of the recipient following marrow 
transplantation [Till and McCulloch, 1961; Trentin and Fahlberg, 1963]; as such, 
the HSC population is the most important cellular constituent of the bone marrow 
graft. 
The serious complications which arise from allogeneic bone marrow transplanta-
tion have prevented extensive application of this therapy. These problems are mostly 
related to the Graft versus Host (GvH) reaction, a dangerous immunological reaction 
against recipient tissues mediated by lymphocytes in the graft. When no special 
measures are taken in allogeneic transplantation, the GvH disease is invariably fatal 
[Bortin, 1970]. 
Many techniques have been devised in attempts to prevent or mitigate the GvH 
disease, but as yet none of them offers full protection. The selection of histocompatible 
donors has been relatively successful in reducing the severity of GvH disease [Gatti 
eta!., 1968; De Koning eta!., 1969; Levey eta!., 197l;Rubinstein eta!., 1971; Van 
Bekkum, 1972; Yamamura eta!., 1972; Stiehm eta!., 1972; Dupont eta!., 1973]; 
however, in spite of selection, bone marrow transplantation still results in an 
approximately 50% incidence of GvH complications and a 25% mortality from GvH 
disease [Storb et a!., 1974]. Moreover, it is worth considering that the selection 
procedure is of very restricted applicability, because of the limited availability of 
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matched donors. For these reasons, histocompatibility testing has not really solved the 
problem of GvH reactions. 
In recent years, it has been shown that the acute GvH reaction which is directly 
caused by lymphocytes in the graft, can be prevented in principle by removal of 
mature lymphocytes from the transplant [Dicke et al., 1968]. Although this principle 
is already being used in the treatment of infants, its application to bone marrow 
transplantation in adults requires further development. The method, however, is of 
no value in preventing the so-called delayed GvH disease and, therefore, the latter 
reaction continues to be the most urgent issue to be approached at the experimental 
level [Van Bekkum and Dicke, 1972; Dicke and Van Bekkum, 1973]. It is supposed 
that the latter reaction is elicited by lymphocytes gradually arising from grafted HSC 
after the cell infusion [Van Bekkum and Dicke, 1972]. 
One of the promising approaches to mitigate delayed GvH disease is the use of 
another haemopoietic stem cell source, the embryonic liver. This organ is a major 
site of haemopoiesis during a long period of prenatal development [Metcalf and 
Moore, 197la]. Cell grafts from fetal liver have previously been extensively investi-
gated in animals [Uphoff, 1958; Crouch, 1959; Urso et al., 1959; Lengerova, 1959; 
Barnes et al., 1961; VanPutten et al., 1968; Bortin and Saltzstein, 1969]. The studies 
showed that the transplantation of these cells not only resulted in preventing acute 
Gv H disease but also in the occurrence of a relatively moderate delayed GvH reaction 
with a markedly longer survival. Notwithstanding, the application of fetal liver cell 
grafting has so far not become an established procedure in man for several reasons. 
The main problem has been that difficulties were encountered in obtaining haemo-
poietic or immunologic restoration with these grafts [Van Putten et al., 1968; Soothill 
et al., 1971; Githens et al., 1973]. It was not possible to determine the biological 
basis for the low repopulation efficiency of fetal liver cells. Another obstacle was the 
logistical problem of collecting suitable embryo donors at the time when a transplan-
tation is required. 
A number of novel technical procedures has been developed in recent years, and 
these permit a new approach to these problems. The methods involve assays for 
HSC proliferation and differentiation and for the quantitation of HSC numbers 
[Till and McCulloch, 1961]. They seem to be of value in acquiring a better insight 
into the factors responsible for the take problems. 
If the low incidence of takes following fetal liver cell grafting is due to an insufficient 
number of HSC in fetal liver, augmentation of the number of HSC prior to grafting 
might be a way to ensure that a take is obtained. The newly developed techniques 
for in vitro cultivation of haemopoietic cells [Pluznik and Sachs, 1965; Bradley and 
Metcalf, 1966] might offer practical possibilities for inducing HSC proliferation in 
culture [Dicke et al., 1971]. Furthermore, the HSC assays permit direct investigation 
of the question as to whether the relatively mild type of delayed GvH reaction follow-
ing fetal liver cell grafting is due to the presence of low numbers of HSC in this tissue 
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or to special cellular properties of the embryonic HSC. In addition, it is envisaged 
that a recently developed method for preservation of HSC [Schaefer et al., 1972a] will 
enable the long term storage of fetal liver cells and diminish the logistical problem 
of having the transplants available at the appropriate time. 
The progress in technical potentialities to approach and possibly solve these current 
questions has created new perspectives for fetal liver cell transplants. This is of 
extreme interest, from the standpoint of the beneficial outcome of fetal liver cell 
grafting as regards the severity of delayed GvH disease, of the unsatisfactory results 
with bone marrow cells, and of the urgent need for a solution to the delayed GvH 
problem. Therefore, fetal liver cell transplantation is the subject of this study. 
1.2 Present status of bone marrow transplantation and GvH disease 
1.2.1 Transplantation of haemopoietic cells 
To obtain a take of grafted "foreign" (allogeneic or xenogeneic*) haemopoietic cells 
in a recipient, it is necessary to suppress the mechanism(s) of the host which controls 
immunological rejection. Lethal irradiation or treatment with immunosuppressive 
agents provide such a "conditioning". Due to the resulting destruction of the pre-
existent marrow cells two other conditions are also accomplished which are usua11y 
favourable to the take ofthe grafted haemopoietic cells: space for the cells to lodge in 
the marrow sites and a stimulus for the cells to proliferate [Van Bekkum and De Vries, 
1967]. Since the discovery that treatment with bone marrow can prevent mortality 
from the acute lethal irradiation injury (the "primary disease"), the irradiated animal 
has provided a profitable experimental model system to which we owe most of our 
current understanding concerning the basic principles of bone marrow transplanta-
tion [Micklem and Loutit, 1966; Van Bekkum and De Vries, 1967]. 
An infusion of a sufficient number of bone marrow cells is capable of repopulating 
the depleted haemopoietic sites and can thus prevent early death from the irradiation-
induced bone marrow aplasia. In this way, the inoculation of syngeneic or autologous 
bone marrow cells produces a lasting recovery. Allogeneic marrow cells can produce 
a similar reconstitution; however, the recipients subsequently develop a complication 
which occurs, at least in the mouse, following the recovery from the radiation sick-
ness and is therefore known as secondary disease. After this secondary disease was 
* To indicate the immunogenetical relationship between donor and host, four categories of trans-
plantations are distinguished in transplantation biology: autologous grafting - the graft is taken 
from the same individual to which it is transplanted; isogeneic or syngeneic grafting - host and 
donor are genetically identical (animals of the same inbred strain or identical twins in humans); 
allogeneic grafting- donor and recipient are genetically different but of the same species; xenogeneic 
grafting - donor and recipient belong to different species. In allogeneic and xenogeneic transplan-
tations, immunological reactions (graft rejection, GvH reaction) between recipient and graft may 
be involved, whereas following autologous and isogeneic (syngeneic) transplantation such reac-
tions do not occur. 
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recognized as being caused by an immune reaction mounted by graft-derived lymphoid 
cells against the host tissues [Barnes and Loutit, 1956; Trentin, 1956, 1957; Loutit, 
1957; Congdon and Urso, 1957; Uphoff, 1957; Uphoff and Law, 1958; Van Bekkum 
et al., 1959], the term "secondary" disease was replaced by the operational term 
"Graft-versus-Host" disease. This disease was also encountered in transplantations 
in which conditioning of host other than irradiation was involved and appeared to be 
a characteristic complication of non-syngeneic haemopoietic cell grafts. The GvH 
reaction has continued to be the most dangerous complication of bone marrow 
transplantation, although much experimental work has been done concerning its 
pathogenesis, prevention, and therapy. 
1.2.2 Acute and delayed GvH reactions 
Two distinct forms of GvH disease can be recognized, each with clearly different 
clinical manifestations (table 1.1). The number of immunocompetent cells present in 
Table 1.1 Graft versus host disease 
Etiology: 
Symptoms and 
pathology: 
Onset: 
Course: 
Acute 
Many immunocompetent cells present 
in the graft which react against the 
recipient tissue antigens 
Severe donor-recipient histo-incom-
patibility 
Diarrhoea (loss of crypts, denudation) 
Icterus (liver cell necrosis, loss of 
epithelial cells in the bile ducts) 
Dermatitis (lymphocyte infiltration, 
dyskeratosis, hyperkeratosis, 
vacuolisation of the basal layer) 
5-10 days after transplantation 
Lethal within 15 days after 
transplantation 
Modified according to Van Bekkum and De Vries, 1967. 
Delayed 
Few immunocompetent cells present 
in the haemopoietic ce11 graft (the 
immunocompetent cells which orig-
inate from the grafted HSC react 
against the recipient (?)) 
Slight donor-recipient histo-incom-
patibility 
Infections 
Immunodeficiency 
Diarrhoea 
Dermatitis 
Icterus 
20-30 days after transplantation 
Less acute 
the graft and the degree of histo-incompatibility between donor and host determine 
the type of GvH disease that will occur [Van Bekkum and De Vries, 1967]. 
Monkey and human bone marrow contain large numbers of immunocompetent 
cells and transplantation leads to the rapid development of a violent GvH reaction, 
the acute or early type of GvH disease, which is usually fatal within 15 days following 
transplantation [Van Bekkum, 1964; Dicke et al., 1968, 1969; Dicke, 1970]. By 
contrast, marrow from rodents, containing relatively low numbers of lymphoid cells, 
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provokes a delayed or late type of GvH disease which is a milder and protracted 
variant of the reaction and which has its onset at about three weeks following trans-
plantation. The acute GvH reaction is the result of a cell-mediated immune attack 
against the host tissues by mature immunocompetent cells which are already present 
in the graft [Simonsen and Jensen, 1959; Vos et aL, 1959; Van Bekkum, 1964], 
whereas the delayed type is assumed to originate from an immunological reaction 
initiated by lymphoid cells which develop from grafted precursor cells after transfer 
to the host. Elimination of the lymphoid cells from primate bone marrow or mouse 
spleen prevents the normally occurring typical acute and vigorous GvH reaction and 
the delayed and mitigated form appears [Dicke et aL, 1968, 1969; Dicke, 1970]; 
conversely, the addition of lymphocytes to rodent marrow grafts leads to an acute 
GvH reaction in the transplanted host [Vas et aL, 1959; Cole et aL, 1959; Goodman 
and Congdon, 1961]. 
The cells reacting in the GvH process represent thymus-dependent (T) lymphoid 
cells [Miller, 1961, 1962]. The recipient target organs affected by these cells are many; 
the multiple sites of damage (intestinal tract, liver, skin, spleen, lymph nodes, and 
bone marrow) as well as the varying degree of clinical expression of the disease 
make its symptomatology a variable one [Simonsen, 1962; Van Bekkum and De 
Vries, 1967]. The GvH syndrome in its most complete form may comprise a number 
of symptoms, only some of which are usually apparent in each individual case: 
diarrhoea, reduction in body weight ("wasting"), hepato-splenomegaly, icterus, 
dermatitis, anaemia, infections, and fever. It is important to note that, during the 
disease, a state of generally suppressed immune responsiveness [Barchilon and 
Gershon, 1970; Zaleski and Milgram, 1973] exists which is thought to be largely 
responsible for the increased incidence of microbial infections [Simonsen, 1962; Van 
Bekkum and De Vries, 1967]. It is not known whether this diverse picture of GvH 
disease is related to differing activities of subpopulations of the cells which participate 
in cell-mediated immune reactions [Tigelaar and Asofsky, 1972; Cantor and Asofsky, 
1972; Cantor, 1972]. 
The actual cause of death during the acute GvH reaction is attributed to severe 
damage to the organs and tissues involved. In the delayed GvH disease, functional 
and pathological changes that can be directly attributed to the Gv H reaction are 
relatively mild, but they are aggravated by infections and inflammations. The over-
whelming infectious complications represent the predominant cause of mortality in 
the delayed form of the disease. 
1.2.3 Mitigation of Gv H disease 
Because of the life-threatening features of GvH disease, bone marrow transplantation 
research in recent years has been predominantly concerned with the prevention and 
the mitigation of GvH reactions. From the variety of methods explored so far, the 
selection of donors which are genotypically identical at the major histocompatibility 
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complex has been shown in experimental animals and in man to be a most valuable 
procedure to mitigate both the acute and the delayed GvH disease [Good et al., 
1964; Storb et al., 1968; Gatti et al., 1968; De Koning et al., 1969; Van Bekkum, 
1972; Storb et al., 1974]. Although this selection significantly reduces the severity 
of the disease, it does not provide absolute protection [Speck et al., 1971; Rubinstein 
et al., 1971; Graw et al., 1971; Stiehm et al., 1972]. In the treatment of panmyelo-
pathy, in spite of donor-recipient HLA/MLC matching, the disease still develops in 
roughly 50% of the cases, half of which results in mortality [Storb et al., 1974]. 
Moreover, a major drawback of the selection method for clinical use is that the 
frequency of identical sibling donors in humans is low. If there are no immuno-
genetically identical family members available, one is restricted to histo-incompatible 
grafting which involves, when engraftment ensues from it, a 100% incidence of fatal 
GvH disease [Bortin, 1970]. It is due to this complication that we are not yet at the 
stage of general application of haemopoietic cell therapy. Therefore, continued 
research in the combat against GvH disease is still of a high priority. 
The acute GvH problem has been essentially solved by the development of a cell 
fractionation technique (discontinuous albumin gradient centrifugation). Using this 
technique, which takes advantage of differences in cellular density between stem cells 
and lymphocytes, separation of lymphocytes from purified stem cell fractions has 
been achieved [Dicke et al., 1968]. The method has been shown to be not only 
effective in terms of prevention of acute GvH disease but is also reliable, since it can 
be controlled by in vitro assays for numerical changes in lymphocytes and stem cells 
in the different fractions [Dicke et al., 1969, 1970; Dicke, 1970]. The demonstration 
that the density gradient centrifugation technique may serve to prevent acute GvH 
disease, even in fully histo-incompatible situations [Dicke and Van Bekkum, 1972, 
1973], implies that the acute GvH reaction is no longer of prime concern as an 
experimental issue and that further research should be centred on its application to 
human patients and on the prevention or control of delayed GvH reactions. 
1.2.4 Approaches for the control of delayed GvH disease 
From our present state of knowledge, experimental efforts to overcome the delayed 
GvH risks may focus on a number of different factors (table 1.2). In this respect, 
Table 1.2 Procedures for the control of delayed GvH reactions 
available methods 
prospective methods (?) 
directed at donor 
donor selection 
improvement in donor-matching 
fetal liver cell transplants 
directed at host 
strict pathogen-free conditions 
manipulation of thymus function 
immunological enhancement 
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five lines of research are to be distinguished: the improvement of donor selection; 
the application of gnotobiotic conditions; the use of embryonic liver cell grafts ; 
the employment of immunological enhancement [Voisin and Kinsky, 1962; Batchelor 
and Howard, 1965; Voisin et al., 1968; Safford and Tokuda, 1970]; and the manipula-
tion of thymus function. The latter t\vo have not yielded very promising results so 
far and will not be discussed separately [Buckley et al., 1971; Van Pullen, 1964]. 
The other three seem to be of more practical interest. 
The first approach concerns the further development of histocompatibility testing. 
It aims at the identification of those individuals among the HLA/MLC identical 
donors, whose bone marrow is incapable of producing GvH disease; and further-
more, it is directed towards the selection of compatible donors among non-family 
members. The successful reconstitution of a CID infant with MLC-negative/HLA-
incompatible bone marrow [Copenhagen Study Group of Immunodeficiencies, 1973] 
may represent a promising lead for expansion of the category of compatible donors. 
A second line of work is based on the observations that, similarly to animals, a 
high proportion of patients suffering from delayed GvH disease, die from bacterial 
infections [Van Bekkum, 1972; Dicke and Van Bekkum, 1973]. It has been demon-
strated in the mouse that almost complete prevention of the delayed GvH mortality 
can be achieved by the establishment of strict gnotobiotic conditions [Van Bekkum 
et al., 1974]. In similar experiments in monkeys, however, it has been found that 
allogeneic bone marrow transplantation in decontaminated recipients also had a 
beneficial effect on survival but still resulted in substantial mortality due to viral 
infections [Hendriks, 1974]. Apparently, the prevention of bacterial infections did 
not suffice to overcome the persistent state of immuno-incompetence. Although 
extension of this approach to patients has to determine its clinical merit in the in-
hibition of human GvH hazards, it is not expected that it will provide a complete 
safeguard in totally incompatible combinations. 
The last avenue for research which will be referred to is the use of fetal liver cell 
grafts. In 1958, it was shown in mice that the transplantation of embryonic haemo-
poietic liver cell grafts instead of bone marrow resulted in the prevention of the 
acute GvH syndrome as well as suppression of delayed GvH mortality [Uphoff, 1958]. 
These results were afterwards confirmed by others in animal experiments [Crouch, 
1959; Urso et al., 1959; Lengerova, 1959; Barnes et al., 1961]. The fact that wide-
spread application in humans has not been effected is due to factors which are not 
related to GvH reactions. The main drawback with respect to clinical application 
has been the difficulties encountered in obtaining takes with fetal liver cells [Thomas 
et al., 1963; Van Pullen et al., 1968; Githens et al., 1973]. Advances in experimental 
haematology and newly developed techniques have created new possibilities for 
solving or at least analysing this problem [Till and McCulloch, 1961; Pluznik and 
Sachs, 1966; Bradley and Metcalf, 1966; Dicke et al., 1968; Lahiri et al., 1970]; this 
is one of the subjects of this investigation. 
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1.3 Fetal liver cell transplantation 
1.3.1 Origin and nature of fetal liver haemopoiesis 
Embryonic haemopoiesis is initiated in the yolk sac [Aberle, 1927; Attfield, 1951; 
Borghese, 1959] and, during the regression of yolk sac function, the liver becomes the 
major fetal haemopoietic organ in most mammals [Rifkind et aL, 1968, 1969; Niewisch 
et aL, 1970; Moore et aL, 1970]. In the mouse, fetal liver haemopoiesis begins in 
the liver anlage by the 10~12th day of gestation and the organ develops to be the 
main site of blood cell production until the time of birth. During the first week 
after birth, liver haemopoiesis disappears completely. The bone marrow, where 
haemopoiesis is established at 3-4 days before term, takes over the role of the liver 
and continues to function as the main site of haemopoiesis for the rest of the life of 
the individual [Moore et al., 1970; Niewisch et al., 1970]. 
In man, fetal liver haemopoiesis begins at about the 7th week and subsides at 22~24 
weeks of gestation. Since most knowledge of developmental haemopoiesis has been 
obtained in small vertebrates and, since the mouse is the subject of investigation in 
this study, we will confine the more detailed discussion of the available information 
to the ontogenesis of this species. 
HSC and progenitor cells which originate de novo in the yolk sac blood islands 
and subsequently migrate via the circulation to colonize developing haemopoietic 
tissues, have been proposed to establish self-replicating stem cell populations in the 
fetal liver, the spleen, and, later, in the bone marrow [Moore and Owen, 1967; 
Metcalf and Moore, 1971a]. This so-called unicentric theory accepts the primitive 
yolk sac stem cell as the common precursor of all other stem cells and proposes 
migration streams of stem cells which emigrate from the yolk sac and settle in the liver. 
Conversely, the multicentric theory is based on an independent evolution of stem 
cells from endogenous precursors in yolk sac, liver, and other haemopoietic sites 
[Niewisch et al., 1970]. 
Although, no definite verification of the unicentric theory can be made, it is 
supported by a number of observations. Extirpation experiments showed that the 
development of embryonic haemopoiesis in the liver requires the presence of a yolk 
sac in an early stage of gestation. Furthermore, a cellular traffic of HSC to the liver 
before the commencement of haemopoiesis has been observed by several investigators 
[Niewisch et al., 1970; Moore et al., 1970; Goss, 1928; Metcalf and Moore, 197lc]. 
Though models of haemopoiesis were postulated around 1930 [Maximow and 
Bloom, 1934] which included the existence of a HSC capable of taking alternative 
pathways of self-reproduction and differentiation towards fully developed elements 
[Vogel et al., 1969], only in 1961 could a cell be experimentally identified which fits 
the criteria for this theoretical entity. This was the haemopoietic cell which following 
its injection into lethally irradiated mice formed visible colonies on the surface of 
the spleen in 7~10 days after transfer of the cells [Till and McCulloch, 1961]. In brief, 
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the identity of the so-called spleen-colony-forming cell (colony forming unit spleen; 
CFU-s) with a multipotent HSC was supported by the following evidence: 
a. By employing a unique chromosomal marker to identify member cells of a single 
clone, it was shown that the majority of the dividing cells within a colony are 
derived from a single precursor cell [Becker et al., 1963; Fowler et al., 1967; Wu 
et al., 1967]. 
b. Cells within such colonies were demonstrated to consist of erythropoietic, granu-
lopoietic, and megakaryopoietic precursor cells [Wu et al., 1967]; furthermore, 
cells obtained from the same clone characterized by a specific karyotype were also 
found to give rise to lymphocytes [Wu et al., 1968; Nowell et al., 1970]. This 
represented elegant proof of a common rnultipotent lympho-haemopoietic cell 
as the initiator of spleen colonies. 
c. The demonstration that spleen colony forming cells had the capacity to produce 
new colony forming cells within the colonies [Siminovitch et al., 1963] and that 
an individual colony could offer complete protection to a lethally irradiated host 
[Trentin and Fahlberg, 1963] was evidence of the extensive self-renewal capacity 
of the spleen colony forming cells. 
Thus, it was established that the cells which give rise to macroscopic colonies in the 
spleens of irradiated mice fulfil the key requirements of pluripotency and "unlimited" 
self-replication capacity of HSC. It was also shown that fetal liver contained spleen 
colony forming cells. 
Numerous studies have been involved with the properties of the fetal liver stem 
cells. Fetal liver stem cells produce colonies which closely resemble those produced 
by stem cells from adult animals [Silini et al., 1968; Vogel et al., 1970; Moore et al., 
1970]. The embryonic stem cells have a more homogeneous and lighter density 
[Moore et al., 1970] and a larger volume [Haskill and Moore, 1970], than those of the 
adult bone marrow. Experiments on the morphological identification of the stem cell 
similar to those carried out on stem cells from adults [Van Bekkurn et al., 1971; 
Dicke eta!., 1973b, 1973c] have not been extended to the cells of fetal origin. 
In vitro exposure of the cells to the lethal effect of tritiated thymidine showed that, 
while the majority of bone marrow stem cells are in the resting state, most fetal liver 
stern cells are rapidly proliferating [Becker et al., 1965; Duplan, 1970]. Furthermore, 
it was found that fetal CFU-s had a higher radiosensitivity and this was shown to be 
independent of the cell cycle state of the cell population [Duplan, 1970]. In addition 
to these physical differences between marrow and fetal liver stem cells, also functional 
differences have been observed, e.g., greater proliferative capacities of fetal liver stem 
cells following a transfer to lethally irradiated recipients as compared to bone marrow 
[Schofield, 1970; Metcalf and Moore, 197le]. 
As to the more differentiated compartment of haemopoiesis in the embryonic liver, 
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erythropoiesis represents by far the most important component of haemopoietic 
activity. It differs from that in the adult animal by the electrophoretically different 
type of haemoglobin [Craig and Russel, 1964; Fantoni et al., 1967] and the very 
low level of haemoglobin content in early erythroblasts [Steiner and Vogel, 1973]. 
The experimental data on the hormonal control of liver haemopoiesis as studied by 
the responsiveness of fetal liver cells to erythropoietin are contradictory: some of 
them indicating a complete lack of sensitivity of liver erythropoiesis to the action of 
the hormone [Jacobson et al., 1959; Bleiberg et al., 1965]; others showing a positive 
requirement of the cells for erythropoietin [Chui et al., 1971; Stephenson et al., 1971; 
Gregory et al., 1973]. This contradiction may be explained by the finding that 
erythropoietin responsiveness is present only in young fetuses and that this res-
ponsiveness is lost during embryonic development [Cole and Paul, 1966]. 
Another indication of a different haemopoietic control in fetal and adult tissues is 
provided by the comparative paucity of granulopoiesis in fetal liver [Silini et al., 
1967]. The findings of low numbers of granulocytic cells in the liver and the generation 
of normal proportions of granulocytic spleen colony numbers by fetal cells in adult 
hosts [Vogel et al., 1970; Moore et al., 1970] support the opinion that the liver 
microenvironment largely determines the suppressed granulopoiesis in the embryo. 
On the other hand, evidence has been obtained that the embryonic cells have 
certain specific growth properties which are not dependent on environmental factors 
but rather on intrinsic cell properties [Schofield, 1970]. The latter may be particularly 
important in haemopoietic cell transplantation. Therefore, they will also be under 
discussion in this investigation. 
1.3.2 The take of fetal liver cell transplants 
For many years, investigations of the proliferative capacity of fetal liver cells have 
employed the parameters of protection of irradiated animals and histological re-
population of the haemopoietic tissue; later, when CFU assays were available, the 
proliferation of the stem cells was also taken as the endpoint. The data on the take 
capacity of fetal liver cell transplants in the literature show a remarkable divergence. 
The results of a quantitative study conducted by Crouch [1959] demonstrated that, 
in comparison to marrow cells, more than twice the number of fetal liver cells were 
needed to obtain a similar percentage survival of lethally irradiated mice. The results 
of Crouch 1:1re difficult to reconcile with other experimental data which indicate a 
more pronounced proliferation capacity for embryonic liver cell transplants. The 
classical competition experiments of Micklem et al. using isogeneic chromosome-
marked cell populations have shown that, beginning as early as 2 weeks following 
injection, the populations derived from the liver outgrew karyotypically-distinguish-
able bone marrow derived populations [Micklem and Lou tit, 1966; Micklem and 
Ford, 1966]. 
In serial spleen colony passaging experiments, the CFU of embryonic origin did 
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not undergo the same decline as bone marrow CFU, which was consistent with the 
idea that fetal liver CFU can sustain a continuous proliferation over longer periods 
of time [Metcalf and Moore, 1971e; Micklem, 1972]. 
The shorter doubling time of the fetal-liver-derived CFU population in the expo-
nential growth phase in the spleen following transplantation was indicative of a 
greater capacity of fetal liver CFU for self-renewal [Schofield, 1970]. The observation 
that stem cells in fetal liver produced spleen colonies of a larger size and with an 
increased rate of DNA synthesis per colony [Micklem, 1972] as compared to bone 
marrow was also suggestive of an enhanced growth rate of these cells. These findings, 
however, were inconsistent with results in which the cellularity and the size of the 
CFU-s and the CFU-c populations of individual spleen colonies of fetal liver origin 
were not significantly different from those of bone marrow derived colonies [Metcalf 
and Moore, 197le]. 
Comparative bone marrow and fetal liver cell transplantation experiments perform-
ed on the basis of the equivalence of the numbers of CFU-s in the cell inocula did not 
allow clear-cut conclusions as to the relative proliferative efficiencies of the cells 
from both sources. The more pronounced splenic and femoral erythropoiesis during 
the first 6 days following transplantation of fetal liver cells in irradiated recipients 
may be ascribed to the transplantation of a relative excess of erythropoietic pre-
cursors in fetal liver rather than to differences in stem cell potencies [Kubanek et al., 
1969]. Restoration experiments in lethally irradiated mice revealed that only 60% of 
the total number of fetal liver CFU-s were needed to provide a similar degree of 
irradiation protection. These investigations were also not conclusive, because they 
did not account for possible differences in spleen colony forming efficiency and 
related differences in absolute numbers of stem cells in the grafts [Duplan and 
Legrand, 1971]. 
Although the results are not decisive, most of them seem to tip the balance in favor 
of a proliferative advantage for fetal liver cells. One should realize, however, that 
most of these experiments were carried out under isogeneic transplantation conditions. 
It is questionable whether the findings apply to histo-incompatible grafting with 
which one is concerned in man. 
Experimental data on the take of fetal liver cell grafts in allogeneic murine recipients 
are scarce. The titration experiments of Crouch [1959] revealed that the efficiency of 
fetal liver cells to produce a certain level of survival following lethal irradiation was 
at least 2-4 times lower than that of bone marrow cells. The author did not specify 
whether one liver provided enough cells to repopulate an entire host. Since the con-
centration of stem cells in both types of grafts may differ markedly [e.g. McCulloch 
and Till, 1963; Micklem, 1966; Silini et al., 1967; Niewisch et al., 1970] and may 
importantly influence the takeability, it is unfortunate that these values could not be 
determined in those days. The larger numbers of fetal liver cells required for re-
population are in accord with the take problems encountered in fetal liver cell 
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grafting in other species, including man [Thomas et a!., 1963; VanPutten et a!., 
1968; Githens eta!., 1973]. 
Giller et al. [1972] observed an enhanced and sustained restoration of the cellularity 
and of the CFU population in the femoral marrow of allogeneic radiation chimaeras 
in a follow-up investigation after the transplantation of fetal liver cells. It is question-
able whether the promoted repopulation by fetal liver is indeed a direct difference in 
repopulation capacity, in view of the high numbers of20 x 106 inoculated cells employ-
ed in these investigations. Because GvH reactions are known to produce severe hypo-
plasia in the lymphoid and haemopoietic organs [Van Bekkum and De Vries, 1967], 
it might also reflect the reduced Gv I-! reaction in the fetal liver group. 
An augmentation of repopulation by fetal liver cells in chimaeras was achieved by 
replacing a part of the liver cell graft by fetal thymus cells which in themselves had 
no capacity for haemopoietic reconstitution. As it was shown that adult thymus cells, 
irrespective of their GvH reactivity, were particularly active in overriding the inhibi-
tion of haemopoietic cell proliferation in non-isogeneic recipients [Goodman and 
Wheeler, 1968; Goodman and Grubbs, 1970; Goodman et al., 1972], the effect of 
the fetal thymus cells might be attributed to the ability of large numbers of these cells 
to overcome the allogeneic resistance [McCulloch and Till, 1963; Cudkowicz and 
Stimpfling, 1964; Hellstrom and Hellstrom, 1965]. On the other hand, the fact that 
extremely low numbers of fetal thymus cells were also effective in promoting such a 
repopulation [Bortin et al., in press] raises doubts as to the validity ofthis assumption. 
On the whole, our understanding of the factors which govern the take of a fetal 
liver cell transplant seems to be fragmentary and conflicting. Since many factors 
such as the number of transfused stem cells, the susceptibility of the cells to genetic 
repression, and the intrinsic proliferative qualities of the cells are involved in the 
initial growth of the graft, a comprehensive study in which these factors are integrally 
evaluated is clearly required. 
1.3.3 Fetal liver cell transplantation and GvH disease 
In I 958, Uphoff was the first to report on experiments with fetal liver cell transplan-
tation. She found an almost 100% survival following the transfer of fetal liver cells 
from either parental strain to lethally irradiated F 1 hosts. These values were in sharp 
contrast to the 10-35% survival of the bone marrow treated group. The lasting benefi-
cial effect of parental fetal liver cells, indistinguishable from a syngeneic transplanta-
tion, has stimulated broad interest in fetal liver haemopoietic cell transplantation. 
Uphoff's publication was followed by numerous others on the same subject. In 
another study [Uphoff, 1959], the same author demonstrated the superiority of fetal 
liver cell grafts in three allogeneic mouse strain combinations. Since then, an increas-
ing body of evidence has confirmed the ability of embryonic liver cells to restore 
irradiated allogeneic recipients and with less severe delayed Gvl-1 reactions, although 
the exact survival data after fetal liver cell transplantation varied from one study 
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to the other [Uphoff, 1958, 1959; Crouch, 1959; Urso eta!., 1959; Lengerova, 1959; 
Barnes eta!., 1961; Bortin and Saltzstein, 1969]. 
More specifically, Crouch [1959] and Barnes eta!. [1961] reported that a marked 
reduction in GvH mortality was obtained, but that the outcome of fetal liver cell 
transplantation was not as good as that following the treatment with syngeneic 
haemopoietic cells. The same investigators established that a low grade GvH disease 
with typical clinical and pathological findings was the cause of the mortality which 
occurred in the fetal liver cell infused mice. The survival rate after fetal liver cell 
allotransplantation was also demonstrated to be dependent on the actual donor-host 
immunogenetic relationship [Crouch, 1959]. This is probably an important key to the 
nature of the diverse survival results in the literature. 
The ameliorated GvH reaction following fetal liver cell transplantation could not 
be ascribed to the deficient maturation of immunocompetent lymphocytes. Apparently, 
a complete repopulation of the lymphoid organs in the host by donor type lymphoid 
cells took place [Vos eta!., 1960]. Within 30-60 days after transplantation, these cells 
were normally reactive in provoking GvH reactions in secondary genetically different 
hosts [Tyan, 1964; Van Bekkum, 1965]. Thus, it is conceivable that the decrease in 
the delayed GvH mortality is due to the fact that the immunocompetent cells which 
arise from embryonic precursor cells have a greater tendency to develop a specific 
immunological tolerance to host tissue antigens. 
A difficult problem in the interpretation of very late mortality following all types 
of bone marrow transplantation is the distinction between mild GvH disease and 
severe immunodeficiency. Some very late mortality after haemopoietic cell trans-
plantation was observed in syngeneic situations, in particular following fetal liver 
cell transplantation [Barnes et a!., 1961]. The fact that the addition of syngeneic 
lymph node cells prevented this very late mortality in fetal liver cell grafted isogeneic 
hosts seemed to prove that at least part of this mortality was due to a deficiency in 
lymphoid proliferation in the irradiated host and not to GvH disease [Barnes eta!., 
1961]. In recent years, the group of Bortin has returned to the idea that an insufficient 
immune restoration following fetal liver cell transplantation could be responsible 
for the late mortality. They demonstrated an improved long-term survival when fetal 
thymus cells were included in the fetal liver cell graft [Bortin and Saltzstein, 1968; 
Bortin and Rimm, 1970]. The authors postulated a compensation by lymphoid 
precursor cells for an immune deficiency. However, the fact that the positive effect 
of intravenously infused thymus cells could be mimicked by fetal thymus cells 
enclosed in cell-tight millipore diffusion chambers makes this explanation unlikely 
and points rather to an effect mediated by thymic factors [Bortin and Rimm, 1970]. 
Apparently, these results do not distinguish between a thymic influence on the 
suppression of GvH development and a direct effect on immunological reconstitution. 
So far, the majority of experimental data indicate that a GvH reaction is the most 
plausible explanation for the late mortality in fetal liver cell transplanted mice 
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[Crouch, 1959; Urso et al., 1959; Lengerova, 1959; V os et al., 1960; Tyan, 1964]. The 
immune deficiency which is a regular feature of the delayed GvH syndrome is assumed 
to be a complication of the GvH reaction itself. 
1.3 .4 Immunological reconstitution after fetal liver cell transplantation 
Although fetal liver tissue is devoid of immunologically reactive cells [Tyan and Cole, 
1963; Bortin and Saltzstein, 1968; Tyan et al., 1973], the cells present are apparently 
fully capable of conferring immunological competence on lethally irradiated syngeneic 
recipients. Embryonic liver cells generate cells which are able to migrate to and re-
populate the lymphoid organs [Vos et al., 1960; Taylor, 1964]. Furthermore, the cells 
to which they give rise are capable of functioning in both humoral and cellular 
immune reactions, including specific antibody responses [Doria et al., 1962; Tyan 
et al., 1967] and GvH reactions [Tyan and Cole, 1963, 1964; Tyan, 1964]. The gamma 
globulins in the serum are rapidly restored to normal levels [Tyan et al., 1967; Tyan 
and Herzenberg, 1968a, 1968b]. Complete restoration is generally achieved in the 
syngeneic host and it is similar to that following the transplantation of adult bone 
marrow cells. 
There are many reports to indicate that the immunological recovery in allogeneic 
hosts after haemopoietic cell transplantation is delayed or incomplete [Doria et al., 
1962; Gengozian et al., 1965, 1971]. From bone marrow transplantation studies, it 
is known that allogeneic mouse chimaeras have suppressed levels of IgM and lgG, 
a reduced cell-mediated immune capacity [Bortin et al., 1971], a lowered primary 
and secondary antibody response, and a qualitatively abnormal antibody synthesis 
as evidenced by the absence of a normal conversion from 19S to 7S antibodies 
[Gengozian and Congdon, 1973]. Although some of these deficiencies may persist, 
even after the disappearance of GvH symptoms, immunological reconstitution is 
sufficient to permit long-term survival of the hosts. Similar to the experience with 
bone marrow transplantation, the rate of immunologic recovery after fetal liver cell 
transplantation is also depressed in allogeneic hosts [Doria et al., 1962]. However, 
the time pattern of reconstitution of allogeneic fetal liver cell recipients appears to 
be more favourable than that of comparable bone marrow recipients [Bortin et al., 
1971]. 
1.3 .5 Preclinical fetal liver cell transplantation in dogs and monkeys 
Fetal liver cell transplantation has very rarely been subject to preclinical evaluation 
in large mammals and, to our knowledge, only a few studies have been performed in 
the dog and the monkey. In dogs, the Seattle group failed to produce consistent takes 
with liver cell allografts from term or near-term fetuses on five occasions [Thomas 
et al., 1963]. At best, temporary signs of a take were noted. Since the authors do not 
comment on the number of cells transfused, a comparison with bone marrow grafts 
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as regards the takeability cannot be made. Obviously, symptoms of GvH disease 
were not seen. 
A more quantitative study was undertaken by VanPutten et al. [1968] in Rhesus 
monkeys. These investigators mention problems in establishing takes of fetal liver 
cell transplants. The total cell yield of a single fetal liver of 100 days gestation did not 
provide sufficient numbers of cells for engraftment in lethally irradiated histo-
incompatible monkeys. Whereas 4 x 108 allogeneic bone marrow cells from adult 
donors (per kg recipient body weight) produce takes in over 90% of the cases, no 
takes were obtained with dosages of 2-4 x 108 fetal liver cells. Therefore pooling of 
several livers from different embryos was necessary; even then, take problems were 
observed. With dosages of 5.5-11 x 108 pooled liver cells per kg, only 4 out of 9 
recipients were repopulated. The mean survival time of the four successfully engrafted 
monkeys of 36 days (range 21--45 days) represents a marked prolongation as com-
pared to that following allogeneic bone marrow transplantation (13.8 days; range 
5-25 days) [Dicke, 1970]. The clinical course after transplantation seemed to be 
rather characteristic of a delayed GvH reaction in all four monkeys. The picture 
was quite similar to that seen in Rhesus monkeys following grafting with purified 
bone marrow stem cell fractions [Dicke, 1970; Van Bekkum and Dicke, 1972]. It 
was concluded that GvH lesions were t:1e direct cause of death in only one animal; 
severe complicating bacterial infections were diagnosed in the other three. 
Thus, the study of Van Putten et al. demonstrated the development of a mild 
delayed GvH reaction following fetal liver cell transplantation but it also clearly 
indicated a relatively low takeability of fetal liver cells. The fact that in the dog the 
liver cell yield per fetus was clearly insufficient, may be related to the multigestational 
state of this species. Considering that a total cell number of 35 x 108 cells from a dog 
embryo liver at 6 weeks of pregnancy provides 3 x 108 cells per kg for a 12 kg recipient 
[Lowenberg and Vriesendorp, 1974], the failures to obtain takes are not surprising in 
the light of the bone marrow data in this species. A number of 4 x 108 incompatible 
bone marrow cells per kg was also incapable of repopulating lethally irradiated dogs 
[Vriesendorp, 1974]. In the monkey, however, the number of fetal liver cells which 
was administered was in the same range as the number of bone marrow cells which 
sufficed to achieve a high proportion of takes. This number of fetal liver cells did not 
produce takes. The latter finding is an indication that different factors are involved 
in fetal liver cell and bone marrow transplantation which operate to the disadvantage 
of fetal liver cell take. 
1.3.6 Fetal liver cell transplantation in man 
The advantage of fetal liver cells with regard to mitigation of GvH disease in 
animals has led several transplantation groups to employ these grafts in human 
patients. The very unsatisfactory results of early efforts to treat patients suffering 
from bone marrow aplasia with fetal haemopoietic cells [Bodley Scott et al., 1961] 
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is the probable reason why attempts at fetal liver cell grafting in man have mostly been 
restricted to immunodeficient (CID) infants. Such patients represent ideal recipients 
from the point of view of graft acceptance, since they possess virtually no immuno-
logically competent cells and have a low body weight. The congenital immunological 
disorder known as severe CID represents a differentiation anomaly in which the 
progress of the HSC along the lymphocytic pathway leads to impaired B as well as T-
cell-dependent immune functions [De Vries eta!.. 1968; Hitzig eta!., 1971; Van 
Bekkum, 1972]. Nevertheless, fetal liver cell grafts as a source of normal HSC, have 
frequently been combined with fetal thymus grafts in the treatment of this disease, 
on the assumption that the secondary involution of the thymus seen in the advanced 
stages of the disease [Hitzig et al., 1971] would prevent a rapid differentiation of 
immunocompetent T cells from grafted HSC. 
In a study of Soothill et al. [1971], combined fetal liver cell and fetal thymus tissue 
therapy was given to a series of 11 CID patients. Restoration of immune functions 
was not obtained in any of them. When GvH disease incidentally occurred, there was 
no way to distinguish whether it originated from the thymus or from the liver 
cell transplant. 
Githens et al. [1973] transplanted three patients with ClD with liver cells. Fetal 
liver cells of 12 and 13 week embryonic age were administered to the first two patients; 
one intravenously and the other intraperitoneally. No signs of either engraftment or 
of GvH disease were noted. In the third infant, due to repeated failures of take, 
sequential transplontations were performed with either fetal liver cells, fetal thymus 
organ grafts, or combined fetal liver cell plus fetal thymus tissue grafts varying in 
maturation time from 9-22 weeks. Again, no reconstitution was obtained in any of 
these attempts. 
According to our present knowledge, the following factors might have contributed 
to these failures. Firstly, frozen fetal liver cells were administered in both studies 
and these may have introduced certain pitfalls. Schaefer et a!. [1972a] have shown 
that the HSC is quite susceptible to damage from the freezing and thawing procedure. 
Because of these findings, these authors devised a special technique which allows 
optimal preservation of HSC. In the above mentioned human fetal liver cell trans-
plantation studies, monitoring for stem cell viability [Schaefer eta!., 1972a] was not 
carried out. The fact that in one study [Githens eta!., 1973] the eosin resistance of 
nucleated cells after thawing had fallen to 23-55%, suggests that the preservation 
procedure might have been responsible for a marked loss of HSC. Secondly, the 
majority of the grafts in both studies were administered via the i.p. route which is 
now known to be a relatively inefficient way of establishing haemopoietic cell grafts 
[Schaefer et al., 1972b]. Taking these losses into account, one can calculate the 
equivalent of the above cell dosages in terms of fresh fetal liver cells when administered 
i.v. The number of cells transfused was reported to vary between 108-109 [Soothill 
et al., 1971]. Assuming a total body weight of the recipients of 5 kg, an i.v.-i.p. route 
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efficiency ratio of 3:1 [Schaefer et al., 1972b], and an average loss of 50% of the stem 
cells following the recovery from freezing [Githens et al., 1973], the above value of 
108-109 cells represents a dosage of3-30 x 106 viable fetal liver cells per kg body weight 
when giveu i.v. Considering that an i.v. dose of 4 x 108 fresh fetal liver cells did not 
result in takes in monkeys [VanPutten et al., 1968], it is conceivable that the inoculates 
employed in these treatments could not provide reconstitutions, even in CID recipients. 
Making allowance for the fact that the take efficiency of fetal liver cell grafts in the 
monkey was about 3-4 times less, 3-30 x 106 fetal liver cells are equivalent to 1-10 x 
106 bone marrow cells. It is also uncertain whether such numbers of unmatched bone 
marrow cells are sufficient to lead to restoration in ClD babies. Although detailed 
information on minimum bone marrow cell numbers needed for immunologic 
repair in CID is not available, it is notable that, where full reconstitution has been 
obtained with matched bone marrow grafts, the cell numbers applied were consider-
ably larger i.e., in the order of 50 x 106 cells per kg (Levey et al., 1971, Van Bekkum, 
1972, Yamamura et al., 1972, Gelfand et al., in press). 
Two reports appeared recently in which fetal liver cells were successfully used to 
correct the T and B cell deficiencies in CID infants [Cooper et al., 1973; Dohmann, 
1974]. In the first case, 2 x 109 fresh fetal liver cells from a 9 week old embryo were 
given i.p. and, following a very slow pattern of reconstitution in which the blood 
lymphocyte count only started to rise at around day 100, complete reconstitution was 
eventually obtained [Cooper et al., 1973; Keightley et al., 1973]. It is unfortunate 
that no markers were available to conclusively prove chimaerism. Except for a tran-
sient skin rash, no signs of GvH disease were seen. However, the patient developed 
a nephrotic syndrome from which he died a little more than one year following the 
transplantation. 
In a second case, 2 x 108 fresh fetal liver cells per kg from a 12 week embryo donor 
were given i.v. This led to a rapid restoration of the immunological deficiency within 
4 weeks following transplantation [Dohmann, 1974]. Genetic markers of the embryo 
were not identified, so that, again, one could not ascertain the true chimaeric state 
after the recovery. The intestinal tract of this patient, who was kept in strict reverse 
isolation, had been completely decontaminated. 
Relevant factors in both of these successful attempts at immunological repair by 
fetal liver cell transplantation seem to be that higher cell numbers were applied, the 
cells were not frozen, and that (at least in the one that showed a rapid reconstitution) 
the cells were given i.v. Furthermore, it is of prime importance that these transplanta-
tions, which were as a matter of fact histo-incompatible, were not associated with 
obvious GvH disease. They represent the first unmatched haemopoietic cell trans-
plantations which appeared to be of benefit in the treatment of CID. Although one 
should be careful in drawing too optimistic conclusions (the first child finally died 
from a possibly immunological complication; the second child is only in the first 
year following grafting; in neither instance was a take explicitly proven), the observed 
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reconstitution of CID following fetal liver grafting without GvH disease may have 
a significant impact on further progress in bone marrow transplantation. As long as 
histocompatibility selection procedures do not provide full safeguards against the 
occurrence of serious GvH reactions, fetal liver cell transplants may provide a suitable 
alternative in haemopoietic cell transplantation. At the same time, this consideration 
emphasizes the necessity of solving the problem of embryonic liver cell takes. This 
is of even more importance if one envisages a development in which the application 
of these transplants is extended to groups of patients with aplasia or leukaemia who 
lack a matched sibling bone marrow donor. 
CHAPTER 2 
MATERIALS AND METHODS 
2.1 Experimental animals and irradiation 
Experiments were carried out with mice derived from CBA/Rij, C57BL/KA, and 
C57BL/Rij inbred strains or with an F 1 hybrid from matings between C57BL/Rij 
and CBA/Rij strains produced in the Rijswijk colony. The donor mice from which 
bone marrow was obtained were 6-8 weeks of age. 
The recipient mice used for survival studies and spleen colony assays were 12-16 
weeks of age. They were irradiated with a supralethal dose of 800 (C57BL) or 900 
rad (CBA/Rij and F 1) of X-rays. The physical properties of the X-irradiation were 
300 kV; 10 rnA; HVL of the beam, 3.0 mm Cu; distance from the focus to the bottom 
of the mouse cage, 51 em; dose rate, 55 radjmin; maximum back scatter; (Philips-
Muller 300 X-ray machine). Animals were routinely housed five to a cage and given 
food and water ad libitum. 
2.2 Preparation of cell suspensions 
2.2.1 Mouse bone marrow cell suspensions 
The femurs were excised and the proximal ends were cut with scissors. A bent needle 
placed on a syringe was introduced into the shaft and moved slightly up and down 
to break up the small bone spiculae. Thereafter, a small amount (approximately 0.2 
ml HBSS) was forcibly injected into the shaft to expel the bone marrow. The collected 
bone marrow was filtered through a nylon gauze sieve and a G 2 sintered glass filter 
(diameter pores: 30-80 ~). 
2.2.2 Spleen and thymus cell suspensions 
After excision, spleens and thymuses were cut into small pieces and the resulting 
tissue fragments were gently squeezed through a nylon gauze sieve consisting of 6 
layers to obtain a dispersed cell suspension. 
2.2.3 Mouse fetal liver cell suspensions 
Mouse embryos were obtained by carefully timed mating. Initially, groups of 20 
females were placed with 3 males in a cage overnight. Later in the study, this 
mating scheme was changed by putting a single breeding pair into a cage for one 
night. This markedly improved the gestation efficiency. After 16 days (day 0 repre-
sents the morning following the night of conception), the pregnant mice were selected 
from the group by inspection and careful palpation and used as embryo donors. 
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They were killed by cervical dislocation under ether anaesthesia. Uteri were removed 
aseptically, placed in Hanks' Balanced Salt Solution (HESS), and the embryos were 
dissected free from the uterus. The fetal livers were removed by use of a binocular 
dissecting microscope; they were pooled and minced with scissors into small cubes 
of l-2 mm. The cubes were incubated for 10-15 min in a 0.15% trypsin solution at 
37o C in order to disaggregate the tissue. At the end of the incubation, the proteolytic 
action of the trypsin was terminated by the addition of horse serum to a concentration 
of 10%. Preparation of the suspension was completed by passing the cells through 
nylon gauze and 0 2 glass (Jena) filters in sequence. The cells were now monocellularly 
dispersed. When gelatinous clumps were present, they were treated with minute 
amounts of DNAse. The cell concentration was determined after washing in HESS. 
2.2.4 Human fetal liver cell suspensions 
Human fetal livers were obtained from embryos removed by caesarean section. They 
were received from three sources: The Department of Gynaecology of the University 
Hospital in Leiden (heads: Prof. Dr. A. Sikkel and Prof. Dr. E. V. van Hall); the 
Division of Gynaecology of the Elizabeth Gasthuis in Haarlem (heads: Dr. P. E. 
R. Rhemrev and Dr. W. A. A. van Os) and the Fetal Tissue Bank of the Royal 
Marsden Hospital in London (head: Dr. S. D. Lawler). The tissues were transferred 
on ice to Rijswijk and with the exception of the embryonic tissues supplied by the 
Fetal Tissue Bank in London, usually arrived at the laboratory within I h after 
collection. The organs sent from London by air in ice-cooled containers were pro-
cessed at approximately 6 h following the operation. After the arrival of the embryos 
or tissues in the laboratory, the preparation was immediately begun. Human fetal 
livers were treated by the same procedure as employed for mouse fetal liver cell 
suspensions. Human fetuses were staged according to measurements of fetal crown-
rump length and to duration of pregnancy on the basis of menstrual history. Deter-
mination of the age of the tissues sent from London was done at Royal Marsden 
Hospital. 
2.2 .5 Cell counting 
Nucleated cells were counted in a haemocytometer in Turck solution (0.01% crystal 
violet and 1% acetic acid in saline). Determination of eosin (0.2%) resistant cells was 
also routinely performed. 
2.3 Identification of mouse chimaeras 
After an interval of 30 days following irradiation and transplantation, donor and 
recipient cells were identified by cytotoxicity typing of cells from peritoneal washings 
and by haemoglobin electrophoretic typing in red celllysates. 
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2.3.1 Cytotoxicity test 
Cytotoxic specific isoantisera plus complement were employed for determination of 
the genotype of the nucleated cells. In this way, peritoneal cells were serologically 
determined according to the method of Bainer [1963]. The cytotoxicity test was 
performed in Falcon microtitre dishes by exposing a 1 111 of suspension containing 
approximately 5,000 cells to similar volumes of antiserum and chick complement 
(the latter sometimes diluted I :2 or I :4). The cells were then placed in an incubator 
at 37'C for 30 minutes. After incubation, I fll of trypan blue solution (0.12% trypan 
blue and 0.3% EDTA in isotonic saline) was added to stain the cells killed by the 
cytotoxic action. The dishes were left to stand for 10 min at room temperature; 
0.5 fll of buffered formalin (30%) was then added to stop any further cellular alter·· 
ations. Reading of the test was usually done within 5 h following its completion using 
an inverted microscope. Dead cells were identified by their failure to exclude trypan 
blue. 
Preparation of the antisera 
Two antisera were used: a CBA-anti-C57BL and a C57BL-anti-CBA isoantiserum. 
Isoantisera were obtained from mice given 5 i.p. injections of the allogeneic spleen 
homogenate (one-fifth spleen per mouse) at weekly intervals. The mice were bled 
one week after the last injection. The serum was pooled and tested for cytotoxic 
potency (titres varying between I :32-1 :256). 
Collection of peritoneal cells 
Peritoneal cells represented the target for the cytotoxicity test and were obtained by 
i.p. injection of 2 ml HBSS or isotonic saline. After a few minutes of gently massaging 
the abdomen, the fluid with the cells was reaspirated via a needle. Cells from a normal 
CBA and a normal C57BL mouse routinely served as controls. 
2.3.2 Haemoglobin typing 
The haemoglobin type of donor and recipient mice was identified by use of the distinct 
electrophoretic mobility properties of the haemoglobin from CBA and C57BL/KA 
mice [Van Bekkum and De Vries, 1967]. The haemoglobin solution was prepared 
from heparinized blood which was obtained by puncture of the orbital vein at about 
4 weeks after transplantation. Repeated washings of the cells in HBSS and subsequent 
lysis by 30 min treatment with distilled water resulted in the production of a haemo-
globin solution in water. Following this, cellulose acetate electrophoresis was perform-
ed. The haemoglobin bands of normal CBA and C57BL/KA mice served as references. 
2.4 Spleen colony assay (mice) 
The spleen colony assay was performed according to Till and McCulloch [1961]. 
An appropriate number of nucleated haemopoietic cells suspended in HBSS was 
injected into the tail vein of each of a group of mice within 5 h following lethal 
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irradiation. The number of cells in 0.5 ml HBSS was adjusted so that the number of 
colonies arising in the spleen was expected to fall within the range of 5-15. A group 
of 8-12 mice were injected per experiment. Eight to ten days later, the surviving mice 
were sacrificed, the spleen dissected out, fixed in Bouin's solution, and the macro-
scopic colonies on the surface of the spleen counted. The average number of colonies 
per spleen within a certain group of mice was expressed as the number of colony 
forming units (CFU-s) per 105 cells injected. The arithmetic means of groups of 
CFU-s values were compared by the Student-T test. 
Multiplication curves of CFU-s in spleen or femur were made by estimation of the 
number of CFU-s in these tissues at various intervals after injection (by assay in 
secondary recipient mice). The recovery values obtained for CFU-s were expressed 
as a percentage of the injected number at time zero. The slope of CFU increase was 
estimated by regression analysis according to Geigy [1970]. Correlation coefficients 
of the lines all fell in the range of 0.90-0.95; it appeared that omission of the estimates 
of the beginning and the end of the CFU recovery slope did not increase the correla-
tion coefficient. The regression coefficients of the slopes of CFU increase in spleen 
or femur were used as an index of the growth rate by the CFU cell population in 
question. 
2.5 Soft agar cultures 
The agar culture techniques for clonal haemopoietic cell growth are based on the in 
vitro systems first described by Pluznik and Sachs [1965] and Bradley and Metcalf 
[1966]. Our culture method, according to a modification adopted by Dicke et al. 
(1971], consisted of an agar underlayer containing feeder cells and an overlayer with 
haemopoietic cells. The underlayer containing fibroblast feeder cells served to 
provide stimulative activity for the growth of haemopoietic colonies in the overlayer. 
The medium used in all experiments was Eagle's Minimum Essential Medium (MEM) 
as modified by Dulbecco (Dulbecco's Medium). It was made up in double strength 
and diluted with equal volumes of agar. 
2.5.1 Fibroblast feeder cultures 
Two variations of fibroblast feeder culture methods were employed: 1. the original 
thin agar layer system (TALS) [Dicke et al., 1971] in which the fibroblast feeder cells 
were spread as a monolayer over the bottom of the petri dish; and 2. a modified 
TALS in which the fibroblasts were dispersed throughout the underlayer. The latter 
modification of fibroblast-mixed-underlayers was adopted, for reasons of simplicity, 
when it turned out that both variants yielded an equivalent colony forming efficiency. 
Preparation of underlayers for use in the original TALS; A quantity of 0.5 x 106 
fibroblasts in 1 ml medium (Waymouth- 20% calf serum) were pi petted into culture 
dishes (Greiner 35 mm diameter) (day 1). Adherence of the cells to the bottom of the 
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dish took place during one day of growth; on the second day (day 2), the cells were 
irradiated (2000 rad) in order to stop their growth. The preparation of the under-
layer was completed by replacing the fluid medium by a standard agar underlaye£ 
medium. The underlayer was a mixture of Dulbecco's medium, horse serum (20%), 
and freshly boiled agar (final concentration 0.5%). The mixture was adjusted to a 
temperature of 40' C and I ml aliquots were subsequently pi petted over the fibroblast 
layers in the dishes. The medium was left to gel at room temperature for 15~20 min. 
Plates were then stored in the incubator and used after an interval of 24--48 h (day 
3 or 4) for haemopoietic cell-plating. The modified TALS was introduced in our 
laboratory to permit the preparation of the bottom layer within one day. The 
procedure was as follows: a mixed suspension of the agar underlayer medium and 
fibroblasts (pre-irradiated 2000 rad y-Rays) was prepared and I ml was directly 
poured on the plates (day 1). Fibroblasts were incorporated in the underlayer at a 
concentration of 0.5 x 106 cells per mi. After solidifying, the dishes were transferred 
to the incubator. At the time of plating (day 2 or day 3), the overlayer containing 
the haemopoietic target cells was layered over the bottom layer. 
Preparation of over/ayers 
The composition of the upper layer was similar to that of the underlayer, but with a 
final agar concentration of 0.25%. The cell number was adjusted so as to grow 30~ 
150 colonies per plate. After solidification of the upper layer, the plates were returned 
to the incubator for 7~9 days and then scored for colony numbers. The incubation 
atmosphere was maintained at 3T C, humidified, and constantly flushed with 7.5% 
C02 in air. 
Preparation of fibroblast eel/lines 
The preparation and the maintenance of the mouse fibroblast lines were as follows: 
Fibroblasts were derived from embryo trunks. The tissues were minced with scissors 
and the fragments trypsinized in flasks containing a magnetic stirrer for 20 min. The 
supernatant with cells was pipetted off, cennifuged, and the cell pellet of fibroblasts 
was suspended in Waymouth medium-calf serum (20%) and dispensed into 10 em 
plates. These plates contained the stock of the fibroblasts. The lines were kept for 
prolonged time in culture; they were trypsinized once weekly and serially passaged 
for months; the medium was refreshed every fourth day. 
2.5.2 Scoring of colonies 
The fibroblast cultures were scored after 7~9 days of culture. Colonies, defined as cell 
aggregates of more than 50 cells, were counted at 25 x magnification using an inverted 
microscope. Duplicate or triplicate cultures were employed for each estimate. In 
conformity to common use, the population of cells in the haemopoietic suspension 
giving rise to colonies was operationally termed "colony forming units in culture" 
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(CFU-c). The concentration of CFU-c in a suspension was expressed as the number 
per 10 5 nucleated cells plated. 
2.6 Liquid cultures 
Liquid cultures were performed in siliconized round bottomed glass tubes which 
contained l ml of medium and l-2 x 106 bone marrow or fetal liver cells. These 
cultures were employed to investigate the kinetics of HSC in culture. At various 
intervals of incubation, cultures were terminated and the number of CFU-s per 
culture was estimated and expressed as percentage recovery of the number inoculated 
into culture at the beginning (see fig. 2.1). A second endpoint was concerned with a 
follow-up of the cycling status of CFU-s during cultivation. 
liquid cultures 
/
bone m~rrow 
suspens1on 
day 0 
uuu 
1 ml svspension 
in Dulbecco/ 20% HOS 
initial CFU-s content 
day 1 day 2 day 3 
incubation u-u-u-···· 
CFU-s recovery at various time intervals of culture 
{per cent of original CFU-s content) 
Fig. 2.1 Haemopoietic cells in liquid culture. Experimental scheme. 
The culture medium was Eagle's MEM as modified by Dulbecco and supplemented 
with 20% horse serum. Cultures were alternatively supplemented with 0.02-0.05 x 106 
irradiated fibroblasts (2000 rad), 20% fresh fibroblast conditioned medium (FCM), 
or 5% haemolysate. Nonstimulated cultures were set up at the same time and served 
as controls. Fibroblast feeder cells were prepared from established lines as described 
above for soft agar cultures. FCM was obtained as the supernatant medium from 
the fibroblast stock plates (see under preparation of fibroblast cells) and was freshly 
added to cultures. Cultures were performed in glass test tubes closed with aluminium 
foil. All cultures were incubated at 37° C in a humidified incubator which was con-
tinuously flushed with a gas mixture of C02 (7.5%) and air. At the time of harvest, 
cultures were taken from the incubator, the cells were suspended by gentle pipetting, 
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and cell suspensions from at least two tubes were pooled. To assure maximum collec-
tion of the cells, the tubes were rinsed twice with 3 ml of HBSS. Following centrifuga-
tion (2000 rpm during 10 min), the cells were resuspended in an appropriate volume 
of HESS. The cells were used immediately afterwards for in vitro thymidine suicide 
or injection into mice for CFU-s assay. 
2.6.1 Preparation of haemolysate 
A lysate of red blood cells was prepared according to Bradley eta!. [1971, 1972]. In 
short, blood was obtained aseptically in heparinized syringes by abdominal puncture 
of the aorta of W AG/Rij rats or by heart puncture of mice. The blood was centrifuged 
at 2500 rpm and the upper part of the cell pellet including the buffy coat, was removed. 
The remaining red blood cells were washed three times in phosphate buffered saline 
(PBS). Following this, a volume of distilled water equal to the volume of the cell 
pellet was added and mixed with the cells. The cells were allowed to stand for 30 min 
to permit lysis. After a final sedimentation, the supernatant was collected and used 
as haemolysate within 7 days of preparation. Haemolysate was added to a concentra-
tion of 5% to cultures. 
2.6.2 Preparation of mouse serum 
Blood was withdrawn from mice by heart puncture and placed into nonheparinized 
syringes. It was allowed to clot for 2 h; after centrifugation for 10 min at 2500 rpm, 
the serum was collected. 
2.7 In vitro tritiated thymidine suicide technique 
The proliferative status of CFU-s was assessed by the tritiated thymidine killing 
technique as described by Iscove eta!. [1970]. The technique is based on the fact that 
administration of high-specific-activity tritiated thymidine in high doses will kill 
cells that incorporate it (i.e., cells inS-phase at the time of the isotope exposure). 
Samples from each culture under test were exposed to four different incubation 
regimens: 
I. HBSS - no thymidine; 
2. 20 !!Ci/ml of 3 HTdR (methyl-3H-thyrnidine; specific activity 18-22 Ci/mM; Radio-
chemical Center, Amersham, U.K.); 
3. 200 !!Ci/ml of 3HTdR; 
4. 3 HTdR (20 !!Ci/rnl) in the presence of excess unlabelled TdR (100 !lg/ml). 
The inactivation of CFU-s by the isotope in incubations 2 and 3 was determined by 
comparison with the CFU-s values of the controls (I and 4). The four tubes containing 
cells from the same culture were incubated in a water bath for 25 min at 37° C and 
were repeatedly agitated by hand. 
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The labelling was terminated by the addition of I 0 ml of cold ( 4 o C) HBSS containing 
200 mg/1 unlabelled TdR. Two subsequent washings with this solution resulted in at 
least a 300-fold dilution of the isotope. Following centrifugation (2000 rpm for 10 
min), the cells were resuspended in a measured volume of HBSS. The cells were 
used immediately afterwards for injection into irradiated mice (CFU-s assay). 
2.8 Storage of haemopoietic cells 
To permit the transplantation of quantified numbers of stem cells in bone marrow 
and fetal liver cell grafts, cells were preserved until the numbers of stem cells in the 
suspensions had been determined following the completion of the CFU-s assay. 
Cells were frozen in sterile glass ampoules of I, 2, or 5 ml volume. The cell con-
centration was always kept between 10-200 x 106 cells per ml, according to the re-
commendations of Schaefer et a!. [1972a]. The HBSS medium was supplemented 
with the cryoprotective agent dimethylsulphoxide (DMSO) (10%) and with calf 
serum (20%). 
Cells were cooled loC/min in a controlled-rate freezer to -40oc. The rate of 
freezing was controlled by a thermocouple inserted into an identical ampoule which 
was placed in the freezing chamber. When the cooling temperature had fallen to 
-40° C, the ampoules were stored in a liquid nitrogen container. Upon removal 
from the liquid nitrogen at the end of the preservation period, the glass ampoules 
were rapidly thawed in a 40° C water bath with gentle agitation. The ampoules were 
opened and the cells transferred to tubes and diluted tenfold with HBSS, so that a 
final DMSO concentration of 1% was reached. This dilution was performed at an 
ultraslow stepwise rate, also according to the procedure of Schaefer et a!. [1972a]. 
The cells were washed in HBSS and finally cell counts were performed. Application of 
this freezing technique yielded complete recovery of stem cell viability as checked by 
CFU-s or CFU-c assays after thawing. 
2.9 Discontinuous albumin gradient centrifugation 
This cell separation method, as described by Dicke eta!. [1969], was used to prepare 
purified stem cell fractions and to study the physical characteristics of adult and 
embryonic haemopoietic cells. 
The cells were suspended in a 17% bovine serum albumin (BSA) solution and pi petted 
(as the lightest layer) on top of a gradient consisting of layers with BSA concentra-
tions increasing to the bottom of the tube (layers of 19%, 21%, 23% and sometimes 
25% BSA solutions). The tube was centrifuged for 30 min at l0°C in an International 
model PR-2 centrifuge at 2000 rpm (1000 gat the bottom of the tube). After centrifuga-
tion, distinct cell layers were visible at the density interfaces in the gradient. Follow-
ing this, each fraction was collected with a pipette, washed in HBSS, and the cell 
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concentration determined in a haemocytometer using TUrck solution. The cell frac-
tion between 17% and 19% BSA was designated as fraction I; the one between 19% 
and 21% BSA, fraction 2, and so on. Depending on the numbers of cells to be 
fractionated, a tube was chosen with a diameter of either 0.8 or 1.6 em, allowing a 
fractionation of cell numbers up to 100-130 x 106 and 900 x 106 cells per tube, 
respectively. 
To achieve optimal efficiency in the separation of HSC, adjusted osmolarity of the 
albumin solution was utilized for each cell suspension. It is known that the osmolarity, 
representing one of the major physical parameters which influences the distribution 
of the cells in the gradient, is one of the factors which determines the degree of 
purification of stem cells [Dicke, 1970]. It appeared that the optimal osmolarity in 
the gradient for stem cell separation of fetal liver was different from that for bone 
marrow fractionation: for mouse fetal liver, 320 mOsmjl; and, for mouse bone 
marrow, 310 mOsm/1. To obtain those differing osmolarities, albumin fraction V 
powder (Sigma) was dissolved to a concentration of 35% in tris buffer (pH 7.2) of 
differing osmolarities, namely 260 mOsm/1 and 250 mOsmjl respectively (pH 5.3). 
By diluting the 35% stock solution of the required osmolarity with increasing volumes 
of sodium chloride-sodium phosphate buffer (N-P buffer; 0.154 m NaC!; 0.01 m Na 
phosphate buffer; pH 7.2), two"percent-step albumin solutions (25% to 17%) were 
prepared. The final albumin concentration was checked by refractometry, as previous-
ly described by Dicke [1970]. Fraction I corresponded to a specific density of 
1.0525 ±0.0012 gjcm', 
fraction 2- 1.0575 ±0.001 gjcm3 
fraction 3- 1.0637 ±0.0008 gjcm3 
fraction 4- 1.0682 ±0.001 g/cm3 
fraction 5 - 1.0734 ± 0.0012 gjcm3 • 
2.10 In vitro stimulation of lymphocytic cells by mitogens 
Various haemopoietic cell suspensions or their density subpopulations were tested 
for their content of lymphocytic cells responding to phytohaemagglutinin (PHA), 
E.Coli endotoxin (LPS, lipopolysaccharide), or concanavalin A (Con A). By mea-
surement of the stimulation of DNA synthesis, cells were distinguished according to 
the general classification of thymus-derived (T) and bursa-equivalent-derived (B) 
cells. Cells capable of a mitotic response to PHA and Con A were considered to 
represent T cells [Janossy and Greaves, 1971; Stobo, 1972; Andersson et al., 1972; 
Shortman et a!., 1973; Stobo and Paul, 1973]. In contrast, E. Coli endotoxin was 
considered a B cell mitogen according to its reported properties of stimulating B 
target cells exclusively [Gery et al., 1972; Andersson et a!., 1972]. Cultures were 
essentially carried out according to the procedure described by Dicke [Dicke et al., 
1969; Dicke, 1970]. 
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2.10.1 Culture conditions 
Hanks' Eagles Minimal Essential Medium (HE-MEM) supplemented with 20% heat 
inactivated fetal calf serum (Flow) plus antibiotics (100 units penicillin/ml and 100 11g 
streptomycin/ml) was used as the culture medium throughout. For each type of 
haernopoietic cell suspension (e.g. mouse spleen, mouse bone marrow), optimal 
culture conditions (mitogen dosages; culture time) as defined by maximal DNA 
synthesis, were established. They are summarized in table 2.1. In general, a fixed 
Table 2.1 Culture conditions for mitogenic stimulation 
haemopoietic nr. of volume 
dosage of mitogen amount of isotope 
total added 
cell cells per PHA Con A LPS cultivation 
suspension X 106 culture ~I ~g ~g time 'H-TdR HC-TdR 
mouse 
bone marrow 1 1 ml 10 30 80 48 h 0.2 tLCi 1 n.d. 
spleen 3 1 ml 10 7 50 48 h 0.2 [LCi 1 0.04 [.LCi 3 
fetal liver 1 ml 10 15 100 48 h 0.2 [J.Ci 1 0.04 !LCi 3 
human 
fetal liver 0.2 0.5 m1 10 n.d. n.d. 96 h 0.25 ~Ci' 0.04 fLCi 3 
fetal thymus 0.2 0.5m1 10 n.d. n.d. 96 h 0.25 ~Ci' 0.04 [J.Ci 3 
The labelling period was inserted for the last 24 h of the total incubation period. 
PHA- phytohaemagglutinin; Con A- concanavalin A; LPS -lipopolysaccharide E. Coli 
1 spec. act. 55 mCi/mMol 
2 spec. act. 110 mCi/mMol 
a spec. act. 13.5 mCi/mMol 
n.d. - not done 
number of cells was suspended in sterile glass or disposable plastic culture tubes with 
a round bottom. Six tubes were used per estimate. Three tubes served as test cultures 
and contained the appropriate concentration of mitogen: the other three, free of the 
mitogen, were run as control cultures. The mouse cultures were incubated in tightly 
closed plastic tubes at 3T C iu air. The human cultures were performed in glass 
tubes with tin foil closures, allowing maximal gas exchange; they were placed in a 
humidified incubator at 37o C with a gas mixture of 5% C02 in air. At optimal 
intervals of incubation (time of maximal DNA synthesis), labelled thymidine was 
added for a second incubation period of 24 h. In the early experiments 3HTdR was 
used as the isotope; in later tests, cultures were routinely incubated with 14CTdR. 
At the end of the 24 h labelling time, the cultures were terminated by placing the 
tubes in an ice bath. Cells were then treated for estimation of thymidine incorporation 
into DNA. 
2.10.2 Processing of cultures 
Cells from the 3 HTdR labelled cultures were washed in 1 ml of cold isotonic saline 
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to remove nonspecific radioactivity. Following centrifugation (2000 rpm for 10 min), 
the supernatant was discarded and the cells were recovered in 2-5 ml of acetic acid 
(3% in distilled water) in order that lysis of the erythrocytes occurred. Then the cells 
were centrifuged again. The cell pellet was resuspended in 1 drop of serum (as carrier 
protein) and 2-5 ml of cold 6.7% TCA (trichloroacetic acid). The tubes were left for 
at least one hour at 4" C in order to allow complete precipitation. The precipitates 
were washed twice with 5 ml of 5% TCA and dried for 2-3 h at 37' C (plastic 
tubes) or 4 hat SO'C (glass tubes). Following this, 0.25 ml of Hyamine was added 
and the tubes were left overnight at room temperature. The lysed cells were transferred 
to the counting vials (Packard Instruments, Brussels, Belgium), containing 15 ml of 
scintillation fluid (4 g PPO and 50 mg PO POP (Merck)) in 1 ltr of toluene (Lamers 
and Indemans, 's-Hertogenbosch, Holland). The tubes were rinsed with an additional 
0.25 ml of Hyamine. 
The thymidine uptake in cultures exposed to the 14C isotope was determined by 
using a filter system: 2 ml of cooled thymidine solution (0.5 mg of unlabelled 
thymidine per ml in distilled water) was added at the end of cultivation. After a few 
minutes, the cells were sucked into filters of a manyfold filter system (glass fibre 
filters; Whatman GA/ A; 01 em). The filters were washed once with unlabelled 
thymidine, and then twice with isotonic saline. After drying at 50-60" C, filters were 
placed into the counting vials and 5 ml of scintillation fluid was added. The scintilla-
tion of the vials was counted in a Mark II Nuclear Chicago Liquid Scintillation 
Counter. 
2.10.3 Expression of responses 
Each value reported in the text generally represents the arithmetic mean of triplicate 
cultures. The mean counts per minute (cpm) were converted into disintegrations per 
minute after appropriate corrections for quenching (with an external standard). The 
value for the background estimates of cultures without mitogen were subtracted 
from the dpm value for cultures with mitogen. The difference (Ll) in dpm was used 
as the net response of the cells to mitogenic stimulation. 
2.11 Morphology 
2.11.1 Cell suspensions 
A modification of the precipitation method for staining cells as described by Sayk 
[1960] was used; this was done in order to also adapt the method for the staining of 
fractionated cell suspensions [Van Bekkum et al., 1971]; 105 cells suspended in 20 [!1 
of a buffer solution were mixed with four drops of isotonic saline (supplemented 
with 20% fetal calf serum) and sedimented onto glass slides for 25 min at room 
temperature. The cells were fixed in 100% methanol for 3 min. Then the slides were 
exposed to May Grunwald stain (diluted 1: 1 with phosphate citric acid buffer of 
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pH 5.6) for I min and to Giemsa solution (diluted I: 17 with the same buffer) for 
15 min. The subsequent immersion of the slides in the pure buffer for I min and in 
glass-distilled water for another min completed the staining procedure. After drying 
in air, cover glasses were placed on the slides and sealed with Entellan balsam (Merck). 
2.11.2 Organs and tissues 
Organs to be examined were prepared either as imprint or sectioned preparations. 
Imprint preparations were treated according to the modified Sayk method described 
above for cell suspensions. Tissues were fixed in 4% buffered formaldehyde and 
routinely precessed for histopathology at the Pathology Department of the Institute 
for Experimental Gerontology TNO. A haematoxylin-phloxin-safran stain was used. 
CHAPTER 3 
A CELLULAR CHARACTERIZATION OF THE FETAL LIVER 
1-lAEMOPOIETIC CELL TRANSPLANT 
The stern cell is held to play a central role in the outcome of haernopoictic cell trans-
plantation. Thus, any of the observed differences between the effects of fetal liver cell 
and bone marrow grafts may be determined by differences in the properties of fetal 
and adult stem cells. In addition to these qualitative aspects, it should be taken into 
account that differences in the number of stem cells in the transplants may have a 
significant impact on the fate of the graft. 
The investigations described in this chapter were intended to clarify the situation 
with respect to stem cell numbers in the fetallivez cell graft. They mainly dealt with 
an enumeration of the 1-lSC population. In view of the role of lymphoid cells in GvH 
Fig. 3.1 Section of 16-day fetal liver tissue: stained with haematoxylin-eosin, x 640. 
Arrows indicate the following cells: 
h =hepatocyte e =erythroblast 
k = Kupffer cell me= megakaryocyte 
n =normoblast m =metamyelocyte 
Note the abundance of cells of the erythroid series with the dark nuclei. 
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disease, particular attention was also given to the quantitative estimation of these 
cells in the transplants. 
Additional studies were initiated which were aimed at clarifying the question as to 
whether adult and fetal HSC exhibit different physical properties. Advantage was 
taken of the discontinuous albumin gradient fractionation method for exploring 
density differences between fetal and adult HSC. 
3.1 Morphological examination ofthefetalliver 
Light microscopic examination of the embryonic liver of the mouse reveals little of 
the adult liver composition. The parenchymatous liver structure does not develop 
until about 3 days before birth and before that time its histological appearance is char-
acteristic of a full blown haemopoietic tissue with some hepatocytes interdispersed 
(fig. 3.1 and 3.2). Cross sections and imprint preparations confirm the predominant 
erythropoietic nature of the organ [Silini et a!., 1967] with red cells present at all 
A_· iJII 
Fig. 3.2 Imprint preparation of 16-day fetal liver cells: stained with May GrUnwald and Giemsa, 
x525. 
Arrows indicate the following cells: 
h =hepatocyte e =erythroblast 
n =normoblast g =granulocyte 
Note that two granulocytes are present in this field. 
STEM CELL/PROGENITOR CELL COMPARTMENT 43 
Table 3.1 Differential morphology of fetal liver and bone marrow cell suspensions 
fetal liver bone marrow 
Cell categories % 
myeloblast 4.5 
promyelocyte 0.4 
metamyelocyte 0.6 
band neutrophil 5.2 
neutrophil 0.2 
eosinophil 
total myeloid cells 10.8 
erythroblast 2.8 
normoblast 86.4 
total erythroid cells 89.2 
lymphoid 
monocyte 
megakaryocyte 
Bone marrow was obtained from 8 week old mice, fetal liver from 16 day embryos. 
500 cells were counted in Sayk preparations of both cell suspensions. 
% 
10.8 
1.8 
0.2 
31.4 
7.6 
4.4 
56.2 
2.4 
36.2 
38.6 
4.8 
0.2 
stages of differentiation. Megakaryocytes and myeloblasts are rare. Hepatocytes are 
identified as individual cells or as small aggregates among the haemopoietic cell mass. 
Lymphoid cells could not be distinguished in a cytological survey of the various 
haemopoietic cells in fetal liver cell suspensions (table 3.1). Notably, the relative 
number of cells belonging to the myeloid series (10.3%) was as much as 5 times 
lower than that in adult bone marrow (56.2%), whereas the fetal liver erythroid cell 
numbers outnumbered those of the bone marrow by about 2 times. In other words, 
the ratio of erythroid-granuloid cells in fetal liver (8.3) greatly exceeded that of 0.7 
observed in the marrow. 
3.2 Stem celljprogenitor cell compartment 
Comparative CFU-s assays [Till and McCulloch, 1961] were conducted in order to 
determine the number of stem cells in fetal liver and bone marrow. Table 3.2 shows 
that the CFU-s in fetal liver are present at a low frequency. The CFU-s ratio in the 
16 day embryonic organ was found to have an average value of 5.5 CFU-s per 105 
nucleated cells, which is 5 times less compared to bone marrow. This number of CFU-s 
seems to increase during the course of ontogenetic development (table 3.3). 
The CFU-s values were utilized for the determination of the absolute number of 
stem cells in the liver cell suspensions by taking into account the spleen colony 
forming efficiency of the infused CFC i.e., the percentage of all infused CFC that 
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Table 3.2 CFU-s concentration in fetal liver and bone marrow cells 
nr. of exp. 
fetal liver (16 day) 85 
bone marrow (adult) 8 weeks 26 
S.E.: standard error 
nr. of CFU-s per 105 nucleated cells 
range 
1.8-15.7 
7.5-44 
mean±S.E. 
5.5 ±0.3 
27.4± 1.6 
fetal liver 
ratio 
bone marrow 
0.20 
will form measurable spleen colonies. These so-called efficiency factors were obtained 
from the CFU growth curve in the spleen. According to the concept of Lahiri et al. 
[1970] they were represented by the extrapolation points of the CFU growth curves 
in the spleen, being the fractions of injected CFU that initiate exponential growth 
and give rise to visible colonies after 7-9 days (see par. 3.6 Addendum). From the 
experiments carried out to determine the slope of CFU proliferation, it became evident 
that the extrapolation numbers of fetal liver and marrow CFU multiplication (fig. 
3.3) were clearly different, with average values of 2.2% and 4.1%, respectively. In 
other words, on the assumption that the extrapolation values closely represent the true 
CFU /CFC ratio, it appears that, of each 100 i. v. administered CFC, the proportion 
of bone marrow CFC that produces detectable spleen nodules, exceeds that of fetal 
liver CFC by a factor of 1.9 (4.1/2.2). By correction for their individual CFUJCFC 
efficiency indices, the total stem cell populations in the fetal liver and bone marrow 
tissues were calculated to equal values of 250 CFC and 668 CFC per I 05 nucleated 
cells, respectively; this represents a difference of a factor of 2.8 (table 3.4). 
Table 3.3 Comparative numbers of CFU-s in haemopoietic tissue at various stages of development 
13-15 day fetal liver 
18 day fetal liver 
8 week adult bone marrow 
nr. of CFU-s per 105 cells 
(mean±S.E.) 
5.3±0.5-----
(14) 
11.1=2.2~===== 
(3) 
27.4± 1.6 _____ _ 
(26) 
The figures in parentheses represent the number of experiments 
statistical 
significance 
of difference 
between groups 
----· >P<0.01 
___ __,_p < 0.001 
STEM CELL/PROGENITOR CELL COMPARTMENT 
Table 3.4 Haemopoietic stem cell numbers in fetal liver and bone marrow cell suspensions 
spleen colony 
forming 
45 
nr. of CFU~s 
per 105 cells 
(mean±S.E.) 
efficiency factor* (f) 
% 
correction for 
efficiency factor nr. of CFC 
per 105 cells 
fetal liver 
(16 day embryo) 5.5±0.3 (85) 2.2 
f.l.: b.m. ratio 1: 5 1: 1.9 
bone marrow 
(8 weeks) 27.4= 1.6 (26) 4.1 
* CFU/CFC ratio(?--;;) 
The figures in parentheses represent the number of experiments 
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Fig. 3.3 Increase in fetal liver and bone marrow CPU in the spleen following injection into irradiated 
syngeneic recipients. 
Each point represents the mean recovery of CFU (±S.E.) from at least 5 separate experiments. 
The recovery values of CFU in the spleen at various intervals after injection were determined by 
spleen colony assay in secondary hosts. 
Extrapolation points of slopes at time zero: 2.2% (fetal liver) and 4.1?--;; (bone marrow). 
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Table 3.5 CFU-c in fetal liver and bone marrow cell suspensions 
fetal liver 
bone marrow 
nr. of CFU-c per 105 cells 
(mean±S.E.) 
25.8± 8.3 (8) 
120.9±22.7 (5) 
fetal liver 
,-~~~-ratio 
bone marrow 
I :4.7 
The figures in parentheses refer to the number of experiments. 
Employing the in vitro colony assay, it was found that the relative number of 
another progenitor cell population, the granulocyte-macrophage precursors (CFU-c), 
is also decreased: 26 CFU-c/105 cells in fetal liver versus an average concentration of 
121 CFU-c in bone marrow (table 3.5). In this case, the CFC-c cannot be estimated 
because plating efficiency is not known. The ratio, however, is very close to that of 
the total number of myeloid cells counted in the cell suspensions (table 3.1). 
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3.3 Discontinuous albumin density gradient centrifugation of fetal 
liver cells 
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Purified stem cell grafts were employed in the transplantation experiments (to be 
reported in chapters 4 and 6) in order to assess the role of the non-stem cells in the 
process of grafting. The technique of discontinuous albumin density gradient centri-
fugation was applied to separate the stem cells and progenitor cells from the large 
majority of contaminating cells and to obtain purified stem cell grafts. The distribu-
tion pattern of the stem cells (CFU-s) following fractionation is illustrated in fig. 3.4. 
It appears that the cell class collected in fraction 2 fulfilled the requirement of a 
purified stem cell suspension; in this fraction, about 40% of the original number of 
stem cells were recovered in an average concentration of 36 CFU-s per 105 cells. 
This represents an enrichment index of 8.4 x in comparison to the unfractionated 
suspension (table 3.6). Conversely, in the higher density fractions, the stem cells were 
diluted to a low concentration due to the accumulation of other cells. It is noteworthy 
that the CFU-s distribution closely parallels the CFU-c density profile. 
Table 3.6 CFURs and CFURc in different density fractions of 16-day old mouse fetal liver 
CFU-s CFU-c 
nr. of concentration % recovery of concentration % recovery of 
CFU-s per 105 index* of fractionated index* of fractionated 
cells CFU-s CFU-s CFU-c CFU-c 
mean ±S.E. mean ±S.E. mean ±S.E. mean ±S.E. mean ±S.E. 
unfractioned 
fetal liver 4.4± 0.2 1 1 
fraction 1 36.7± 10.2 9 ±1.8 4.9±0.8 5 ±1.3 2.7±0.6 
fraction 2 35.6± 4.8 8.7 ±1.1 43.7±4.4 6.7 ±1.2 36.0±6.3 
fraction 3 7.2± 1 2.4 ±0.5 21.0±4.9 1.1 ±0.3 16.8±3.9 
fraction 4 0.3± 0.1 0.07±0.01 2.9±0.3 0.06±0.01 1.9±0.5 
* Concentration index represents the ratio of CFU-s (or CFURc) per 105 cells in the fraction and 
CFURs (or CFU-c) per 105 cells in the original suspension. 
3.4 The presence of mitogen reactive lymphocytic cells 
Because of their relationship to Gv H disease, special attention was paid to the 
presence of mature lymphocytes in fetal liver cell grafts. U nfractionated fetal liver 
cells did not show positive mitogenic responses upon in vitro stimulation with the T 
cell mitogens concanavelin A and phytohaemagglutinin and the B cell activator 
lipopolysaccharide (table 3.7). The ratio for DNA synthesis in stimulated cells and 
nonstimulated cells (control) did not exceed a value of 1.3. This contrasted with the 
high stimulation index of spleen cell suspensions, which exceeded the control incuba-
tion by a factor of 7-20 x for the three mitogens. Fetal liver cell responsiveness was 
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Table 3.7 In vitro mitogen reactivity of 16-day old mouse fetal liver cells and fetal liver cell density 
fractions 
control Con A PHA LPS 
fetal liver (total) 9746±700 11170±1546 12761 ±201 3587 ±506 
7066±397 5279±184 7211±757 5568±81 
fr. 1 2642 1445 
5828 6495 
fr. 2 6249±585 4454±273 5503 ±3 5083±120 
15145±1896 17646±1544 18024± 1354 13110±1090 
fr. 3 6112±174 6542±491 7196±240 2948±9 
12597 ±254 13875±889 15095±940 5694±1019 
fr. 4 6242±361 4708±301 5294±522 2572±209 
1679±185 1120±90 1373±115 1660± 127 
bone marrow 2174±240 2515 ±219 3363±475 1607 ±83 
6680±140 12216±886 6707 ± 719 4531 ±2747 
spleen 1112±78 11284±909 16476±579 7517±833 
2217 ::!:::54 38167±5387 45958i,3081 24287 ±1984 
The figures represent mean dpm ±S.D. 
Results of 2 experiments; bone marrow and spleen cells were used for comparison. 
more comparable to that of bone marrow. LPS activity of bone marrow cells m 
culture was also negative and the responses to Con A and PHA were only slightly 
positive (i.e. maximum stimulation index assessed: 1.8 x ). Assaying for in vitro 
mitogen responsiveness in fetal liver by incubating the separate density cell fractions 
with the mitogen also did not reveal clearly positive activity which indicated the 
absence of subpopulations ofT or B lymphocytes in the fetal liver tissue (table 3. 7). 
3.5 Discussion 
A low content of CFU-s was demonstrated in fetal liver tissue, which is in accord 
with observations of other investigators (table 3.8). A major difficulty in deriving a 
realistic estimation of the absolute stem cell number from CFU-s values in haemo-
poietic tissue is the approximation of the fraction, f, of the stem cells which will 
lodge in the spleen (seeding efficiency) and actually form colonies. 
On the basis of the considerations outlined at the end of this chapter (par. 3.6 
Addendum), we have used the extrapolation of the slope of multiplication of CFU in 
the spleen of the irradiated animal to estimate the f factor [Lahiri et al., 1970]. It was 
found tbat the spleen colony forming efficiency of fetal liver CFC is on the average 
1.9 x lower than that of bone marrow CFC. 
Inspection of the CFU population recovery curves published by other investigators 
likewise gives support to the assumption of a relatively low colony forming efficiency 
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Table 3.8 CFU~s numbers in mouse fetal liver cell suspensions (as reported in the literature) 
compared to 
adult bone 
fetal liver marrow 
nr. of CFU~s nr. of CFU-s 
references strain fetal age per 105 cells per 105 cells 
Till and McCulloch, 1961 
McCulloch and Till, 1963 C57BL near-term 5.5-6.3 8-15.8 
Micklem, 1966 16 d. 2.2-3.7 
Silini et al., 1967 
Silini et al., 1968 (C3H X C57BL)F, 12-17 d. 13.2-7.2 23-46 
17-19 d. 7.2-9.0 
adult liver 0.04 
Swiss 12-17 d. 1.6-3.6 20-40 
17-19 d. 3.6-4.2 
adult liver 2.4 
Duplan, 1968 strain XVII 13-18 d. 6-9 43.5 
Vogel et al., 1970 C3H 13 d. 6.1±1.9 
16 d. 3.8±1.2 
new born 3.4±1.3 
Niewisch et aL, 1970 C57BL 12 d. 9 
13-15 d. 3.5-2 
16-19 d. 2-4 
C3H 12 d. 6 
13-15 d. 5-2 
16-19 d. 5-11 
Schofield, 1970 (C3HxAKR)F, 17-18 d. 8.9±0.5 21.8±1.2 
LOwenberg, 1974 present study C57BL 13-15 d. 5.3±0.5 27.4±1.6 
16 d. 5.5±0.3 
18 d. 11.1±2.2 
in the spleen, although no exact data were documented [Schofield, 1970; Vogel et al., 
1970]. The 2-3 times reduced Siminovitch factor for fetal liver CFU also corresponds 
with the lower efficiency of fetal colony forming cells in the formation of spleen 
colonies [Moore et al., 1970]. This factor representing the recovery of CFU-s at a 
period of 2 h following infusion is considered to be an index of the efficacy of initial 
seeding in the spleen [Siminovitch et al., 1963]. In other words, of the two processes 
- the initial lodging in the spleen and the subsequent loss during the next day (fig. 
3.6) - the first one in particular seems to be responsible for the decreased efficiency 
in colony formation by fetal liver cells. The spleen colony forming efficiency of fetal 
liver CFC reported by Matioli et al., [1968] was obtained in quite a different manner. 
Their method is based on the concept that the low efficiency of CFC to grow into 
countable colonies in the spleen is mainly dependent on the dispersion of the cells 
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throughout the body following i.v. injection (dilution). It compares the yield of spleen 
colonies in the i.v. spleen colony assay with that in a local assay (direct injection into 
the spleen). The so-called dilution factor thus obtained was 3.9% for fetal liver CFC 
[Vogel et al., 1970] as well as for bone marrow CFC [Matioli et al., 1968]. This is 
somewhat different from our efficiency figures of 2.2% and 4.1 %, respectively. In 
particular, the equivalence of the dilution factor for fetal liver and bone marrow CFC 
is surprising, in view of the significantly different seeding factors for both CFU 
populations [Moore et al., 1970] and the marked differences in CFU recovery in the 
spleen at 24 h. The validity of this technique has been questioned in that errors may 
occur due to loss of cells into the circulation [Hendry, 1971] and that some of the 
colonies formed at the site of injection do not arise from one stem cell but from the 
cumulative contributions of a number of cellular elements not necessarily being HSC 
[Till and McCulloch, 1972]. 
The CFU-s assay indicated a 5 fold difference between fetal liver and bone marrow 
cells. By adjustment for the CFUJCFC index, the stem cell number (CFC) in a 16-day 
mouse fetal liver has been calculated at 1/2.8 or 36% of the proportion of stem cells 
in the bone marrow tissue (table 3.4). It is evident that the lower content of stem 
cells should be regarded as an important factor in the evaluation of the takeability 
of fetal liver cell grafts (chapter 4). The low spleen colony forming efficiency of fetal 
liver CFC results in the CFU -s values overrating the underpopulation of stem cells in 
fetal liver. 
The in vitro colony assay was used to assess the size of another population of cells 
(CFU-c) belonging to the progenitor cell compartment of the liver. The concentration 
of CFU-c per 105 fetal liver nucleated cells was found to be about 1/5 of that of bone 
marrow (table 3.5). The 5 x decreased values of CFU-c in the fetal liver is consistent 
with the approximately 5 x reduction in mature granulocytic cells (table 3.1) and 
suggests that one has to trace the granulopoietic scarcity backwards to before the 
stage of the CFU-c to a very primitive portion along the differentiation pathway of 
this cell lineage. 
The normal granulopoiesis by fetal liver cells upon transfer to an adult environ-
ment [Silini et al., 1967; Moore et al., 1970; Vogel et al., 1970] strongly suggests that 
the poor myeloid representation in fetal liver is due to local environmental conditions 
which either exert a selectively inhibitive influence on granulopoiesis or, conversely, 
a preferential influence on another line of differentiation (erythropoiesis) at the 
expense of myeloid proliferation. 
Purified fetal liver stem cell grafts were obtained by the elimination of the admixed 
cells using a discontinuous density gradient centrifugation. Fraction 2 had a CFU-s 
ratio of as many as 36 CFU-s per 105 cells which correlates with a mean CFU-s 
concentration factor of 8.7 (table 3.6). Suppose that, in the projected transplantation 
studies, X number of stem cells is to be grafted which is mixed in with 100 other 
cells in the unfractionated fetal liver cell suspension, then the stem cell concentrate-
METHODOLOGY OF SPLEEN COLONY FORMING EFFICIENCY 51 
grafts are minus 88 of the contiguous cells. This purification seems to permit a 
discrimination between the impact of the more mature embryonic haemopoietic 
cells and the stem- and progenitor cells on the events observed after transplantation. 
From the CFU-s and the CFU-c density distribution values, it appears that the 
embryonic precursors are of lighter density than are the corresponding cell populations 
in the adult haemopoietic tissue which routinely appeared in fraction 3 [Dicke, 1970; 
Dicke eta!., 1969, 1973a}. This physical difference between embryonic and adult stem 
cells is in accordance with investigations of Moore eta!. [1970; Metcalf and Moore, 
1971} which indicated a sequential appearance of higher density subpopulations of 
CFU-s and CFU-c during development. 
As to the incidence of lymphocytes in fetal liver, no mitogen reactivity was found 
in the cell suspension. If low-grade activity was present, it was not such that it could 
be measured in any of the fractions of the gradient. As phytohaemagglutinin (PHA) 
and concanavalin A (Con A) are considered to be selective T cell stimulators 
[Janossy and Greaves, 1971; Andersson eta!., 1971; Stobo, 1972; Shortman eta!., 
1973; Stobo and Paul, 1973; Byrd et a!., 1973} and the mitogen Escherichia coli 
endotoxin (LPS) a mouse B cell activator [Andersson eta!., 1971, 1972; Gery eta!., 
1972}, the absence oflymphocytes (BandT) in the histological preparations is thereby 
affirmed. The in vitro responsiveness of fetal liver cells resembles that of bone marrow 
to a large extent and indicates a low number of immunocompetent cells in the organ. 
The question is open as to whether this absence of lymphocytes is specific to the site 
or to the relatively immature state of embryogenesis. The negative T cell reactivity 
is compatible with the lack of mature GvH reactive cells [Tyan and Cole, 1963; 
Bortin and Saltzstein, 1968; Umiel eta!., 1968} and of MLC reactive cells in fetal 
liver [Tyan eta!., 1973}. Thus the cells which bring about immunological reconstitu-
tion [Doria eta!., 1962; Tyan eta!., 1967; Tyan and Herzenberg, 1968a, 1968b; 
Stutman and Good, 1971} and GvH disease following transplantation are most likely 
to arise from progenitor cells in the fetal liver cell graft. In this respect, it seems that 
the mouse liver tissue diverges from the human embryonic liver which may be strongly 
PHA positive at or beyond a gestational time of 16 weeks (table 7.1). 
3.6 Addendum 
Methodology of estimation of spleen colony forming efficiency 
There are several factors which determine the quantification of stem cells in a cell 
suspension by the spleen colony assay; e.g., possible selective losses during the 
preparation of the cell suspension, the proportion of the cells which localize in the 
spleen, and the capacity or failure of these stem cells, for one reason or another 
(migration, extinction, cell death) to grow into visible colonies in due time [Till and 
McCulloch, 1972} (fig. 3.5). Loss during preparation must be left out of consideration, 
since this cannot be estimated. Only about 20% of i. v. injected CFU reaches the 
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Fig. 3.5 Factors determining the quantitation of stem cells in a cell suspension by the spleen colony 
assay. Schematic representation. 
The number of HSC initially seeding in the spleen is approximated by the Siminovitch factor; the 
number that actually produce colonies, by the Lahiri factor. Effects of death, extinction (differentia-
tion), and migration of HSC leading to a modification of the fraction that gives rise to colonies are 
difficult to separately assess. 
spleen. This can be determined by extracting the cells from the spleen at 2 h after the 
injection into the host and assaying for the number of recoverable CFU by spleen 
colony estimation in secondary recipients. By so doing, it was found that, of the 
CFU which go to the spleen during the first 2 h [Siminovitch factor], an important 
fraction disappears again during the subsequent 24 h [Lahiri et al., 1970] (fig. 3.6). 
Following this early drop in CFU in the spleen, an exponential increase of CFU 
occurs [Lahiri and Van Putten, 1969]. Therefore, the CFU recovery curve can be 
characterized by a decline of CFU during the first 24 hand an exponential rise there-
after (fig. 3.6). The latter is usually regarded as a function of exponential multipli-
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Fig. 3.6 Curve of per cent recovery of bone marrow CPU in the spleen at varying time intervals after 
injection into irradiated hosts (adapted from Lahiri et al., 1969, 1970). 
The two sections of the curve are indicated: the initial drop in CPU in the spleen and the subsequent 
exponential increase. Arrows indicate the Siminovitch factor which is the % recovery of injected 
CPU at 2 h after injection [Siminovitch et al., 1963] and the Lahiri factor which represents the time-
zero-extrapolation point of the exponential slope of CPU [Lahiri et al., 1970]. The curve of CPU 
recovery in the spleen of the 3-day-preirradiated animal (without early dip) is plotted in the same 
figure. 
cation of CFU, on the assumption that the efficiency in a secondary host does not 
substantially differ from that in a primary recipient. 
The number of injected CFU that seed in the spleen and initiate exponential 
growth probably represent those CFU that will finally form colonies [Lahiri et al., 
1970]. Therefore, the starting point of the exponential component of the CFU 
recovery curve must be determined to allow enumeration of the portion of injected 
CFU that give rise to colonies. 
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However, there is a serious obstacle in directly establishing this starting point of 
exponential proliferation of CFU in the spleen. This is due to the overlapping of 
the early decrease in CFU with the beginning of the rise in CFU. In other words, 
the decline in CFU in the spleen in the first hours after injection probably masks an 
early proliferation of other CFU [Lahiri et a!., 1970]. 
It is a matter of debate as to whether the appearance of the initial dip in recovered 
CFU should be attributed to an imbalance in the proliferation possibilities of dif-
ferentiation and self-reproduction of CFU with differentiation being favoured 
[Vogel eta!., 1968; Lahiri eta!., 1970] or to expulsion ofCFU from the spleen due to 
a post-irradiation shrinking of the organ [Testa eta!., 1972; Lord and Hendry, 1973]. 
The fact that the dip is less when CFU which were rapidly self-replicating in the 
donor [Labiri et al., 1970), are injected seems to offer support for the first possibility. 
The first possibility was also favoured by experiments in mice of wwv genotype 
which contain haemopoietic cells lacking the capacity to give rise to macroscopic 
spleen colonies and which can be used as recipients for spleen colony assay without 
irradiation [Till and McCulloch, 1972]. It was shown that the injection of haemo-
poietic cells of normal littermates ( + j +) into unirradiated WW' mice and geno-
typically normal mice lead to the production of the same numbers of spleen colonies. 
Whether these data may be regarded as valid evidence against the loss of CFU due 
to splenic shrinkage from irradiation is questionable because they were obtained 
under pathological conditions and they may not similarly apply to the process of 
spleen colony formation in normal mice. Certainly, the greater amount of experi-
mental data is in favour of the idea of shrinkage of the spleen causing the early dis-
appearance of CFU from the spleen. Such evidence has come from detailed studies 
in which correlations were made between the spleen size of the host and CFU recovery 
values and direct CFU-s assays [Lord and Hendry, 1973]. Furthermore, Lahiri et al. 
[1970] found that, in the spleens of mice which were irradiated 3 days prior to the 
injection of haemopoietic cells, the increase in recovery values for CPU did not coin-
cide with an initial decrease and that the exponential growth of CFU commenced 
as early as 2 h after injection (fig. 3.6). The absence of the dip in the 3-day-preirradi-
ated mice was apparently not the result of an earlier predominance of selfreplication 
over differentiation; in that case, the slope ofCFU increase in the 3-day-preirradiated 
animal would have been more steep than in the freshly irradiated host. In fact, the 
angle of the slope and the actual recovery values for CFU in the spleens of pre- and 
freshly irradiated mice were similar; the only difference being the absence of the 
initial fall in CFU (fig. 3.6). Therefore, it is most probable that shrinkage of the 
spleen causes the early disappearance of CFU and that the dip does not occur in the 
3-day-preirradiated animals, because the splenic contraction [Lord, 1971] has already 
taken place before the injection. The identical CFU growth curve, except for the dip, 
indicates that it makes no difference to the efficiency of the spleen colony assay 
whether the shrinkage occurs before or after the injection. This is actually supported 
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by the demonstration by two groups [Shadduck et al., 1971; Lord and Hendry, 1973] 
that the colony yield in a CFU-s assay is not altered in the preirradiated animal as 
compared to that in a freshly irradiated mouse. This means in effect that one has a 
choice of obtaining the efficiency factor of the spleen colony assay either from the 
previously shrunken spleen or from the spleen which will shrink after the injection 
of CFU. For practical reasons (i.e., the shorter duration of the assay), we have 
used the extrapolation value of the CFU growth curve assayed in the spleen of the 
newly irradiated mouse for f and used this estimate for calculation of the total 
number of CFC in fetal liver and bone marrow cell suspensions from the CFU-s 
estimates. 
This approach yielded an efficiency number for bone marrow CFU (4.1%) which 
was roughly of the same order of magnitude as alternative estimations off by means 
of very different methods; i.e., the primary transplantation technique, based on the 
radiation response of CFU, which allowed the calculation of the absolute numbers 
of endogenous and exogenous splenic CFU and thereby the efficiency of the exo-
genous assay (f= 2.7%) [Hendry, 1971]; and another first transplantation technique 
which compared the number of colonies arising from the intrasplenic and the i.v. 
routes of administration to compute the relative efficiency (dilution) of colony 
formation of stem cells after injection into the circulation (f = 3.9%) [Matioli et al., 
1968]. 
CHAPTER 4 
TAKEABILITY AND REPOPULATION KINETICS OF 
FETAL LIVER CELLS 
In laboratory and clinical practice, the application of fetal liver haemopoietic cell 
transplants has been associated with a relatively low takeability. Only very rarely 
has chimaerism resulted from fetal liver cell grafting in man [Bortin, 1970; Soothill 
et al., 1971; Githens et a!., 1973], monkeys or dogs [Thomas et al., 1963; Van 
Putten et al., !968]. In the mouse, it has been found that comparatively high numbers 
of fetal liver cells were required for repopulation [Crouch, 1959]. The cause of the 
low takeability is largely unknown. 
When this property of fetal liver cell grafts was reported for the first time in 1959 
[Crouch], two hypothetical reasons were put forward as explanation: 
a. the fetal liver tissue contains relatively few proliferative haemopoietic cells or, 
b. fetal liver cells encounter important difficulties in adapting to the adult environ-
ment. 
Experimental haematology had not advanced far enough at that time to permit 
verification of these possibilities. As investigations into the mechanism of fetal liver 
cell take have progressed, confusion was added to the situation; several of them 
indicated enhanced proliferative potencies for fetal-liver-derived cells [Micklem and 
Loutit, 1966; Micklem and Ford, 1966] and, more specifically, for fetal liver HSC 
as compared to bone marrow [Schofield, 1970; Micklem, 1972; Metcalf and Moore, 
197le]. These results could not be reconciled with the difficulties experienced in ob-
taining engraftment. In none of these studies was the proliferation kinetics of the grafted 
stem cells assessed in direct relation to the criterion of take. A critical difference 
between the transplantation studies in which one was confronted with difficulties in 
achieving repopulation, on the one hand, and those indicating a more vigorous fetal 
liver cell proliferation, on the other, was that the former had mostly been carried out 
in allogeneic and the latter in isogeneic host-donor combinations. Thus, although a 
reasonable amount of experimental data on fetal liver cell proliferation has been 
collected piece by piece, this does not furnish a clear understanding of the basis for 
the problems of fetal liver cell take. 
The following factors are held to influence the take: 
l. the number of stem cells grafted; 
2. the proliferative capacities of these cells; and 
3. the sensitivity of haemopoietic proliferation to allogeneic inhibition. 
In order to more adequately explain the failures of fetal liver cells to take, it is 
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necessary to analyse each of these factors in direct relation to take. Investigations 
which were concerned with this subject are described in this chapter. 
The first series (A) of experiments dealt with the transplantation of fetal liver 
cells into syngeneic recipients. The takeability of fetal liver cells was assessed in 
comparison to bone marrow grafts in survival studies. Major allowance was made 
for the number and role of the stem cells in the grafts in these studies. This was done by: 
a. measurement of the number of HSC in the grafted cell suspension; 
b. employment of purified stem cell suspensions which were free of most of the 
other fetal liver cells; 
c. estimation of the self-renewal of HSC in the spleen and marrow; 
d. measurement of the production of differentiated cells by fetal stem cells during 
the process of haemopoietic recovery following transplantation. 
In the second series (B), the repopulating fetal liver and bone marrow grafts were 
investigated following injection into allogeneic recipients. The main problems to be 
investigated were: How is the growth of the HSC modified in the allogeneic host? 
Is the allogeneic effect on the proliferative response of bone marrow and fetal liver 
cells different and, if so, can this difference be explained and quantified in some way? 
Finally as an approach to enhancing fetal liver cell take, it was investigated whether 
practical use could be made of thymus cells to promote haemopoietic cell prolifer-
ation following grafting in non-isogeneic recipients [Goodman and Shinpock, 1968; 
Goodman and Grubbs, 1970]. 
4.1 Part A: Transplantation of syngeneic fetal liver and bone 
marrow cells 
4.1.1 Survival experiments 
In order to measure the takeability of fetal liver and bone marrow cells in syngeneic 
hosts, groups of lethally irradiated mice were transplanted with grafts containing 
graded numbers of CFU-s from bone marrow and fetal liver (unfractionated and 
purified). Repopulation efficiency was evaluated by taking the minimum number of 
CFU-s which permitted the recipients to survive for at least 30 days (i.e., the time 
interval covering the critical period of mortality from the irradiation-induced aplasia 
[Micklem and Loutit, 1966; Van Bekkum and De Vries, 1967]). The survival data 
are presented in table 4.1. The repopulation efficiency of the cells was expressed in 
terms of cell numbers required to obtain a level of at least 80% survival. This was 
done because, even with optimal reconstitution treatment, a small proportion of the 
animals are lost following supralethal irradiation exposures employed in studies of 
this kind [Van Bekkum and De Vries, 1967]. It is evident from table 4.1 that 120 
CFU-s (2-3 x 106 nucleated cells) from fetal liver and 240 CFU-s (0.8-0.9 x 106 
nucleated cells) from bone marrow led to such a survival rate. The figures correspond 
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Table 4.1 Survival of lethally irradiated mice following transplantation of increasing numbers of 
fetal liver and bone marrow cells 
Syngeneic C57BL->-C57BL 
fetal liver bone marrow 
number of cells number of cells 
transplanted transplanted 
total per cent total per cent 
nucl. survival nucl. survival 
cells nr. of cells nr. of 
CFU-s CFC* (X 10') mice day 15 day 30 CFU-s CFC* (X 10') mice day 15 day 30 
7 318 0.1-0.2 10 0 0 7 171 o.oz 10 0 0 
15 682 0.2-0.4 30 24 21 15 366 0.05 10 0 0 
30 1364 0.5-0.7 30 54 46 30 732 0.1 24 0 0 
60 2727 1-1.5 30 77 67 60 1463 0.2 20 10 5 
120 5454 2-3 28 85 85 120 2926 0.4 25 52 52 
240 10908 4-6 30 96 89 240 5854 0.8-1.0 40 85 82 
480 22000 8-12 20 100 78 480 11708 1.6-1.9 20 100 88 
* Calculated from CFUMs values by correction for spleen colony efficiency factor: 2.2% (fetal liver) 
and 4.1% (bone marrow) (see chapter 3). 
Survival data represent the mean values of 2 separate experiments. 
with roughly the same numbers of CFC from both types of grafts (i.e., 5454 fetal 
liver CFC * and 5854 bone marrow CFC *) and are indicative of equal repopulation 
potencies of the HSC from both sources. However, the administration of the equiva-
lent number of fetal liver HSC required the infusion of 3 x more nucleated cells as 
compared to bone marrow. It was investigated as to whether, besides the HSC, these 
admixed cells (mostly erythroblasts) added to the protective effect of fetal liver. 
Therefore, the capacity of purified fetal liver HSC to prevent death from the lethal 
irradiation injury was explored. By comparison of these data (table 4.2) with those 
ofunseparated fetal liver cell grafts (table 4.1, left part), it can be seen that the pattern 
of survival was independent of purification. The same number of 120 purified CFU -s, 
now present in only 0.3-0.4 x 106 nucleated cells, sufficed to provide 80% 30-day 
survival. Thus, the idea is favoured that the HSC are the cells which determine re-
population and that survival is largely independent of the more mature cells in the 
graft. 
4.1.2 Proliferative capacities of fetal liver stem cells 
The proliferative capacities of fetal liver stem cells were also assessed directly. The 
repopulation rate of CFU was estimated by determining the increase in CFU in the 
spleen and in the marrow. The curves for accumulation of fetal liver and bone marrow 
* Calculated from CFU-s figures after correction for spleen colony efficiency values (according to 
procedure discussed in Chapter 3). 
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Table 4.2 Survival of lethally irradiated mice following transplantation of increasing numbers of cells 
from purified fetal liver stem cell fractions 
Syngeneic C57 BL-+ C57 BL 
number of cells transplanted 
total 
nucl. number per cent survival 
cells of 
CFU-s CFC* (X 10") mice day 15 day 30 
15 682 0.04 20 5 0 
30 1364 0.09 29 31 28 
60 2727 O.t-0.2 25 60 52 
120 5454 0.3-0.4 30 90 83 
240 10908 0.6-0.8 30 93 93 
480 22000 1.2-1.6 18 90 83 
* Calculated from CFU~s values by correction for spleen colony efficiency: 2.2% (according to data 
in chapter 3). 
Survival results represent the mean values of 2 separate experiments. 
CFU are depicted in figure 4.1. The slopes for recovered CFU differed significantly 
(P < 0.02). The mean population doubling time (T0 ) of fetal liver CFU was 26 h 
(±S.D.: 25 and 27 h), whereas that of bone marrow CFU was 32 h (±S.D.: 30 and 
35 h). The shorter doubling time for the fetal-liver-derived CFU population apparently 
compensated for the lower fraction, f, of such cells that doubles in the spleen; there-
fore, in spite of the lower spleen colony forming efficiency of fetal liver CFU, the 
total number of CFU in the spleen by day 7 was approximately the same as that 
following infusion of an equal number of bone marrow CFU (fig. 4.1). 
It was pointed out in chapter 3 that the slope of increase in CFU as obtained by 
CFU-s estimations in secondary recipients can be regarded as a true index of prolifer-
ation only if the spleen colony forming efficiency during that time is constant. With 
fetal liver CFU, in particular, it has to be excluded that the embryonic CFU undergo 
a gradual rise in the f-value to higher, i.e., more adult marrow-like levels following 
seeding in the sites of the adult organism. A limited number of experiments served 
to sort out whether the greater accumulation of fetal liver CFU in the spleen as com-
pared to bone marrow CFU should be really regarded as the reflection of more 
vigorous self-reproduction or instead of increasing spleen colony forming efficiency 
in the secondary hosts. CFU in fresh fetal liver cell suspensions and CFU derived 
from the same suspensions after proliferation in irradiated hosts for 7 days were 
compared for their spleen colony forming efficiency. For practical reasons, the per-
centage of recoverable CFU in the spleen at 24 h following injection, which closely 
approximates the real efficiency value, was estimated instead of the entire curve of 
CFU recovery. From table 4.3, it is evident that the 24 h recovery values for the fetal 
liver cell suspensions had not changed significantly. Consequently, it can be concluded 
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Fig. 4.1 Recovery of bone marrow and fetal liver CFURs in spleen following the injection into irradiated 
syngeneic recipients. 
Recovery is expressed as a percentage of the number of CFUMs injected at time zero. Points represent 
means (±S.E.) of 6-12 separate experiments. 
Table 4.3 Recovery of fetal liver CFU-s in the spleen at 24 h following injection 
Comparison between primary and secondary cell suspensions 
primary suspension 
% recovery (24 h) 
5.6 
5.7 
5.0 
3.6 
mean 5.0 ±0.5 (S.E.) 
Primary cell suspension: freshly prepared. 
secondary suspension 
% recovery (24 h) 
6.8 
6.3 
4.0 
3.0 
mean 5.0±0.9 (S.E.) 
Secondary cell suspension: cells recovered from the spleen of lethally irradiated recipients at 7 days 
after transplantation. 
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with some confidence that the more rapid increase in fetal liver CFU in the spleen is 
a true manifestation of a more rapid repopulation by the embryonic CFU. 
A limited number of experiments were directed toward measuring recoverable 
CFU populations in the femur shafts. It was found that the characteristic differences 
in fetal liver and bone marrow CFU proliferation as established in the spleen also 
applied to the proliferative events in the marrow (fig. 4.2). Firstly, the embryonic 
CFU population showed a higher capacity for CFU repopulation of the marrow 
than did bone marrow CFU. The mean population doubling time of fetal-liver-
derived CFU of29 h (±S.D.: 25 and 33 h) was shorter than that of bone marrow 
CFU (Tn = 36 h; ±S.D.: 32 and 41 h). Secondly, as in the spleen, the fraction of 
injected fetal liver CFU to lodge in the femur and give rise to daughter CFU was 
lower than that of bone marrow CFU. The difference between the two slopes was not 
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Fig. 4.2 Recovery of bone marrow and fetal liver CFU~s in femur following injection into irradiated 
syngeneic recipients. 
Recovery (in one femur shaft) is expressed as a percentage of the number of CFU~s injected at time 
zero. Points represent means (±S.E.) of 3-4 separate experiments. 
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statistically significant but it is suggested that, as was the case in the spleen experi-
ments, statistical significance would be acquired if more experiments were performed. 
4.1.3 Regeneration of peripheral blood cells 
The release of functional end cells into the blood stream is the ultimate step in a 
series of repopulation events which dete::mines posttransplantation survival by 
preventing the lethal effects of the thrombocytopenia and the leukopenia of the bone 
marrow syndrome [Van Bekkum and De Vries, !967]. In order to compare the 
capacities of fetal liver and bone marrow HSC in generating these mature cellular 
elements, lethally iuadiated mice which were transplanted with bone marrow or 
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Fig. 4.3 Blood cell counts of lethally irradiated mice after fetal liver cell and bone marrow transplan· 
tation (syngeneic). 
Each estimate is the mean of blood values of 3 animals taken from a group of 20 recipients. On the 
ordinate the cell counts are plotted, on the abscissa the time (days, weeks) after transplantation. 
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fetal liver cell grafts providing extended survival (85% and 89%, respectively) were 
assayed for peripheral blood values throughout the first month. The curves of the 
blood cell counts are depicted in figure 4.3. The appearance and rise of the mature 
circulating cells of the varying cell lines after fetal liver cell transplantation occurred 
parallel to those after bone marrow transplantation. The fact that both grafts were 
approximately equally effective in restoring the low peripheral cell counts in the blood 
correlates well with the achievement of the same percentage of survival. 
4.1.4 Regeneration of lymphoid cells 
Because of the importance of lymphocytic regeneration for survival, and in view of 
the absence of lymphopoiesis in the fetal liver tissue (chapter 3), information on the 
extent of lymphoid repopulation after fetal liver cell transplantation is required. 
Therefore, the responsiveness of recipient spleen cells to stimulation by Con A and 
LPS was assayed at monthly intervals following the transplantation of 480 bone 
marrow CFU-s and 240 fetal liver CFU-s (fig. 4.4 and 4.5). These in vitro reactions 
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(syngeneic). 
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were regarded as parameters for the appearance ofT and B cells. The reactivity of the 
spleen cells of some of the animals to the mitogens was still subnormal at one month 
postgrafting; however, at the second month, all animals which were tested showed 
normal responses. Sequential analysis for up to 6 months revealed that reconstitution 
was stable in both groups. From this, it was concluded, that fetal liver and bone 
marrow cell suspensions are roughly equally capable of conferring lymphocyte 
reactivity (in vitro) on lethally irradiated animals. 
4.1.5 Discussion 
In experiments based on the restoration of haemopoietic function in lethally irradiated 
syngeneic mice (bone marrow syndrome), it was revealed that 2-4 times more fetal 
liver cells (2-3 x 106 cells) than bone marrow cells (0.8--0.9 x 106 cells) were needed 
to allow the animals to recover from the effects of radiation. The survival after 
transplantation with purified stem cell fractions demonstrated that the beneficial 
effect on 30-day survival could not be attributed to the transfusion of more mature 
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haemopoietic cells. This supported the concept that HSC represent the principal 
constituent of the graft which are responsible for reconstitution and it justified the 
approach to investigate fetal liver cell takeability mainly at the level of HSC. It was 
found that both types of haemopoietic cell suspensions required approximately 
equal numbers of HSC for irradiation protection. In other words, the difference in 
effective cell numbers between fetal liver cell and bone marrow transplants did not 
reflect a different repopulation proficiency of the two cell populations. but rather the 
lower frequency of HSC in fetal liver. The equivalent repopulation efficiency of fetal 
and adult HSC was compatible with their proliferative behaviour: 
a. the f-value for i.v. administered fetal CFU in the spleen was approximately 50% 
lower than that for bone marrow CFU; 
b. the more rapid production of fetal-liver-derived CFU in the spleen accounted for 
the fact that one more fetal liver CFU population doubling had occurred by day 7. 
The result of these two processes was that, after about one week, the total number of 
fetal liver and bone marrow derived HSC in the haemopoietic tissue was the same, 
if an equal number of HSC from both sources had been grafted at day 0. These 
findings should be considered in view of the fact that protection against the irradiation-
induced aplasia due to the haemopoietic cell grafts was almost completely achieved 
in the first 14 days following irradiation and that early haemopoietic proliferation 
determined graft success (survival). 
Similarly, a lower seeding efficiency coupled with a shorter doubling time of fetal 
liver CFU was observed in the femoral sites. The relative importance of CFU pro-
liferation in spleen and marrow for the haemopoietic repopulation as a whole is 
difficult to judge. 
As regards the contribution of haemopoiesis in spleen and marrow, respectively, 
the following calculation can be made. From the injected number of 5454 fetal liver 
CFC or 5854 bone marrow CFC in the grafts (sufficient for survival), 120 CFU and 
240 CFU, respectively, started to proliferate exponentially in the spleen. Accounting 
for their doubling times, they produced a total quantity of 10,860 fetal liver CFU 
(6.4 doublings) and 8,820 bone marrow CFU (5.2 doublings) by day 7. If the propor-
tion of injected fetal CFU and bone marrow CFU that reproduced in the marrow 
is represented by the extrapolation numbers of the CFU recovery curve, i.e., 0.28% 
and 0.37%, respectively, if it is further assumed that one femur represents 1/60* of 
the total marrow haemopoietic tissue of the organism and, finally, if the femoral 
marrow is accepted as being representative also for the other marrow sites, it follows 
that, out of 5454 injected fetal liver CFC or 5854 bone marrow CFC, 912 fetal and 
* According to Van Bekkum (1969), the total marrow content of an adult mouse can be taken as 
6 x 108 cells. If we consider that one femur shaft contains in the order of 10 X 1 o~ cells, it represents 
1/60 of the total marrow cellularity of the animal. Others have calculated the size of the bone 
marrow cell population in the mouse at 3-5 x 108 cells [Lajtha, 1965] and 8 X 10s cells [Pegg, 1962]. 
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1,260 bone marrow CFC initiated proliferation in the marrow, Considering their 
respective population doubling times (in the femur) of 29 h and 36 h, these cells 
gave rise to 50,760 (5.8 doublings) fetal-liver-derived CFU and 32,760 (4.7 doublings) 
bone-marrow-derived CFU during 7 days of growth. If we add this to the number 
of CFU generated in the spleen, the total yields of CFU from the fetal liver and bone 
marrow grafts were 10,860+ 50,760 = 61,620 CFU and 8,820+ 32,760 = 41,580 CFU, 
respectively. 
Thus, the more rapid doubling rate of fetal liver CFU did not just counterbalance 
the lower fraction, f, of injected CFU that was engaged in regeneration; it even over-
compensated for the lower f-value when compared with bone-marrow-derived re-
population. The difference in production of CFU in the organism by a factor of 1.5 
between both grafts seems too small to be detected in a transplantation study based 
on titration of cell numbers. Therefore these numbers of CFU could well agree with 
the observed equivalent protective efficiency. However, if one accepts the experimental 
evidence in the literature [Vogel et al., 1970; Schofield, 1970] which indicates that the 
exponential increase in CFU continues for another 3 days, the total yield at day 10 
becomes 415 x 103 fetal-liver-derived CFU and 186 x 103 bone-marrow-derived CFU. 
This difference in production of CFU is too large to disregard, in particular in view 
of the fact that the more efficient generation of new CFU by fetal liver cells does not 
lead to better survival; or, stated otherwise, why do fetal liver HSC, though having 
an equivalent efficiency in terms of affording survival, require a larger net production 
of HSC in the host? The most logical explanation is that fetal liver cell repopulation 
involves at the same time a proportionally smaller propensity for cell differentiation 
or a greater tendency for differentiating cells to die. Such an interpretation would be 
in good agreement with our finding that, in spite of the more rapid repopulation of 
the haemopoietic tissues with fetal-liver-derived CFU, the rise in peripheral blood 
cells was virtually similar following fetal liver cell and bone marrow transplantation. 
This could also fit in with a general concept that fetal cells have a higher propensity 
for proliferation and a smaller tendency towards differentiation than do adult cells. 
Others have also suggested that an increased self-replication capacity of early 
embryonic CFU is related to impaired differentiation [Metcalf and Moore, 197lb]. 
As long as we have no methods to separately measure replication, differentiation, 
and death of cells on the basis of HSC injected, one cannot compare the relative 
involvement of embryonic and adult HSC in any of these processes and verify such 
a concept. 
Evidence was obtained for a nearly identical time pattern oflymphoid reconstitution 
after fetal liver cell and bone marrow transplantation. Because of the poor lympho-
poiesis in the fetal liver (chapter 3), it is indicated that the lymphocytes which appeared 
were products of differentiation from stem cells. This is further evidence for equivalent 
repopulation capacities for both stem cell populations. 
The more rapidly ascending growth curves for fetal CFU as compared to bone 
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marrow CFU were observed in the spleen as well as in the femoral marrow. This is 
an indication of different intrinsic growth characteristics of CFU specific to the source 
of the cells. In the spleen. such differences have previously been noticed by Schofield 
[1970]. The fetal liver CFU population generation time of 16 h assessed by this 
investigator was markedly shorter than our value of 26 h. Although no definite 
explanation can be given, it is possible that differences in animal strains employed or 
in the embryonic age of the fetal liver donors account for this dissimilarity. Other 
workers have established that T0 values of fetal liver CFU markedly vary (between 
18-30 h). depending on embryonic maturation [Vogel et al., 1970]. 
In chapter 3, the low spleen colony forming efficiency of fetal liver CFU was 
extensively discussed. It has been shown in this chapter that this low figure was 
probably not due to a different distribution of fetal CFU, in the sense that more CFU 
settled in the marrow, and, accordingly, fewer fetal liver CFU reached the spleen. 
From the results set out in this chapter, it was suggested that the colony forming 
efficiency of fetal liver CFU was also lower in the marrow of the femur shaft than 
that of bone marrow CFU. Thus, one is left with the question as to why the efficiency 
of colony formation by fetal liver CFU is consistently lower. The most likely possi-
bility is that fetal liver CFU encounter greater difficulties in adjusting to the new 
environment and that a higher proportion of injected fetal liver CFU is "inactivated" 
after the abrupt transfer from the embryonic to the adult environment. If this is so, 
the two explanations formerly offered by Crouch [1959] for the higher number of 
fetal liver cells needed for transplantation, i.e., the low number of proliferating cells 
in fetal liver and the difficulties associated with the change to a different micro-
environment, would both be valid. 
4.2 Part B: Transplantation of allogeneic fetal liver and bone 
marrow cells 
4.2.1 Survival experiments 
Experiments very similar to those described in part A, but in allogeneic recipients, 
were carried out. In table 4.4, the survival data are compiled for groups of CBA 
mice receiving graded numbers of CFU-s * of fetal liver and bone marrow cell suspen-
sions obtained from C57BL donor mice. It appeared that the numbers of fetal liver 
and bone marrow CFU-s which were necessary for at least 80% survival were the 
same for both cell suspensions. However, the cell inocula from the two sources con-
tained quite different numbers of HSC (i.e., CFC) and of nucleated cells. 
The number of nucleated cells in the transplants was 4-5 x 106 bone marrow cells 
or 20-30 x 106 fetal liver cells per recipient. In order to determine whether or not the 
* The nwnber of CFU-s was determined as usual by injection of haemopoietic cells into lethally 
irradiated syngeneic mice. 
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Table 4.4 Survival of lethally irradiated mice following transplantation of increasing numbers of 
/eta! liver and bone marrow cells 
Allogeneic C57BL-> CBA 
fetal liver bone marrow 
number of cells number of cells 
transplanted transplanted 
total per cent total per cent 
nucl. survival nucl. survival 
cells nr. of cells nr. of 
CFU-s CFC' (X 10°) mice day 15 day 30 CFU-s CFC* (X 10') mice day 15 day 30 
15 682 0.2-0.4 10 20 0 15 366 0.05 10 0 0 
30 1364 0.5-0.7 26 54 23 30 732 0.1 20 35 0 
60 2727 1.0-1.5 30 67 3 60 1463 0.2 35 26 0 
120 5454 2 -3 30 87 60 120 2926 0.4 30 77 10 
240 10908 4 -6 30 87 60 240 5854 0.8-1.0 30 77 37 
580 26364 10-14.5 30 100 78 580 14146 1.9-2.4 32 87 69 
1200 55000 20-30 41 98 80 1200 29300 4-5 39 99 99 
2000 86000 35-50 72 94 92 2000 46300 6-8 47 98 94 
* Calculated from CFU-s values by correction for spleen colony efficiency: 2.2% (fetal liver) and 
4.1% (bone marrow) (according to data in chapter 3). 
Survival data represent the mean values of 2 separate experiments. 
protective effect of the fetal liver cell transplant was substantially dependent on the 
much higher number of more differentiated nucleated cells (6 x that of bone marrow), 
Table 4.5 Survival of lethally irradiated mice following transplantation of increasing numbers of cells 
from purified fetal liver stenr·cell fractions 
Allogeneic C57BL--+CBA 
number of cells transplanted 
total 
nucL number per cent survival 
cells of 
CFU-s CFC* (X 10') mice day 15 day 30 
15 682 0.04 20 25 0 
30 1364 0.09 38 79 24 
60 2727 0.1-0.2 40 88 35 
120 5454 0.3-0.4 40 88 40 
240 10908 0.6-0.8 29 86 62 
580 26364 1.4-1.8 40 98 77 
1200 55000 3-4 41 100 95 
2000 86000 5-7 38 100 95 
* Calculated from CFU-s values by correction for spleen colony efficiency: 2.2% (according to data 
in chapter 3). 
Survival results represent the mean values of 2 separate experiments. 
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the efficiency of purified stem cell grafts was also investigated. From these data, it 
became evident that fetal liver stem cell fractions exhibited about the same repopula-
tion potential as did the unseparated fetal liver cell suspensions (compare table 4.5 with 
table 4.4, left section). The number of CFU-s (1200) and CFC (55,000) in the fetal 
liver stem cell concentrate which produced 80% survivors was the same as for the 
unfractionated embryonic liver cell transplant, although the absolute cell number 
had been reduced to as low as 3-4 x 106 cells. This finding reinforces the notion that 
HSC represent the cell population largely responsible for graft success, also in allo-
geneic recipients. 
The number of HSC in the fetal liver cell graft (55,000 CFC) which was calculated 
from the CFU-s figures by correction for the spleen colony forming efficiency 
(chapter 3) was nearly double that of CFC present in the bone marrow transplant 
(29,270 CFC) (table 4.4). These findings show that, whereas fetal liver and bone 
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Fig. 4.6 Recovery of fetal liver CFU-s in spleen following injection into irradiated syngeneic and 
allogeneic recipients. 
Recovery is expressed as a percentage of the number of CFU-s injected at time zero. Points represent 
means (±S.E.) of 4-12 separate experiments. 
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marrow HSC were found to be equally capable of repopulating a lethally irradiated 
animal in syngeneic transplantation, fetal liver HSC were approximately half as 
effective in the allogeneic situation. 
4.2.2 Proliferation of fetal liver stem cells following allotransplantation 
Experiments were conducted in order to discover the basis for the stronger allogeneic 
barrier inhibiting repopulation by HSC from fetal liver. Grafts of bone marrow and 
fetal liver cells were injected into lethally irradiated mice and the variation in the 
recoverable fraction of injected CFU in the spleen with time after transplantation 
was determined.* The growth curve of the embryonic CFU population in the allo-
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Fig. 4.7 Recovery of bone marrow CFU-s in spleen following injection into irradiated syngeneic and 
allogeneic recipients. 
Recovery is expressed as a percentage of the number of CFU-s injected at time zero. Points represent 
means (±S.E.) of 4-12 separate experiments. 
* This was done by injecting the cells collected from both syngeneic and allogeneic chimaeras into 
syngeneic lethally irradiated mice for regular CFU-s assay. 
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geneic spleen (plotted in fig. 4.6) shows that the production of fetal liver CFU in the 
allogeneic animal is delayed in comparison to its syngeneic counterpart. The delay 
in multiplication of fetal liver CFU corresponds with a reduction by a factor of 0.5 
in tbe f-value in the allogeneic spleen (stat. sign. of diff. P < 0.001). By contrast, the 
rate of doubling of bone marrow CFU following injection into the allogeneic recipient 
appeared nearly identical to that in the syngeneic spleen (fig. 4. 7). It is remarkable 
that the respective slopes of CFU regeneration in allogeneic were similar to those in 
syngeneic spleens; mean population doubling times of fetal liver CFU of 26 h (±S.D.: 
24 and 30 h) and of bone marrow CFU 30 h (±S.D.: 25 and 37 h) were nearly equal 
to those reported in part A. The fact that the f-factor for bone marrow CFU was 
not reduced, while that for fetal liver CFU was decreased by a factor of 0.5 in allo-
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Fig. 4.8 Recovery of fetal liver CFU-s in femur following injection into irradiated syngeneic and 
allogeneic recipients. 
Recovery (in one femur shaft) is expressed as a percentage of the number of CFU-s injected at time 
zero. Points represent means (±S.E.) of 3-4 separate experiments. 
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geneic situations may offer a satisfactory explanation for the 2-fold difference in fetal 
liver and bone marrow cell numbers needed for allogeneic repopulation. 
Repopulation of the femoral marrow exhibited essentially the same aspects of CFU 
proliferation as seen in the spleen (fig. 4.8 and 4.9): 
a. the rate of proliferation (slope) of the CFU populations of fetal and adult origin 
did not differ from those in the syngeneic femur; 
b. the fraction, f, of fetal liver CFU was reduced in the allogeneic femur to a larger 
degree than f for bone marrow CFU, as compared to the comparative syngeneic 
f-values. 
These data seem to provide insight into the causes for the difference between the 
repopulation capacity of fetal liver cell and bone marrow grafts in allogeneic irradiated 
recipients. However, they do not provide an explanation for the large difference in 
cell numbers needed for syngeneic versus allogeneic repopulation by the two types of 
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Fig. 4.9 Recovery of bone marrow CFU-s in femur following injection into irradiated syngeneic and 
allogeneic recipients. 
Recovery (in one femur shaft) is expressed as a percentage of the number of CFU-s injected at time 
zero. Points represent means (±S.E.) of 3 separate experiments. 
ALLOGENEIC FETAL LIVER CELL TRANSPLANTATION 73 
grafts. Why does allogeneic haemopoietic cell transplantation require 5 x more bone 
marrow cells and l 0 x more fetal liver cells than does syngeneic grafting? This is a per-
tinent question in that CFU repopulation at any time interval after allotransplanta-
tion was identical to that after syngeneic transplantation when marrow grafts were 
used, while they differed by a factor of 2 for fetal liver cell grafts as a result of a lower 
f-value. Therefore the possibility must be considered that inhibition of the differentia-
tion capacity of HSC was largely responsible for the iso-allo difference in cell numbers. 
Experiments were designed to ascertain whether the iso-allo difference in cell numbers 
could be associated with reduced cellular differentiation. This was done by perform-
ing spleen colony assays in allogeneic hosts. Spleen colony formation is essentially 
understood to be the product of replication of HSC and the subsequent production 
of differentiated progeny; it is the size of the latter population which determines 
whether a colony becomes visible or not. Since the number of HSC which reaches 
the spleen to start proliferation as well as the doubling rate of this population have 
been determined, the degree of suppression of colony numbers in allogeneic hosts 
which is due to an impaired production of the more mature progeny can be derived 
from these data and the difference in colony counts. Direct comparisons were made 
with colony number estimations in syngeneic animals and allogeneic inhibition was 
expressed as an iso-allo ratio of spleen colony forming ability 
( 
= number of macroscopic spleen colonies in allogeneic host x lOO%). 
number of macroscopic spleen colonies in syngeneic host o 
From the results (table 4.6), it appeared that spleen colony formation by bone marrow 
CFU in allogeneic recipients was suppressed to 60% of the syngeneic values. Because 
in allogeneic hosts repopulation of bone marrow CFU has been shown not to be 
decreased, this 0.6 x depression may be entirely attributed to less differentiation in 
the colonies. Depression of the spleen colony forming ability of fetal liver cells in 
non-isogeneic hosts was much more pronounced; i.e., to about 30% of syngeneic 
figures. If one allows for the 50% reduced f-factor of fetal liver CFU in the allogeneic 
Table 4.6 Spleen colony formation in isogeneic and allogeneic recipients 
number of colonies per 105 celts injected 
type of graft 
bone marrow 
fetal liver 
isogeneic 
C57BL~C57BL 
28.3±3.4 (10) 
8.2±0.6 (12) 
* Repression ratio in per cent 
Mean ±S.E. 
allogeneic 
C57BL~CBA 
17.4± 1.9 
2.5±0.2 
The figures in parentheses represent the number of experiments. 
~Uogen~ic (%) * 
tsogenetc 
63.7±6.4 
33.6±3.4 
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spleen, one may calculate that a percentage of 60 of the remaining CFU numbers is 
suppressed in terms of differentiation in the colonies. 
Because the supply of functionally mature peripheral blood cells is a very close 
parameter for efficient repopulation following transplantation, separate experiments 
were directed toward estimating the rate of recovery of peripheral blood cell counts. 
The results indicated that, after the transplantation of marginal numbers of haemo-
poietic cells, the increase in cells in the peripheral blood was delayed to tbe dis-
advantage of the allogeneic grafts (fig. 4.10 and 4.11). In particular, recoveries of the 
erythroid and the lymphoid cell lines occurred more slowly in the allogeneic recipient; 
patterns of recovery of platelets were the same in the isogeneic and allogeneic animals 
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Fig. 4.10 Blood cell counts of lethally irradiated mice after transplantation of syngeneic and allo-
geneic fetal liver cells. 
Each point is the mean of blood values of 3 animals taken from a group of 20 recipients. On the 
ordinate the cell counts are plotted, on the abscissa the time (days, weeks) after transplantation. 
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Fig. 4.11 Blood cell counts of lethally irradiated mice after transplantation of syngeneic and allo~ 
geneic bone marrow cells. 
Each point is the mean of blood values of 3 animals taken from a group of 20 recipients. On the 
ordinate the cell counts are plotted, on the abscissa the time (days, weeks) after transplantation. In 
the group of allogeneic recipients there were no survivors beyond day 21. 
at the transplanted cell dosages used. However, these data on repression of differentia-
tion do not seem to entirely explain the 5-f old difference in cell numbers required for 
isogeneic and allogeneic repopulation. 
4.2.3 Nature of allogeneic repression 
Some experiments were devoted to clarifying the delayed haemopoietic cell repopula-
tion in the allografts. Attention was paid to distinguishing between the two main 
groups of causative factors which are believed to influence non-isogeneic grafting: 
immunological and environmental (hybrid resistance). Because hybrid resistance is 
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the most outstanding example of the latter category, it was investigated whether the 
features of allogeneic suppression resembled the hybrid resistance phenomenon. 
Therefore, fetal liver and bone marrow CFU (parental) were grafted into lethally 
irradiated F 1 hybrid mice and assayed for colony forming capacity in the spleen. It 
was found that hybrid resistance acted quite strongly and suppressed colony numbers 
to 17% (bone marrow) and 5% (fetal liver) of the isogeneic values (table 4.7). It has 
been reported in the literature that hybrid resistance, at least against bone marrow 
cells, can be overcome by adding large numbers of thymocytes from adult animals 
Table 4.7 Spleen colony formation in isogeneic and hybrid recipients 
number of colonies per 105 cells injected 
isogeneic 
type of graft C57BL~C57BL 
bone marrow 21.0±1.6 (8) 
fetal liver 4.6±0.7 (5) 
* Repression ratio in per cent. 
Mean ±S.E. 
hybrid 
C57BL-+F1 
(C57BL X CBA) 
3.5±0.3 
0.3±0.1 
The figures in parentheses represent the number of experiments. 
hybrid (%)* 
isogeneic 
17.2± 1.9 
5.1±1.4 
(isogeneic to the haemopoietic cell graft) to the transplant [Goodman and Wheeler, 
1968; Goodman and Grubbs, 1970]. An attempt was made to find out whether 
such abrogation could also be obtained in the case of hybrid resistance against fetal 
liver cells. These experiments revealed that both fetal liver and bone marrow CFU 
were susceptible to the effect of simultaneously injected thymic cells (tables 4.8 and 
4.9). P-+ F 1 repression could be entirely abolished when the thymus cell inoculum 
contained in the order of I 00 x 106 cells. Following this, the allogeneic variant of CFU 
suppression was tested for its sensitivity to be abrogated by injected thymocytes. It 
was found that the allogeneic inhibition could be overcome similarly to that in P-+ F 1 
transplantation (tables 4.10 and 4.11). However, the allogeneic repression was less 
pronounced than hybrid suppression and abolition of resistance could be achieved 
by lower numbers of thymocytes - approximately 30 x 106 cells. The fact that allo-
geneic inhibition was totally abolished by the action of the thymocytes may be regard-
ed as an indication that allogeneic inhibition and hybrid resistance had the same basis. 
It is noteworthy that modification of growth in the allogeneic host due to the addi-
tion of thymus cells not only led to an increase in colony numbers up to the syngeneic 
level, but even to an overshoot of colony counts when compared to syngeneic values. 
In the case of fetal liver CFU, this resulted in a near doubling of isogeneic numbers. 
The increase over syngeneic values suggests that, also in a syngeneic recipient, spleen 
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Table 4.8 Effect of adult thymocytes on spleen colony formation by fetal liver cells in hybrid hosts 
C57 BL ~ F,( C57 BL x CBA) 
nr. of thym. 
injected 
(X 10") 
0 
0.5 
5 
10 
30 
100 
control 
fetal liver 
C57BL->C57BL 
number of CFU-s per 105 fetal liver cells 
exp. 1 exp. 2 exp. 3 exp. 4 exp. 5 
0.5 0.1 0.2 0.2 0.2 
0.4 0.1 0.2 0.3 
0.6 0.1 0.2 0.2 
1.0 0.2 0.3 0.2 0.7 
1.9 0.5 0.9 1.0 
3.6 3.7 4.1 
5.4 2.3 3.6 6 5.8 
100 x 10s thymocytes: 0.6±0.2 CFU-s. 
% of syngeneic colony numbers 
mean ±S.E. 
5±1 
5±1 
6±1 
10±3 
22±4 
110±26 
100 
colony formation does not reach maximal expression without supplementation with 
thymocytes. This hypothesis was tested by adding thymocytes to the cells in a syn-
geneic spleen colony set-up. Indeed, the results showed that, when the grafts were 
supplemented with thymus cells, the CFU values increased above normal values 
(table 4.12). Most striking was the elevation of colony numbers of syngeneic fetal 
liver cells which showed a nearly 2-fold increase over the controls. One could argue 
whether the increase in colonies in the presence of thymocytes was really fetal-liver-
derived and not of thymus cell origin. The latter possibility was unlikely because 
numbers of 100 x 106 thymocytes produced only 0.6 spleen colonies per recipient on 
Table 4.9 Effect of adult thymocytes on spleen colony formation by bone marrow cells in hybrid hosts 
C57BL~F,(C57BLX CBA) 
nr. of thym. 
injected number of CFU-s per 105 bone marrow celts 
(X 10') exp. 1 exp. 2 exp. 3 exp. 4 exp. 5 
0 
0.5 
5 
10 
30 
100 
control 
3.0 
3.5 
3.3 
8.4 
9.8 
24.6 
bone marrow 21.5 
C57BL~C57BL 
4.7 
6.7 
7.8 
9.6 
12.4 
28.7 
19.6 
100x 106 thymocytes: 0.6±0.2 CFU-s. 
4.5 2.4 4.0 
7.8 
9.3 
14.7 
16.6 9.7 
35.4 27.6 
25.6 15.8 14.7 
% of syngeneic colony numbers 
mean ±S.E. 
17±2 
27±5 
31±8 
49±5 
58±6 
147 ±15 
100 
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Table 4.10 Ejf€!ct of adult thymocytes on spleen colony formation by fetal liver cells in allogeneic 
hosts 
C57BL~CBA 
nr. of thym. 
injected number of CFU~s per 105 fetal liver cells 
(X JO") exp. 1 exp. 2 exp. 3 exp. 4 exp. 5 
0 2.6 1.6 2.8 2.8 2.9 
0.5 2.0 1.0 
5 1.9 2.6 4.5 3.5 
10 4.8 2.5 8.3 2.6 2.3 
30 18.6 13.8 13.0 7.8 
control 
fetal liver 6.6 8 6.9 8 7.3 
C57BL~C57BL 
100x 106 thymocytes: 0.6±0.2 CFU~s. 
% of syngeneic colony numbers 
mean ±S.E. 
35±4 
21±9 
42±7 
42±10 
187±36 
100 
the average. Furthermore, this possibility was minimized by the results of experiments 
listed in table 4.13, from which it became evident that: a. colony formation did not 
occur when the fetal liver cells had been exposed to a high dose of irradiation in 
vitro (2000 rad y) prior to the injection; this is argument in favor of the idea that the 
colony forming cells had a fetal liver origin and against the possibility that the 
synergistic activity had a reverse direction, i.e., the fetal liver cells unmasked colony 
forming activity in the thymus cell suspension; b. the same in vitro preirradiation of 
the thymocytes did not reduce the colony forming ability of fetal liver cells or fetal 
liver cells plus thymus cells. These findings indicate that colony forming ability, in 
Table 4.11 Effect of adult thymocytes on spleen colony formation by bone marrow cells in allogeneic 
hosts 
C57BL~CBA 
nr. of thym. number of CFU~s per 105 
injected bone marrow cells 
(X 10') exp. 1 exp. 2 exp. 3 
0 15.0 23.3 17.8 
0.5 18.7 14.6 14.3 
5 17.5 20.6 24.4 
10 23.3 26.6 26.1 
30 22.5 25.5 30.0 
control 
bone marrow 22.5 24.7 27.5 
C57BL~C57BL 
100 x 106 thymocytes: 0.6±0.2 CFUNs. 
exp. 4 
18.6 
20.0 
21.6 
22.8 
% of syngeneic colony numbers 
mean ±S.E. 
77±7 
65±9 
84±3 
100±3 
104±3 
100 
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Table 4.12 Effect of adult thymocytes on spleen colony /ormation by fetal liver and bone marrow 
cells in syngeneic hosts 
C57BL~C57BL 
%of 
control 
without 
number of CFU-s per 105 cells thymocytes 
~-1~2~.3~.4~.5~.6~.7~.8=m±~E 
fetal liver 
-thymocytes (control) 6.1 6.6 8.0 6.9 8.0 7.3 10.0 7.5 100 
+30 x 10° thymocytes 11.4 13.1 !1.0 7.2 14.4 9.4 139±15 
+ 100 x 106 thymocytes 16.0 14.0 17.2 11.5 8.8 12.0 175±24 
bone marrow 
-thymocytes (control) 27.8 17.2 16.7 14.0 5.7 30.8 !3.3 15.8 !00 
+30 X 106 thymocytes 35.2 17.0 16.7 116±6 
+ 100 x 106 thymocytes 32.0 36.3 28.0 16.3 5.0 35.2 135 ±19 
lOOx 106 thymocytes: 0.6±0.2 CFU-s. 
particular of fetal liver cells, can be markedly enhanced in isogeneic conditions. It 
could mean that the thymocytes remove not only allogeneic but also syngeneic 
barriers against transferred fetal haemopoietic cell growth. 
4.2.4 Potentiation of take by thymocytes 
Faced with the relatively low takeability of fetal liver cell allografts and the findings 
that thymic cells markedly stimulated fetal-liver-derived haemopoiesis in genetically 
different hosts, it was investigated whether supplementation of the transplant with 
thymus cells could be of practical use to promote fetal liver cell allo-engraftment. In 
a number of experiments in which varying dosages of C57BL fetal liver cells were 
injected into CBA mice, the effect of administration of thymus cells was measured 
by the criterion of irradiation protection. 
Experiments were carried out with 3 dosages of adult thymus cells; namely, 
0.1 x 106, 5 x 106, and 100 x 106 cells per recipient, thus covering a rather broad 
Table 4.13 Effect of adult thymocytes on the ability of fetal liver cells to form spleen colonies in 
syngeneic hosts 
nr. of cells injected 
fetal liver + thymus 
2x10' + 
lxl05 + 50xl06 
1 x 10' + 50x 10" (2000 rad y) 
2 X 10' (2000 rad y)+ 50 X 10' 
CFU-s per 105 fetal liver cells 
exp. 1 exp. 2 
6.3 
9.5 
12.0 
0 
8.5 
14.3 
12.9 
0 
80 TAKEABILITY AND REPOPULATION KINETICS 
Table 4.14 Effect of injection of adult thymocytes on survh•al after allogeneic fetal liver cell trans-
plantation 
C57BL~CBA 
nr. of 
-adult thymocytes +adult thymocytes 
fetal liver cells m. of Yo survival nr. of thymocytes nr. of %survival 
(x 10") animals day 30 day 100 (X 10") animals day 30 day 100 
0.1-0.2 20 0 100 15 0 
13 46 0 0.1 15 13 0 
5 13 0 
9 0 5 8 25 0 
100 7 0 
2 9 33 11 100 9 0 
30 15 100 27 0.1 14 86 23 
12 58 8 5 13 23 0 
100 13 0 
range. The results (table 4.14) were by no means indicative of an increased early 
survival rate. In most instances, the combined fetal liver/thymus cell grafts had an 
adverse, detrimental, effect. The large number of 100 x 106 cells induced a severe 
acute Gv H reaction and led to 100% mortality within 30 days, irrespective of tbe 
number of fetal liver cells transplanted. Neither did the two other thymus cell dosages 
support better early survival. With the exception of a somewhat prolonged survival 
Table 4.15 Effect of injection of fetal thymocytes on survival following allogeneic fetal liver cell 
transplantation 
C57BL~CBA 
nr. of 
-fetal thymocytes +fetal thymocytes 
fetal liver cells nr. of %survival nr. ofthymocytes nr. of %survival 
(X 10") animals day 30 day 100 (X 10") animals day 30 day 100 
0.03-0.2 39 0 0.001-0.007 44 11 5 
0.4 78 9 2 0.01 85 35 14 
25 8 0 0.1 25 36 8 
44 39 9 O.QJ 41 51 12 
47 38 4 0.1 53 26 4 
22 28 0 5 27 18 0 
30 15 100 27 0.1 14 28 23 
1 15 80 13 
27 81 19 5 25 84 15 
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in one of the test groups, only negative influences on the rate of 30-day survival were 
noted. 
Because fetal thymocytes involve fewer risks for GvH disease and because low 
numbers of these cells have been claimed to enhance fetal liver cell take [Bortin et a!., 
1973], the capacity of these cells to enhance survival was also examined. The results 
are presented in table 4.15. While dosages of0.03-0.4 x 106 fetal liver cells alone were 
incapable of supporting significant survival, addition of small numbers of fetal 
thymus cells caused substantial improvement. Such a beneficial effect of the thymus 
cell inoculum could not be reproduced when supplemented to higher numbers of 
fetal liver cells which alone gave about 30% survivors at 30 days. 
4.2.5 Discussion 
A summary of cell numbers which were required to achieve a minimum survival of 
80% is presented in table 4.16. These data demonstrate that: 
a. Whereas the same number of fetal liver and bone marrow HSC had to be given 
for repopulation in the syngeneic combinations (part A), the number of embryonic 
HSC required in the allogeneic host was double that of bone marrow HSC. 
Apparently fetal liver HSC encounter a comparatively greater barrier in repopula-
ting allogeneic recipients. 
b. This greater barrier could be identified with a decrease in the production of fetal 
liver HSC in the allogeneic sites to half of the syngeneic values as a result of a 
decrease in the f-value, whilst, under the same conditions, production of bone 
marrow HSC was not reduced. 
c. The 2 x higher stem cell number needed for fetal liver cell take, coupled with the 
3 x lower frequency of HSC in this tissue, accounted for a 6 x larger number of 
nucleated cells needed for survival after fetal liver cell allotransplantation as 
compared to bone marrow allografting. Thus, the difference in cell numbers 
between effective fetal liver and bone marrow cell grafts was more pronounced 
Table 4.16 Number of injected haemopoietic cells required for 80% survival of lethally irradiated 
recipients at 30 days 
bone marrow transplant 
fetal liver transplant 
onfractionated 
stem cell rich fraction 
syngeneic 
C57BL ~ C57BL 
240 CFU-s 5800 CFC 
0.8-1.0 x 106 nucl. cells 
120 CFU-s 5400 CFC 
2-3 x 106 noel. cells 
0.3-0.4 x 106 nucl. cells 
Summarized results from tables 4.1, 4.2, 4.4 and 4.5. 
nucl. cells= nucleated cells. 
allogeneic 
C57BL~CBA 
1200 CFU-s 29300 CFC 
4--5 X 106 noel. cells 
1200 CFU-s 55000 CFC 
20-30 x 106 nucl. cells 
3-4 x 106 nucl. cells 
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than in the syngeneic experiments in which the requirement for more cells just 
corresponded with the 3 x lower concentration of HSC in fetal liver. 
d. These numbers of fetal liver cells required to restore lethally irradiated allogeneic 
mice (80% survival by 20-30 x 106 cells; 50% survival by 2~3 x 106 cells) are in 
accord with the protective activity of nucleated cells from fetal liver as reported 
by other investigators [Crouch, 1959; Bertin et al., 1973]. Because survival was 
independent of removal of a great number of the cells (discontinuous albumin 
density gradient centrifugation), it appeared that the HSC were responsible for 
survival following fetal liver cell transplantation and not the other admixed cells. 
It was found that one mouse embryonic liver of 16 days' maturation yielded 
28 x 106 cells on the average. Thus, it is evident that cells from one organ may 
suffice to successfully engraft an allogeneic recipient in this species. 
Very characteristically, the allogeneic spleen and femur sites were shown to allow, 
without modification, the growth rates of bone marrow CFU as well as fetal liver 
CFU, which were specific of either type of cells in syngeneic hosts. The essential 
difference between the allogeneic curve of repopulating fetal liver CFU and the 
syngeneic curve was that the fraction, f, was depressed. This indicated that allogeneic 
suppression of fetal liver CFU recovery values was produced during the first 24 h of 
exponential multiplication. Theoretically, this could be the result of either a low 
seeding efficiency of fetal CFU to the allogeneic spleen and marrow or an inactivation 
of a proportion of the CFU after they settled in those sites. The latter possibility is 
favoured. In so far as allogeneic inhibition of spleen colony formation was due to 
impaired differentiation within the colonies, this was not the product of a suppressed 
seeding rate but of local suppression of growth. The fact that the entire suppression 
could be completely eliminated (by injection ofthymocytes) suggests that the decreased 
f-factor had a common origin with the reduced differentiation effectivity. 
In considering mechanisms for the very early repressive influence upon the fraction, 
f, of embryonic HSC, and for repression of differentiation in the spleen colonies 
formed by allogeneic CFU, it should be taken into account that the initial take of 
haemopoietic cell transplants in non-isogeneic hosts may depend on a number of 
genetically determined factors [Goodman and Wheeler, 1968]. Some of them have 
traditionally been classified as immunological. Primary attention should be paid to 
the immunological response of the host which leads to rejection of the grafted cells 
[e.g., Van Bekkum and De Vries, 1967]. Furthermore, it should be considered that 
a GvH reaction, if present, may have a negative influence on repopulation [Boranic 
et al., 1973]. Finally, in recent years it has become clear that haemopoietic cell growth 
is also governed by nonimmunological parameters, including the so-called hybrid 
resistance factors [Cudkowicz and Stimpfiing, 1964; Cudkowicz and Bennett, 1971]. 
The influence of these latter physiological factors has been interpreted in terms of a re-
quirement of the grafted cells for a series of environmental conditions which direct or 
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control cell proliferation [Cudkowicz and Bennett, 1971; Trentin, 1971]. In this sense, 
it is conceivable that hybrid resistance is the result of unsuccessful adaptation of the 
grafted cells to the foreign local environment [McCulloch et al., 1973]. Indirect evi-
dence has suggested that this effect depends on short range influences by macrophage 
cells in spleen and marrow [Cudkowicz and Bennett, 1971; Lotzova et al., 1974 in 
press]. It is not known whether the activity is achieved by cell-cell contact or by sub-
stances diffusing over short distances, although there are indications that at least some 
short range interactions are mediated through specific cell surface components that 
can be characterized genetically [McCulloch et al., 1973]. Whereas experimental data 
have established many of the characteristics and the mode of action of immunological 
reactivity, the properties and mechanism of hybrid resistance are as yet only vaguely 
defined. The question as to whether the reduced repopulation of transplanted allo-
geneic CPU in the reported experiments was the result of an immunological process 
or of environmental resistance to these cells cannot be answered with certainty. How-
ever, in our opinion, a nonimmunological activity of host against graft offers the most 
satisfactory explanation for the aspects of repression of CPU proliferation and spleen 
colony formation observed; notably, for the following reasons: 
Firstly, the possibility of a Gv H reaction interfering with repopulation early after 
transplantation should be rejected because the haemopoietic fetal liver tissue contained 
few, if any, immunocompetent cells (chapter 3). 
Secondly, the possible operation of an immunological host-versus-graft response 
may also be discounted because: a. CPU repression was less marked when C57BL 
cells were injected into CBA hosts than when administered to F 1 (CBA x C57BL). 
Since the grafted cells might be expected to meet a strong histocompatibility barrier 
in the former case and in the latter none, these results make the operation of an 
immunological host-versus-graft reaction improbable; b. the large dose of irradiation 
given to the recipients may be expected to have abolished any immunological reaction 
of the host, at least during the 7-9 days period of assaying for CFU proliferative 
activity [Smith and V os, 1963; Cudkowicz and Bennett, 1971]; c. the rapid onset of 
the repressive effect on the f-value of fetal liver CPU within 24 h after transplantation 
renders an immunological reaction improbable, since this usually involves an induc-
tion and effector phase (including cell proliferative events) of more than one day's 
duration. 
Thirdly, the kind of repression observed shared some characteristic features of 
hybrid resistance: Hybrid resistance has been considered a clearcut example of environ-
mental resistance, because basic immunogenetic principles founded on observations 
concerning organ and tissue transplantation indicate the absence of immunological 
host-anti-donor activity. This opinion was further substantiated by findings that 
hybrid resistance was different from the usual immunological response in several 
other aspects (e.g., not modified by neonatal thymectomy) [Cudkowicz and Bennett, 
1971]. The inhibition of fetal liver and bone marrow-derived haemopoiesis in the 
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allogeneic recipient showed a remarkable resemblance to the kind of repression 
observed in the hybrid host: I. the growth kinetics of CFU in the allogeneic spleen 
were similar to those previously reported in the hybrid spleen (decreased f-value of 
CFU proliferation in the presence of unchanged doubling time) [McCulloch et al., 
1973; Buurman et al., 1974 in press] and 2. hybrid resistance against haemopoietic 
cell growth can be overcome by injection of very large doses of donor type thymus 
cells [Goodman and Wheeler, 1968; Goodman and Shinpock, 1968; Goodman and 
Grubbs, 1970; Trentin, 1971]. We have shown that repression of spleen colony 
formation by bone marrow as well as fetal liver CFU, in both allogeneic and FI 
hybrid mice, could be overcome by the same means. 
On the other hand, the demonstration that, beyond the first day, the growth rate of 
CFU was as rapid as in syngeneic conditions in all situations tested, seems contra-
dictory to the claim that the function of environmental resistance is relatively radio-
resistant (not depending on direct cell proliferation) [Cudkowicz and Bennett, 1971]. 
While there was almost no additional mortality after the second week following 
the cell injection in syngeneic transplantation, considerable mortality was still 
encountered in the 3rd and 4th weeks in the allogeneic experiments. This indicated 
that the repopulation events which occurred beyond the first 10-day period following 
grafting were still relevant to the efficiency of survival in allotransplantation. It 
cannot be excluded that immunological activities (e.g., some recovery of homograft 
response) also come into effect at these later time intervals. Neither do the experi-
ments give assurance that the effects on stem cell proliferation which occur at later 
stages involved the same quantitative relationships as those observed during the first 
week. This places some restrictions on the value of these findings on initial haemo-
poietic repair in furnishing a generally adequate insight into the engraftment process 
as a whole. 
It has been pointed out that the number of stem cells which were capable of re-
populating lethally irradiated allogeneic mice exceeded those in syngeneic transplanta-
tion by factors of 5 (bone marrow) and of 10 (fetal liver) (table 4.16). These iso-allo 
differences in requirement for cell numbers were not consistent with the degree of 
reduction in CFU repopulation of the tissues. If we consider that the iso-allo ratio 
of required bone marrow cell numbers was 5, it is surprising that production of CFU 
in spleen as well as in femur was almost not depressed. As has been stressed earlier, 
the 10-fo1d cell requirement in allogeneic versus isogeneic fetal liver cell transplanta-
tion cannot be explained on the basis of CFU production either, the latter being 
only 50% less in allogeneic conditions. As in the case of bone marrow transplantation, 
therefore, a factor of 5 cannot be accounted for. In addition, it was demonstrated 
that a reduced generation of mature end cells in allogeneic conditions interfered with 
early repopulation. This was evidenced by the decreased regeneration of end cells in 
the blood following allotransplantation as compared to that after syngeneic grafting. 
Furthermore, spleen colony formation was reduced, which could only be ascribed in 
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part to a lower f-value of CFU. As far as differentiation impairment was involved in 
reduced spleen colony formation in allogeneic animals, this was calculated to account 
for a repression by factors of 0.6...0.7. Although this leaves little room for doubt that 
the allogeneic interference with differentiation counteracts graft success and leads 
to the demand for larger cell numbers to be grafted, this degree of suppression can 
only account in part for the 5 x impaired takeability. The remainder of the iso-allo 
difference in cell numbers, still unexplained, is thus 3-3.5 x. One is therefore tempted 
to postulate that repopulation during the 10 days of our observation period does not 
fully predict the eventual haemopoietic recovery required for 30 day survival; e.g., 
developing GvH activity or homograft responsiveness of the host could both disturb 
the kinetic relationships which are involved in an earlier phase. Whatever the explana-
tion, the extension of the observation period of the kinetics of repopulation to later 
time intervals seems clearly required. 
Measurement of the recovery of cell counts in the blood throughout the first 
month after transplantation gave evidence that cells of the varying cell lines exhibited 
dissimilar susceptibility to repression. The recovery of thrombocytes was slightly 
repressed and that of erythroid and lymphocytic cells markedly. The delayed restora-
tion of the lymphocytic cells in the blood could be indicative of a comparatively 
prolonged state of immunological incompetence of the allogeneic host. This would 
be consistent with results described in chapter 6 which demonstrated that mitogen 
responsiveness (in vitro) of lymphoid cells in the spleen in a proportion of the allo-
geneic chimaeras remained subnormal for several months. The cause of the lympho-
penia may, at least partly, be related to involvement of these cells in GvH reactions, 
e.g., due to their migration from the blood to sites of immunological activity. The 
postulate that the GvH disease is at the root of the suppressed lymphocyte counts, 
and also of decreased lymphocyte reactivity, would fit in with other findings indicating 
that the decreased immunological reactivity in allogeneic chimaeras is not a primary 
repopulation defect but is instead a secondary phenomenon of GvH disease (chapter 6). 
It has been reported that thymus cells do not augment haemopoietic cell growth 
following transplantation in syngeneic hosts [Goodman and Shinpock, 1968]. This 
conclusion was based on experiments with bone marrow cells in which the rate of 
Fe59 incorporation was the endpoint for measurement of haemopoietic activity. 
Our results were at variance with these findings and indicated a slight increase in 
isogeneic spleen colony numbers following addition of thymus cells to the bone 
marrow graft. More impressive was the nearly 2-fold increase in fetal-liver-derived 
colony numbers upon combined fetal liver cell/thymus cell injection. To our know-
ledge, similar studies on thymus cell influences on syngeneic fetal liver cell derived 
haemopoiesis have not been previously published. The meaning of these findings 
could be that, by analogy with the allogeneic system, even in a syngeneic fetal liver 
cell transfer system not all requirements for growth are met without the addition of 
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thymocytes. The thymus cell effect on fetal liver CFU is particularly marked. A 
possibility which comes to mind to explain this finding is that a kind of resistance due 
to the inappropriate adaptation of the fetal cells to the adult environment (ontogenetic 
resistance) is overcome. It is clear that, for more definitive interpretation, the experi-
ments need extension. 
Attempts at engraftment of haemopoietic cells in non-isogeneic hosts usually rely 
on suitable conditioning of the recipient and the infusion of proper cell numbers. A 
new approach would be provided by the modification of the cellular constitution of 
the transplant as a means to promote take. In this respect, the attempts which took 
advantage of the potentiating effect of thymocytes on fetal liver haemopoiesis were 
not very promising. Although it is known that thymocytes are 10-100 x less GvH 
reactive on a cell-for-cell basis than spleen cells and lymph node cells [Vos et al., 
1959; Mathe et al., 1964; Blomgren, 1973; Tigelaar and Asofsky, 1973], the injection 
of larger numbers of adult thymocytes entails the danger of inducing very severe 
acute GvH disease. All animals in the group receiving the largest thymus cell dose 
succumbed from GvH disease, which was consistent with previous experience [Good-
man and Shinpock, 1968]. When testing these cells at lower concentrations, anta-
gonistic effects on survival were also noted in several instances. Although the lowest 
number of thymus cells inoculated did not elicit a detectable GvH reaction, it also 
did not lead to improved survival. It seems of great interest to test irradiated thymo-
cytes which have lost GvH potencies for their capacity to enhance take in the allo-
geneic system. This is particularly so, in view of the fact that irradiated thymocytes 
were shown to retain their stimulatory activity on fetal liver haemopoiesis in syngeneic 
splenic colonies. However, the fact that adult thymus cells of the same immunogenetic 
constitution are obviously not available in man, rules out a possible practical value 
of this procedure for clinical fetal liver cell transplantation. Therefore one can only 
consider the feasibility of using fetal thymocytes to promote take of fetal liver cells. 
Results obtained by the inoculation of fetal thymocytes in mice were also some-
what more favourable than that of adult thymocytes, in that no acute GvH reaction 
appeared following their administration and under certain conditions somewhat 
better survival was obtained than with fetal liver cells alone. Colony assays with 
fetal thymus cells were not performed and it is therefore not certain whether the effect 
of the small numbers of these cells is comparable with that of the large numbers of 
adult thymocytes. Additional experiments may clarify the question as to whether 
they exert their action in overcoming environmental resistance. For the time being, 
one can conclude that the degree of improvement in early survival provided by these 
cells was moderate (at best survival increased from 8 to 35%). These results were in 
the same range as those described by Bortin et al. [1974]. Furthermore, the enhancing 
effect of the fetal thymus cells was confined to a rather narrow dose range of fetal 
liver cell numbers. Because one can expect only a limited effect from the employ-
ment of these cells, their usefulness in human practice must be doubted. 
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In the above considerations, fetal thymocytes of man were taken to be the equiva-
lent of the fetal thymocyte population of the mouse, but in view of the positive 
PHA-reactivity of the former cell population (table 7.1) and differences in maturation 
of the ontogenetic stages of both species [Rugh, 1958] it is possible that they are more 
comparable to thymus cells from adult mouse donors. Therefore, when applying fetal 
thymocytes in humans, preventive measures against the development of GvH disease 
may be indicated. It is not known whether irradiated thymus cells are still capable 
of enhancing take. In view of this, extension of the experiments for testing the effect 
of irradiated adult thymus cells on take following fetal liver cell allotransplantation 
in the mouse deserves intensified interest. There is a second factor which is uncertain 
in the application of fetal thymus cells in man: does the cell number dependency of 
adult thymus cells for a stimulatory effect on haemopoiesis in the mouse warrant 
application in the human being? One should be aware that it will not be feasible to 
obtain the cell number requirements in man which are involved in the mouse, i.e., 
30-100 x 106 adult thymus cells per murine recipient of 20 g; this corresponds with 
the unrealistic fetal thymus cell yield of 8-25 x l 09 cells* from one human embryo 
for a CID patient of 5 kg. However, it is not certain whether these quantitative 
relationships can be extrapolated to transplantation in man without modifications. 
Therefore, it seems particularly worthwhile to carry out investigations in primates 
(monkeys) aimed at testing the validity of the procedure under the quantitative 
conditions which are obtainable in man. 
The investigations reported have disclosed some of the peculiar repopulation features 
of fetal liver stem cells which could underlie the low takeability of fetal liver cell 
transplants. In the syngeneic host, the repopulation capacities of fetal liver and bone 
marrow stem cells were shown to be approximately equivalent and this was attri-
buted to the sum of the effects of a reduced f-factor and a more rapid proliferation rate 
and a lower differentiation capacity of fetal liver stem cells. A further decrease in the 
f-value of fetal liver stem cells was induced in the allogeneic host. From these findings, 
in conjunction with the observation of the low content of HSC in fetal liver, the fact 
that fetal liver cell grafting required many more cells than bone marrow grafting for 
efficient repopulation could be understood. If one extrapolates the quantitative rela-
tionships involved in fetal liver cell takeability to the human species, the great num-
ber of failures in fetal liver cell transplantation in man seem to be satisfactorily ex-
plained (paragraph 7.4). This is even more so if one takes into account the application 
of a poor cell freezing technique and the low efficiency of the i. p. route of administra-
tion of the cells usually employed in human transplantation (paragraph 1.3.6). Ac-
cording to the experimental results reported in this chapter, there is every reason to 
* The yield of one human embryonic thymus did not exceed 0.5 x 109 cells in our series of fetal 
material. 
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conclude, in line with Crouch [1959], that fetal liver cell take suffers the drawbacks of 
the low content of proliferative cells (i.e. stem cells) and of a lower adaptability of the 
cells to the allogeneic environment (i.e., reduced f-factor) and maybe even to the 
adult syngeneic environment. 
CHAPTER 5 
STEM CELL MULTIPLICATION IN VITRO 
The take problem encountered in fetal liver cell grafting involves the requirement 
for comparatively larger numbers of cells for repopulation as well as the insufficient 
cell yield from one embryonic liver for complete restoration of the recipient. It has 
been shown in mice that this barrier can be overcome by increasing the cell number, 
e.g., by pooling cells from more than one fetal liver per transplant. Such an approach 
presents no problems in inbred mouse strains; in man, however, the pooling of 
livers necessarily leads to a graft of a heterogeneous immunogenetic origin. This has 
significant disadvantages in terms of takeability and logistics [Van Bekkum, 1969a]. 
One of the hypothetical solutions to this problem is to increase the number of stem 
cells from one donor by inducing multiplication of HSC in tissue culture prior to 
grafting. 
There are culture techniques which allow the growth of clones of haemopoietic 
cells, e.g., macrophages, granulocytes, and erythrocytes [Pluznik and Sachs, 1965; 
Bradley and Metcalf, 1966; Stephenson et al., 1971]. However, evidence has been 
provided that these colonies are not formed by HSC but by precursor cells of the 
committed cell lines [Metcalf and Moore, 197la; Gregory et al., 1973]. One possible 
exception is the thin agar layer system (TALS) in wbich irradiated fibroblasts are 
employed as feeder cells. In this culture system, developed in our laboratory, involve-
ment of the pluripotent HSC in the process of colony formation has been suggested 
by the demonstration of an increase in CFU-s in the colonies [Dicke et al., 1971, 
1974]. The basis for the proliferation of the HSC in this in vitro system is not known. 
Elucidation of the factors which influence stem cell proliferation might open the 
possibility for a further increase in the number of stem cells in culture, so that such 
a system might eventually be used for preparative and transplantation purposes. One 
of the first requirements for the understanding of this system is an analysis of the 
kinetics of proliferation in vitro. Unfortunately, such investigations have been im-
possible so far because of the solidified agar in the TALS. 
In this chapter, attempts to obtain proliferation of murine HSC by using the 
constituents of fibroblast cultures in a liquid system as an analogue to the TALS 
will be discussed. The experiments were concerned with an analysis of the in vitro 
kinetics of HSC in this system. It was particularly examined whether an actual increase 
in the initial number of HSC could be obtained. In order to determine whether a 
humoral factor caused stem cell proliferation in the fibroblast-enriched culture, the 
effect of fibroblast conditioned medium was investigated. Certain other stimuli 
which are known to influence haemopoietic cell growth were also tested for stem cell 
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activation. In the first series of the experiments (part A) bone marrow of adult mice 
was used as a source of HSC. In the second part of this chapter (part B), results on 
the behaviour of fetal liver HSC in liquid culture will be reported. 
5.1 Part A: The kinetics of bone marrow stem cells in 
liquid culture 
5.1.1 Effect of fibroblast feeder cells on maintenance of bone marrow CFU-s in culture 
Bone marrow cells were incubated in liquid culture and the cultures were discontinued 
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Fig. 5.1 E./feet of irradiated fibroblast feeder cells and fibroblast-conditioned medium on maintenance 
of bone marrow CFU-s in short term culture. 
The percentage recovery of the initial number of CFU-s (bone marrow) placed in culture was deter-
mined at different intervals. Each point represents the mean (±S.E.) of 4-6 separate experiments 
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at daily intervals for assaying of CFU-s numbers as a function of time. The number 
of CFU -s harvested per culture was expressed as the per cent recovery of the initial 
number seeded. The survival rate of HSC from bone marrow in fibroblast cultures 
was investigated in this manner during the course of a 5-6 day culture period. In 
fig. 5.1, the results of estimations performed at !-day intervals in a limited series of 
experiments are shown. In the control cultures without fibroblasts, CFU-s decrease 
exponentially with a half-time of 24 h, resulting in a recovery of 10% of the initially 
seeded number of CFU-s at 3 days. In the presence of irradiated fibroblasts, the 
initial decline is very similar, but the rate of disappearance is less between 2 and 4 
days (fig. 5.1). All estimates which were performed in these and other experiments 
on day 3 of culture are collected in table 5.1. The results show a statistically signifi-
cant difference in CFU-s values between cultures with and without fibroblasts 
(P < 0.0005). 
Table 5.1 The effect of fibroblasts and FCM on maintenance of bone marrow CFU-s in vitro 
(determined at day 3) 
day 3 recovery significance 
additive to (%)* of difference 
culture nr. of exp. mean ±S.E. with control 
fibroblasts (2000 rad) 19 30.7± 3.7 P<0.0005 
FCM 4 61.5±15.7 P<0.0005 
none (control) 10 9.6± 2.1 
* CFU recovery is expressed as a percentage of the initial number of CFU present at time zero of 
cultivation. 
If the improved maintenance of CFU-s numbers in fibroblast-supplemented cultures 
is due to factors released by the feeder cells into the medium, the early precipitous 
decline in CFU -s might be caused by an insufficient level of these factors in the medium 
during the first day. To test this, the effect of the addition of fibroblast-conditioned 
medium (FCM) at time zero was investigated. It is shown in fig. 5.1 that the resulting 
CFU-s values on day I were significantly higher (P < 0.005) than those in cultures 
containing fibroblasts. The increased yield on day I was followed by increased 
recovery values during the next 3-4 days. After day 4, a fall in the plateau values of 
CFU-s occurred in the FCM culture, which is compatible with the assumption 
that the active principle of FCM becomes depleted at that time. These findings suggest 
that the effect of fibroblasts on stem cell survival is mediated by a factor released by 
these cells. 
It is known that FCM contains colony stimulating factor (CSF) which has the 
same biological activity as CSF from pregnant mouse uterus extract [Van den Engh, 
1974]. It is of interest to know whether the factor affecting stem cells in culture 
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Table 5.2 The effect of "fresh" and "stored" FCM added to the cultures on maintenance of bone 
marrow CFU-s in vitro 
% recovery of CFU-s * 
(day 3) significance 
FCM nr. of exp. mean ±S.E. of difference 
fresh 4 61.5±15.7 
stored** 5 23.4± 4.8 P<0.05 
* CFU recovery is expressed as a percentage of the original number of CFU inoculated into the 
culture. 
** Storage for approximately 4-6 weeks at 4°C. 
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Fig. 5.2 Effect of haemolysate on maintenance of bone marrow CFU-s in short term cultures 
containing irradiated fibroblast cells. 
The percentage recovery of the initial number of CFU-s (bone marrow) placed in culture was deter-
mined at different intervals. Each point represents the mean (±S.E.) of 4-6 separate experiments. 
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is identical to CSF. This seems not to be the case, because the addition of purified 
CSF from pregnant mouse uterus did not result in increased CFU-s recovery. 
Another difference between the two factors is that storage of FCM at 4'C for 4-6 
weeks significantly reduced its capacity for maintaining stem cell numbers (table 5.2), 
while it is known that CSF can be stored for such periods without loss of activity. 
This suggests that the activity exerted by FCM on HSC resides in a material distinct 
from CSF. 
5.1.2 Ejj"ect of other substances on maintenance of bone marrow CFU-s in culture 
Bradley et al. [1972] and Testa and Lajtha [1973] reported that the addition ofhaemo-
lysate or red blood cells to agar culture systems results in an increase in the number 
and size of macrophage-granulocytic colonies and in the improved maintenance of 
CFU-s numbers in culture. Therefore it seemed of interest to investigate the effect 
of haemolysate in combination with fibroblasts or FCM on persistence of CFU-s 
in liquid culture. The result is shown in fig. 5.2. In contrast to Testa's findings with 
red blood cells in agar cultures, haemolysate alone does not maintain the CFU-s 
numbers in the liquid system. However, in the presence of fibroblasts, haemolysate 
gives rise to an increased CFU-s recovery which is statistically significant for the 
day 3 values. 
Note that the initial loss of CFU-s in the first 24 his not influenced by the addition 
of haemolysate. The effect of haemolysate on FCM-containing cultures was also 
examined. Figure 5.3 shows that the presence of haemolysate does not significantly 
change the CFU-s values in the first 4 days of culture. However, the sudden decline 
in CFU-s numbers in FCM cultures on day 5 does not occur in the presence of 
haemolysate. 
Table 5.3 The effect of serum from pre-irradiated mice on maintenance of bone marrow CFU-s in 
culture 
%recovery of CFU-s* 
additive to culture day 1 day 3 day 6 
serum from pre-irr. mice (20%) 65.6 7.8 2.2 
serum from pre-irr. mice (30%) 50 15.6 0.6 
no serum (control) 55.4 12.9 n.d. 
serum from non-irr. mice (30%) n.d. 4.9 n.d. 
Mean values of 2 experiments. 
Serum was obtained from adult mice which had been irradiated 3 days in advance with a lethal dose 
of X-rays. The serum was pooled and freshly added to cultures in two concentrations (20% and 30%). 
These results may also be compared with the data on CFU-s maintenance in non-supplemented cul-
tures plotted in fig. 5.1. 
* CFU recovery is expressed as a mean percentage of the original number of CFU inoculated into 
culture. 
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Fig. 5.3 Effect of haemolysate on maintenance of bone marrow CFU~s in short term culture containing 
fibroblast-conditioned medium. 
The percentage recovery of the initial number of CFU-s (bone marrow) placed in culture was deter-
mined at different intervals. Each point represents the mean (±S.E.) of 4-8 separate experiments. 
Because irradiated mice provide an in vivo environment in which stem cells pro-
liferate rapidly (see e.g., paragraph 4.1.2), we have also investigated the effect of fresh-
ly-obtained serum from 3 day-pre-irradiated mice (with a lethal dose of X-rays) on the 
maintenance of stem cells in culture. The results may be compared with the data 
plotted in fig. 5.1; they indicate that no significant stem cell maintaining activity 
could be demonstrated in the serum (table 5.3). 
5.1.3 Proliferative status of bone marrow CFU-s in culture 
When considering the mechanism underlying the maintenance of HSC numbers in 
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bone marrow cultures exposed to irradiated fibroblasts, it seemed of particular 
interest to establish whether this was the result of: 
a. preservation of HSC originally present in suspension; or 
b. stimulation of HSC proliferation and concomitant disappearance of HSC. 
Since the second process implies an active cycling of stem cells, thymidine suicide 
experiments were carried out during the first 3 days of culture. 
As the in vitro thymidine suicide technique was considered insufficiently sensitive 
to distinguish small differences in cell proliferation, the data were utilized mainly 
Table 5.4 In vitro thymidine suicide of bone marrow CFU-s cultivated for 1, 2, or 3 days 
% of CFU-s surviving thymidine 
type of culture 
fibroblasts 
FCM 
fibroblasts+ 
haemolysate 
FCM+ 
haemolysate 
haemolysate 
control 
(medium) 
thymidine exposures 
(per ml) 
I HBSS 
2 20 !J.Ci 3HTdR 
3 200 ~Ci 'HTdR 
4 20 ~Ci 'HTdR+100 ~g TdR 
1 HBSS 
2 20 !J.Ci 3HTdR 
3 200 ~Ci 'HTdR 
4 20 ~Ci 'HTdR+IOO ~g TdR 
1 HBSS 
2 20 11-Ci 3HfdR 
3 200 ~Ci 'HTdR 
4 20 ~Ci 'HTdR + 100 ~g TdR 
1 HBSS 
2 20 11-Ci 3HTdR 
3 200 ~Ci 'HTdR 
4 20 ~Ci 'illdR+IOO ~g TdR 
1 HBSS 
2 20 11-Ci 3HfdR 
3 200 ~Ci 'HTdR 
4 20 ~Ci 'HTdR +!00 ~g TdR 
I HBSS 
2 20 ~Ci 'HTdR 
3 200 ~Ci 'IDdR 
4 20 ~Ci 'HTdR+100 ~g TdR 
incubation (mean) 
at day I at day 2 at day 3 
100 (3) 100 (1) 100 (3) 
93 65 
+ 
40 
+ 87 45 56 
100 109 87 
100 (2) 100 (2) 100 (4) 
79 
+ 
68 
+ 
75 
+ 78 72 77 
107 100 102 
100 (1) 100 (1) 100 (3) 
88 87 82 
81 87 87 
93 101 97 
100 (3) 100 (I) 100 (3) 
96 71 
+ 
87 
85 79 77 
104 91 92 
100 (2) 100 (I) 100 (2) 
99 110 91 
100 112 103 
98 102 103 
100 (1) 100 (1) 100 (3) 
81 98 111 
88 110 101 
97 103 103 
The number of CFU-s estimated following incubation in HBSS (control) was set at 100%. The other 
CFU-s exposure values are expressed relative to the control. 
~: kill of CFU-s by isotope exposure < 20% - resting 
+: kill of CFU-s by isotope exposure > 20% - cycling 
The figures in parentheses represent the number of separate experiments. 
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to define the cell population as cycling or non-cycling. A suicide percentage of less 
than 20% was arbitrarily taken to characterize a largely resting population of HSC, 
while killing percentages exceeding 20% were taken to indicate cycling popubtions. 
According to these criteria, CFU-s were found to remain predominantly in the 
resting state during a 3-day culture period in control cultures (table 5.4). In contrast, 
a majority of CFU-s cultured in the presence of fibroblasts or FCM were found to 
move into S-phase during the first 3 days of culture, although with a lag period 
of 1 day in the cultures containing fibroblasts. The results also suggest that the cell 
cycle activation of the HSC in the latter cultures was reduced by the addition of 
haemolysate. The lysate itself did not induce proliferation of CFU-s in any of the 
experiments. 
5.1.4 Discussion 
From the survival kinetics presented for CFU-s, it can be concluded that the recovery 
of CFU-s is markedly improved in the presence of irradiated fibroblasts. This main-
tenance of CFU-s numbers is associated with a substantial activation of the cells 
into cycling. The fact that CFU-s numbers are better maintained with a larger fraction 
of the cells proliferating can only be explained by self-replication of at least a propor-
tion of the cycling cells. lf all proliferating stem cells in fibroblast cultures were to 
differentiate into more mature progeny, the loss of CFU-s should be more rapid; 
on the assumption that the mean duration of the S-phase is shorter than 24 h, or, in 
other words, that the 50% fraction of CFU-s wltich is found in DNA synthesis on 
days 2 and 3, do not represent the same cells. If we interpret the 50% S-phase killing 
as representing the entire CFU population which is in proliferation, if we further 
attribute all proliferation to self-renewal activity of CFU, and if we finally assume 
that the mean cycling time, as in vivo, is in the order of 32 h (chapter 4), the CFU 
population in culture should double nearly every day. The observation that the self-
reproduction is not paralleled by a net increase, but by a slow fall in CFU-s numbers 
in the cultures, suggests that some other process (either death or differentiation of 
CFU-s) counteracts the increase due to proliferation. These findings are compatible 
with the observations that stem cell replication occurred in colonies in the TALS 
without resulting in a net increase over the whole culture-dish [Dicke et al., 
1971]. 
It is possible that the reported activity of fibroblasts is shared by cells from other 
sources such as renal tubules. Whereas the latter feeders have been shown to result 
in improved recovery values of CFU-s [McCulloch and Till, 1971], the actual survival 
of CFU-s was somewhat lower (day 3 recovery about 15%) than the values described 
here for fibroblast-enriched cultures (on day 3; 30% CFU-s recovery). These investi-
gators also performed 3HTdR uptake experiments and noted an increased suicide 
of CFU-s in cultures containing kidney tubules. However, these data are not directly 
comparable to our suicide figures, because a prolonged isotope exposure was employed 
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in the former study (the isotope was incorporated for 2 days into the bone marrow 
cultures). 
The similar effect of fibroblasts and FCM on the maintenance of CFU-s numbers 
and on their cycling status suggests that the effects of fibroblasts are mediated by a 
factor elaborated by the cells into the medium. Cultures to which FCM has been 
added, did not show the delay seen in fibroblast supplemented cultures during the 
first 24 h, which may indicate that this lag period is due to a gradual build up of an 
effective level of the factor in the medium. It is difficult to explain why Testa and 
Lajtha [1973] using a FCM supplemented culture obtained strikingly lower CFU-s 
survival profiles; by day 4, only 10% of the original number of CFU-s could be 
detected. Since these authors do not explicitly mention the necessity of using freshly 
harvested medium, the disagreement with our data may depend on their use of aged 
medium. 
Since it has been confirmed that promotion of stem cell maintenance in culture 
cannot be achieved by CSF [Summer et al., 1972; Van den Engh, 1974], a factor other 
than CSF should be considered as activating stem cells in cultures containing fibro-
blasts. The factor differs from CSF in that it cannot withstand a storage period of 
4-6 weeks at 4 oc. It is certainly of interest to investigate whether there is a relation-
ship between the fibroblast-derived factors and other stem cell cycle activating sub-
stances, e.g., cAMP and various neurotransmitters [Byron, 1971]. 
Among the multiple effects of red blood cells and their products on in vitro haemo-
poiesis [Bradley et al., 1972], a favourable influence on the survival of stem cells in 
FCM containing cultures has been reported [Testa and Lajtha, 1973]. Our results in 
liquid culture indicate that the lysate alone is unable to promote an improved CFU-s 
maintenance as do fibroblasts and their products. The additional rise in absolute 
CFU numbers in fibroblast cultures supplemented with haemolysate goes parallel 
with a substantial reduction in the sensitivity of these cells to 3 HTdR killing. These 
phenomena suggest that the enhanced persistence of HSC by fibroblasts and by hae-
molysate may not be due to the same mechanism. Whereas a process of active stem 
cell proliferation is induced by fibroblasts, indications are that the lysate when 
combined with the fibroblasts may operate by preventing resting stem cells from 
differentiating or dying. 
On the basis of the available results, it is not possible to speculate whether the 
stem-cell-activating mediators released by fibroblast feeder cells have physiological 
relevance. Though stem cells replicate rapidly in irradiated mice, the failure to demon-
strate in vitro stem cell maintenance activity in the serum of these mice may be due to 
interference by inhibitors rather than to the actual absence of in vivo stern cell stimula-
ting regulators in the serum. 
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5.2 Part B: The kinetics of fetal liver stem cells in liquid culture 
5.2.1 Maintenance of fetal liver CFU-s in culture 
The survival of fetal liver HSC in culture was determined in the same way as in the 
experiments with bone marrow cells (fig. 5.4). On comparing figs. 5.1 and 5.4, a 
striking difference between the maintenance of bone marrow and fetal liver CFU-s 
can be seen; the persistence of fetal liver CFU-s in unstimulated cultures was markedly 
better. Whereas only 10% of the initial number of bone marrow CFU-s could be 
recovered in control cultures after 3 days, a significantly higher proportion of 36% 
( ± 5.5) of seeded CFU-s was found in fetal liver cell cultures (P < 0.05). As fetal 
liver CFU-s are in a rapidly cycling state in vivo [Becker et al., 1965; Duplan, 1970], 
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Fig. 5.4 Effect of fibroblast conditioned medium and haemolysate on maintenance of fetal liver CFU-s 
in short term culture. 
The percentage recovery of the initial number of CFU-s placed in culture was determined at different 
intervals. Each point represents the mean (±S.E.) of 6-8 separate experiments. 
FETAL LIVER STEM CELLS IN LIQUID CULTURE 99 
it is assumed that the increased fetal liver CPU values are due to a continuation of 
the proliferative activity following the transfer to culture. 
Thymidine suicide experiments confirmed that fetal liver CFU-s proceed to 
proliferate following their seeding in non-supplemented cultures (table 5.5). A high 
proportion of the cells is still found in cycle on day 2; only by day 3 do the cells 
appear to shift to a predominantly resting state. 
Table 5.5 In vitro thymidine suicide of fetal liver CFU~s in non~supplemented cultures 
thymidine exposures 
(per ml) 
% of CFU~s surviving thymidine 
incubation (mean) 
I HBSS 
2 20 ~Ci 'HTdR 
3 200 ~Ci 'HTdR 
4 20 ~Ci 'HTdR+!OO ~g TdR 
at day 2 
100 (2) 
78 + 
66 
93 
at day 3 
!00 (3) 
89 
82 
!08 
The number of CFU~s estimated following incubation in HBSS (control) was set at 100%. The other 
CFU-s exposure values are expressed relative to the controL 
-: kill of CFU-s by isotope exposure < 20% - resting 
+: kill of CFU-s by isotope exposure > 20% -cycling 
The figures in parentheses represent the number of separate experiments. 
5.2.2 Effect of FCM on maintenance of fetal liver CFU-s in culture 
Because the best maintenance of bone marrow CFU-s numbers was observed in 
FCM cultures, the influence of FCM on fetal liver CFU-s was also studied. The 
numbers of fetal liver CFU-s were found to persist at a plateau of about 70% during 
the first 3 days (fig. 5.4). Comparison of these values with the control figures shows 
a clear difference (stat. sign. at day 3: P < 0.001). Following day 3, a decline in CFU-s 
in culture takes place. In contrast to the CFU-s in the control cultures which are no 
longer proliferating on day 3 (table 5.5), a large proportion continues inS-phase during 
this time interval in the cultures containing FCM (table 5.6). 
5.2.3 Effect of haemolysate on maintenance of fetal liver CFU-s in culture 
Neither haemolysate alone (fig. 5.4) nor haemolysate in combination with FCM 
(fig. 5.5) promotes the increased survival of CFU-s. The failure of the lysate to influence 
cycling of fetal liver CFU-s is compatible with the impression gained in the bone 
marrow experiments that the lysate selectively preserves a resting population of CFU-s. 
It was also found that the proliferative status is not significantly altered in the 
presence of the red blood cell preparation (table 5.6). 
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Table 5.6 In vitro thymidine suicide of fetal liver CFU-s following 3 days of culture 
% of CFU-s surviving 
thymidine exposures thymidine incubation 
type of culture (per ml) (mean) 
FCM 1 HBSS !00 (2) 
2 20 ~Ci 'HTdR 75 
+ 3 200 !J.Ci 3HTdR 69 
4 20 ~Ci 'HTdR+100 ~g TdR 92 
FCM +haemolysate 1 HBSS 100 (!) 
2 20 ~Ci 'HTdR 8! 
+ 3 200 v.Ci 3HTdR 75 
4 20 ~Ci 'HTdR+100 ~g TdR !00 
haemolysate 1 HBSS 100 (4) 
2 20 [LCi 3HTdR 100 
3 200 ~Ci 'HTdR 91 
4 20 ~Ci 'HT dR + !00 ~g T dR 89 
medium (control) I HBSS !00 (3) 
2 20 [J.Ci 3HTdR 89 
3 200 [J.Ci 3HTdR 82 
4 20 ~Ci 'HTdR+IOO [Lg TdR 108 
The number of CFU-s estimated following incubation in HBSS (control) was set at 100%. 
The other CFU-s exposure values are expressed relative to the control. 
~: kill of CFU-s by isotope exposure < 20% ~resting 
+: kill of CFU-s by isotope exposure > 20% - cycling 
The figures in parentheses represent the number of separate experiments. 
5.2.4 Discussion 
In vitro survival studies and thymidine suicide experiments indicate that the improved 
maintenance of fetal liver CFU-s in nonsupplemented cultures results from a con-
tinuation of in vivo cycling of CFU-s. This is consistent with the finding that bone 
marrow CFU-s which are rapidly proliferating in the donor also survive in greater 
numbers in culture [Testa and Lajtha, 1973]. It was found that the fetal liver CFU-s 
in the control cultures cease active cell cycling by day 3. The finding that CFU-s 
showed prolonged survival and continued to be in a proliferative state for a longer 
period in the presence of FCM, suggests that the increase in survival of fetal liver 
CFU-s in FCM supplemented cultures depended on self-replication of CFU-s due 
to action of the stem cell activating factor (SAF) in the FCM. The level of recoverable 
fetal liver HSC in FCM supplemented culture appeared to be of the same order of 
magnitude as for bone marrow cells, i.e., at about 70% at day 3. The fact that SAF 
did not produce an actual increase in the initial number of fetal liver HSC or bone 
marrow HSC indicates that the fibroblast system as described above does not yet 
fulfil the need for stem cell multiplication for clinical bone marrow transplantation. 
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Fig. 5.5 Effect of haemolysate on maintenance of fetal liver CFU-s in short term cultures containing 
fibroblast conditioned medium. 
The percentage recovery of the initial number of CFU-s placed in culture was determined at dif-
ferent intervals. Each point represents the mean (±S.E.) of 6-8 separate experiments. 
As has been suggested above, an explanation for the absence of a net increase in HSC 
numbers during culture may be the simultaneous operation of differentiation stimuli 
at the level of HSC. This would be compatible with the indications that the HSC is 
the parent cell of at least some of the colonies of mature cells which grow in the 
fibroblast culture systems. [Dicke et a!., 1971]. If this is the case, the separation of 
SAF from such associated stimulative substances in FCM may be of crucial im-
portance for further development of the manipulation of stem cell reproduction. 
CHAPTER 6 
DELAYED GRAFT VERSUS HOST REACTIVITY OF 
FETAL LIVER CELLS 
The literature contains extensive experimental data indicating that the delayed Gv H 
disease following allogeneic fetal liver cell transplantation is less severe than that 
following bone marrow transplantation [Uphoff, 1958; 1959; Urso et al., 1959; 
Crouch, 1959; Lengerova, 1959; Barnes et al., 1961; Bortin and Saltzstein, 1969]. 
It is not certain as to which cellular element in the liver cell graft is responsible for 
the weak GvH reaction. It could be due to the progeny of lymphocytes which may be 
present in the graft in very small numbers or to immunocompetent cells originating 
from the HSC during the first month after transplantation. The answer to this ques-
tion has direct practical implications because, if small numbers of lymphocytes cause 
the weak Gv H reaction, these might be removed by density fractionation of fetal 
liver cell suspensions. Our finding that mature lymphocytes could not be detected in 
fetal liver neither by a morphological survey nor by mitogen stimulation, even in 
density subfractions (paragraph 3.4), seems to provide an answer. The indication is 
that lymphocytes newly matured from the HSC after grafting give rise to the GvH 
reaction. 
With the consideration that lymphocytes differentiating from HSC following the 
cell transfer play a principal role in the occurrence of delayed GvH disease, the 
question arises as to whether the reduced GvH mortality could be due to a failure 
of the fetal HSC to generate functionally competent lymphocytes. This is quite un-
likely, because the lymphoid cells arising from fetal liver grafted cells have been 
found to be capable of eliciting GvH reactions in third party hosts within 30-60 days 
after transplantation [Tyan, 1964; Van Bekkum, 1965]. It is also not likely in view 
of the same rate of recovery of mitogen responsiveness in spleen cells following the 
inoculation of fetal liver and bone marrow cells (paragraph 4.1.4). Thus it seems that 
the decreased GvH mortality following fetal liver cell transplantation is not the conse-
quence of a deficient production of immunocompetent cells by the grafted embryonic 
HSC. It suggests rather that the lymphocytes arising from fetal liver HSC in the host 
tissue environment differ from those originating from bone marrow HSC in that they 
more easily attain a state of specific immunological tolerance. 
The available data do not provide evidence on whether the characteristics of the 
lymphocytes developing from the fetal liver cell transplant differ from those being 
generated by the bone marrow as the result of: 
a. the low number of HSC in the liver leading to a very gradual appearance of 
immunocompetent cells with a resulting tolerance; or 
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b. qualitative differences which already reside in the fetal liver HSC and which are 
transmitted to the lymphocytic offspring. 
Clarification of this situation is of some practical importance, because, if the first 
factor accounts for the mild outcome of GvH disease, the use of smaller numbers 
of HSC can be considered as a means of preventing the delayed type of GvH disease, 
as has been advocated by Van Bekkum [1972] for treatiug CID infants (sneak-in). 
The experiments described in this chapter were concerned with this issue. 
6.1 Survival experiments after transplantation of fetal liver and 
bone marrow cells 
The severity of GvH disease was determined following the infusion of equal numbers 
of bone marrow and fetal liver CFU-s, in order to exclude quantitative differences in 
the numbers of grafted HSC as the reason for the different patterns of GvH disease. 
Moreover, to rule out the influence of cells other than HSC, the effect of purified 
HSC grafts from both sources on delayed GvH disease was also studied. 
The survival data after fetal liver cell transplantation are collected in table 6.1 
(left section). It is evident from these results that the start of the mortality followed 
an effective protection during the first 30 days; mortality continued to occur over the 
second and the third months. The final 100-day survival varied between 32-42%. 
The progressive mortality was, according to the time of appearance, typical of a 
delayed Gv H syndrome. This survival pattern was in clear contrast with the com-
parable bone marrow experiments (table 6.2, left section) in which, after a similarly 
effective initial repopulation, almost total mortality had occurred at 100 days after 
transplantation. It should be noted that this mortality was strictly confined to the 
second month in contrast to the fetal liver experiments. 
Transplantation of purified stem cell fractions containing the same number of 
Table 6.1 Survival following allogeneic fetal liver cell transplantation (C57BL---+CBA) 
group I group II 
unfractionated fetal liver stem cell concentrates (fetal liver) 
graft size 
for groups I and II nr. of nr. of 
nucl. nucl. 
nr. of nr. of cells nr. of %survival cells nr. of %survival 
CFU-s CFC* X 106 mice day 30 day 60 day 100 X }06 mice day 30 day 60 day 100 
1200 56000 20-30 41 80 49 32 3-4 41 95 59 37 
1900 86000 35-50 72 92 56 42 5-7 38 95 47 32 
I pooled 
data 113 88 53 39 79 95 53 35 
* Calculated by correction for spleen colony efficiency factor (2.2%). 
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Table 6.2 Survival following allogeneic bone marrow transplantation ( C57BL .....o;.- CBA) 
group I group II 
graft size unfractionated bone marrow stem cell concentrates (bone marrow) 
for groups I and II 
nr. of %survival nr. of %survival 
nr. of nr. of nucl. cells nr. of day day day nucl. cells nr. of day day day 
CFU-s CFC* X 106 mice 30 60 100 X 106 mice 30 60 100 
1200 30000 4-5 39 99 5 3 0.7 27 74 15 4 
1900 46000 6-8 47 94 6 4 1 -1.2 37 86 5 0 
3500 86000 12-15 81 84 1 0 1.8-2.2 33 91 3 0 
I pooled 
data 167 80 4 2 97 85 7 
* Calculated by correction for spleen colony efficiency factor (4.1%). 
stem cells as were present in the unseparated haemopoietic cell transplants failed to 
modify the survival rate in the fetal liver or in the bone marrow infused hosts (tables 
6.1 and 6.2, right sections). The unaltered GvH mortality pattern following the 
inoculation of stem cell concentrates (from which as much as 80-90% of the other 
100 
~ 
transplants (1200-3500 CFU-s) 
·; 80 bone marrow 
~ bone marrow stem cell fr-. 
" 
fetal liver 
" 0 
• 
fetal liver stem cell fr • 
~ 60 
40 
20 
2 4 6 8 10 12 
weeks after transplantation 
Fig. 6.1 Survival of lethally irradiated mice following allotransplantation of fetal liver and bone 
marrow cells (C57BL.....,._CBA) 
Pooled data from tables 6.1 and 6.2. 
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cells had been selectively removed (chapter 3)) indicates that the role of cells other 
than stem cells in the grafted cell suspension can be neglected in the pathogenesis of 
the delayed GvH reaction. This is consistent with the idea that the delayed GvH 
mortality after both fetal liver cell and bone marrow transplantation is initiated by 
cells derived from stem cells in the tissue. It is also apparent that the degree of 
delayed mortality among the subgroups receiving varying numbers of CFU-s of fetal 
liver or bone marrow did not change significantly (tables 6.1 and 6.2). In view of this, 
it is likely that the distinct mortality patterns are conditioned by qualitative prop-
erties of the embryonic and adult stem cells rather than by quantitative parameters. 
The survival profiles following fetal liver cell and bone marrow transplantation 
give an overall picture of the characteristic difference between the two tissues (fig. 6.1 ). 
Despite the lower incidence of death following fetal liver cell grafting, the proportional 
mortality is still of considerable magnitude, namely, about 60%. 
The literature [Barnes eta!., 1962; Bortin and Saltzstein, 1969] contains indications 
that a primary incomplete immune restoration rather than a secondary immuno-
deficiency due to GvH disease is responsible for the delayed mortality following fetal 
liver cell treatment. A precise distinction between the two possible etiologies is made 
difficult by the fact that GvH reactions are regularly accompanied by immuno-
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Fig. 6.2 Weight curves of mice following allotransplantation with unfractionated bone marrow and 
fetal liver cells. 
The numbers of mice which were used for the follow-up measurements of body weight varied be-
tween 36-41 per group. 
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Table 6.3 Pathology of allogeneic chimaeras ( C57BL-+ CBA} 
fetal liver 
lesions nr. of animals* 
duodenum 
- no abnormalities 3/10 
- dead cells or cellular 
debris 7/10 
ileum 
- no abnormalities 2/10 
- dead cells or cellular 
debris 8/!0 
colon 
- no abnormalities 4/10 
- dead cells; submucous 
oedema 2/!0 
- cellular debris, dead 
cells, submucous oedema, 
infiltration of I. propria, 
hyperplastic crypts 4/10 
liver 
- no abnormalities 0/!0 
- dead cells; granulocytic 
infiltration 10/!0 
spleen 
- no abnormalities 8/10 
- hypotrophy of 
lymphoid cells 2/10 
lymph node 
- normal repopulation 
(follicles with germ centers) 6/10 
- atrophy 4/10 
bone marrow 
- normal repopulation 10/10 
skin 
- normal 0/10 
- dyskeratotic cells; 
acanthosis 10/10 
grading of GvH pathology 6/10 
per individual recipient 4/10 
degree of 
GvH disease 
± 
± 
± 
+ 
±/+ 
+ 
+ 
±I+ 
minimal 
moderate 
bone marrow 
nr. of animals* 
6/10 
4/10 
7/10 
3/10 
2/10 
0/10 
8/10 
5/10 
5/10 
10/10 
0/10 
2/10 
8/10 
10/10 
0/10 
10/10 
3/10 
6/10 
1/10 
degree of 
GvH disease 
± 
± 
+I++ 
+I++ 
+ 
±I+ 
minimal 
moderate 
severe 
Ten mice from each group of recipients treated with fetal liver cell or bone marrow grafts conw 
taining 1200 CFUws were killed at 5 weeks after transplantation for histopathological examination 
of the organs. The degree of GvH reaction has been scored according to Van Bekkum and De Vries 
[1967]:- no GvH lesions;± dubious;+ slight;++ moderate;+++ severe lesions. Grading 
of GvH pathology per individual host was done according to the criteria of ACS/NIH Bone Marrow 
Transplant Registry (1973). 
* The proportion refers to the fraction of the total number of mice (10) which manifested the histow 
logical changes concerned. 
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deficiency [Simonsen, 1962; Van Bekkum and De Vries, 1967; Barchilon and 
Gershon, 1970; Zaleski and Milgrom, 1973]. 
In an attempt to make such a distinction, the histological changes in various 
organs have been studied by sacrificing mice at 5 weeks after the cell infusion. Micro-
scopic examination revealed lesions typical of delayed GvB disease [Van Bekkum 
and De Vries, 1967]; the changes observed were colitis (necrosis, infiltration, sub-
mucous oedema), lymph node atrophy, cellular necrosis in the liver, and slight 
abnormalities of the skin (acanthosis, dyskeratosis) (table 6.3). The marrow was 
always found to be fully repopulated. These microscopic observations coincided 
with the characteristic clinical symptoms of diarrhoea and weight loss (fig. 6.2). On 
the whole, the macroscopic and microscopic abnormalities in the bone-marrow-
treated recipients were similar but somewhat more pronounced. A high frequency of 
infectious complications was established. The incidence of positive blood cultures 
following death was in the order of 50-80% and involved mostly Gram negative 
< 
•• 0 
~ , 
0 
< 
~ 
c 
e 
0 
< 
. 
0 
0 
-" 
"' ~ D 
4 
10 
Concanavalin A 
• 
.. ~ 
" 
• 
• 
• 
• 
8-12 weeks 
chimaeras 
E. Coli lipopolysaccharide 
A 
•• 
mice transplanted with 
"'- fetal liver (toto!) 
c. fetal liver (stem cell fr.) 
• normo I control 
8-12 weeks 
chimaeras 
Fig. 6.3 In vitro mitogen responsiveness of spleen cells from allogeneic fetal liver cell chimaeras 
(C57BL~CBA). 
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bacteria. These findings are consistent with the classical picture of a delayed Gv H 
syndrome [Van Bekkum and De Vries, 1967]. 
In order to verify whether an immunodeficient state plays a role in the mortality 
of the fetal liver cell recipients, as found after allogeneic bone marrow transplantation 
[Van Bekkum and De Vries, 1967; Van Bekkum et al., 1974], the mitogen responsive-
ness of the spleen cells was estimated. It was found that, during the period of 8-12 
weeks after grafting, the spleen cells of the test animals displayed a subnormal in vitro 
lymphocyte reactivity to Con A (fig. 6.3). It had been demonstrated in chapter 4 
that the mitogen reactivity in the syngeneic situation had returned to normal levels 
by this time. The cells of the animals gave normal responses to LPS, with one excep-
tion, which indicates that the recovery of the cell mediated immunity may be specific-
ally impaired. If the decreased lymphocyte activity represents a primary immuno-
deficiency, the addition of lymphocyte precursors to the graft might compensate for 
the deficiency. On the basis of the findings of Bortin and co-workers [Bortin and 
Saltzstein, 1969; Bortin and Rimm, 1970], the effect of injection of fetal thymocytes 
as regards their ability to promote survival after fetal liver cell transplantation was 
investigated. 
The results (table 6.4) show that the combination of fetal thymus lymphocyte 
precursor cells with the fetal liver cells did not have a beneficial effect on 100 day 
survival. Low numbers of adult thymocytes also had no positive effect, whereas 
higher numbers induced acute GvH disease. The finding that the immunological 
incompetence could not be overcome by treatment with lymphoid precursor cells, 
suggests that it represents a secondary manifestation of Gv H disease. 
Table 6.4 Effect of injection of fetal and adult thymocytes on survival following unfractionated fetal 
liver cell and bone mar-row transplantation (C57BL-+CBA) 
nr. of mice 
fetal liver cells 
28 x 106 nucl. cells - 2000 CFU-s 
no thymocytes 27 
+O.l-1 x 106 fetal thymocytes 29 
+ 5 x 106 fetal thymocytes 28 
+0.1 x 106 adult thymocytes 14 
+5 x 106 adult thymocytes 13 
bone marrow cells 
6.4 x 106 nucl. cells- 2000 CFU-s 
no thymocytes 
+5 x 106 fetal thymocytes 
+5 x 10u adult thymocytes 
19 
20 
20 
per cent survival 
day 30 day 60 
81 44 
83 28 
89 25 
86 29 
23 8 
95 5 
95 5 
20 0 
The fetal and adult thymus cells were added to the haemopoietic cell transplant. 
day 100 
22 
17 
18 
21 
0 
5 
5 
0 
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6.2 Discussion 
The data presented in this chapter show improved survival of recipients receiving 
fetal liver cells as compared to animals grafted with adult allogeneic marrow. This 
is in accordance with the consensus in the literature on the favourable effect of fetal 
liver cells in reducing delayed mortality (table 6.5, summary of results). The dif-
ference in the survival pattern following fetal liver cell and bone marrow grafting 
has been shown to be due to differences in the severity of delayed GvH disease 
provoked by the two tissues. 
Table 6.5 Survival following non-isogeneic fetal liver cell transplantation (mouse) 
(collected data) 
fetal liver 
cell nr. 
strain dose of 
investigator combination X }061 mice 
Uphoff, I958 C57BL-+F1 3.7-I5 40 
(C57BL x DBA) 
DBA-+F1 3.7 10 
Crouch, 1959 C57BL~CBA 12.5-50 60 
70-I35 I8 
CBA~C57BL 12.5-50 49 
Urso et al., 1959 F,(IOI X C3H)~ 50-65 47 
F,(C57BLXA) 
Lengerova, 1959 (non inbred) 20 104 
Barnes et al., 1961 C57BL~CBA 3-I2 ? 
Bortin et al., 1969 A/J-+CBA/J 20 160 
20 30 
LOwenberg, 1974 C57BL~CBA I200 41 
CFU-s 3 
86000 76 
CFC 4 
1 per recipient ~of bone marrow and fetal liver) 
2 60 day survival 
gestational 
age 
(donor) 
in days 
I4-I6 
14-16 
I4-16 
14-16 
14-I6 
12-I9 
2-3 
prenatal 
I5-I8 
I3 
18 
I6 
I6 
bone marrow 
(when included as ref-
% erence in same study) 
survival nr. of %survival 
90--IOO d mice 90-IOO d 
92 I04 II 
90 80 34 
14' 34 36' 
59" 
87' 40 40' 
71 88 15 
62.5 
80-60 ? IO 
42 50 0 
58 
32 39 3 
42 81 0 
3 1200 CFU-s- 4-5 x 106 bone marrow or 20-30 x 106 fetal liver nucl. cells 
4 86000 CFC - 12-15 x 106 bone marrow or 35-50 x 106 fetal liver nucl. cells 
It was considered unlikely that the mortality after transplantation of fetal liver 
cells was due to a primary immunological insufficiency. This conclusion was based 
on the following findings: 
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I. The histological picture of the recipient animals was consistent with characteristic 
Gv H disease. 
2. The absence of a beneficial effect on survival by the supplementation of the graft 
with fetal thymic cells. 
The marked lymphoid tissue atrophy, the in vitro signs of reduced mitogen activity, 
and the frequent occurrence of overt infections are suggestive that the immuno-
deficiency, though associated with and most likely caused by Gv H disease, is the 
main causative factor in the mortality after fetal liver cell transplantation. The results 
of our experiments with the fetal thymus, do not agree with the data of Bertin and 
co-workers, who observed a positive effect of these cells on survival and concluded 
that a primary immunodeficiency was the major cause of late mortality after allo-
geneic fetal liver cell infusions [Bertin and Saltzstein, 1969; Bertin and Rimm, 1970]. 
The reason for this disagreement is unclear; perhaps differences in the mouse strain 
combinations are involved. 
It has been demonstrated that the usefulness of gradient centrifugation is restricted 
to the elimination of cells responsible for eliciting the acute GvH reaction [Dicke 
et a!., 1968, 1969]. This procedure apparently does not abrogate the delayed GvH 
reactions arising from bone marrow or from fetal liver cells. 
The delayed GvH reactions occurring after bone marrow and fetal liver cell 
transplantation are presumed to be evoked by immunocompetent cells originating 
from the grafted HSC population. It cannot be excluded that lymphocytes derived 
from committed lymphoid precursor cells present in the graft take part in the delayed 
GvH reaction. Information with regard to the involvement of this cell population in 
the production of GvH disease can be obtained only when detection methods for 
committed lymphoid precursor cells become available. The results of our experiments 
in which purified stem cell suspensions were employed as grafts are in accordance 
with the concept that differentiation of HSC into immunocompetent cells is the cause 
of the delayed GvH reaction. The fact that the delayed GvH disease appeared to be 
unaffected by the removal of roughly 90% of the more differentiated cells in the grafts 
is compatible with the above concept. 
These results are in support of inherent differences in fetal liver HSC as compared 
to bone marrow HSC. The possibility that numerical differences in the HSC popula-
tions in fetal liver cell and bone marrow grafts were responsible for the different 
degrees of delayed GvH disease was dismissed on the basis of survival data of groups 
of mice which received varying dosages of CFC and CFU-s. The bone marrow and 
fetal liver subgroups of recipients grafted with the largest cell inoculum received 
approximately equal quantities of HSC (calculated at about 86,000 CFC); yet the 
profiles of GvH mortality were consistently characteristic of the source of the haemo-
poietic cells transplanted. The possibility that a different distribution of injected 
HSC to spleen and marrow accounted for the divergent type of GvH syndrome also 
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was unlikely because the distinct survival patterns after fetal liver cell and bone 
marrow grafting remained unchanged when the numbers of CFU-s were matched 
instead of the CFC numbers. The data therefore favour the idea that the fetal liver 
type of GvH disease is brought about by specific attributes of embryonic stem cells. 
This leads to the conclusion that the development of acute and delayed GvH 
disease is determined by the content of mature immunocompetent cells in the grafts 
[Van Bekkum and De Vries, 1967; Dicke et al., 1969] and the type of the HSC 
grafted will determine whether a severe or a mild delayed GvH reaction will appear. 
It is plausible to relate the special stem cell properties of fetal liver cells to the imma-
ture stage of development. Since embryonic HSC are the precursors of the adult 
stem cell population in normal ontogenesis [Metcalf and Moore, 197lf], it would 
have been more logical to expect that a bone marrow pattern of GvH mortality would 
occur after fetal liver cell grafting, be it with a certain delay. This would also have 
been in keeping with the finding that fetal liver stem cells undergo normal ontogenetic 
cellular changes after transfer to an adult environment [Metcalf and Moore, l97lf]. 
In view of the observation that lymphocyte recovery after fetal liver cell and bone 
marrow transplantation occurred at a similar rate (chapter 4), there is no real indica-
tion suggestive of a delayed development of immunologically competent cells, which 
would in turn favour the induction of tolerance in the fetal liver chimaeras. As the 
less severe GvH reaction has to be attributed to an enhanced tendency of the newly 
generated lymphoid cells to develop immunological tolerance to the antigens of the 
allogeneic hosts [Vos et al., 1960; Tyan, 1964], this tendency has to be regarded as 
the expression of intrinsic differentiation properties specific of fetal liver stem cells. 
It seems to imply that the bone marrow stem cell offspring originating from grafted 
fetal liver stem cells in the allogeneic host is not identical with a bone marrow stem 
cell population which has descended from embryonic liver cells in normal maturation, 
i.e., noninterrupted and in a syngeneic environment. 
Although the survival rate following fetal liver cell transplantation proved to be 
superior to bone marrow grafting in the present investigation, there is still a consid-
erable incidence of mortality when no additional treatment is applied. The demonstra-
tion of a high incidence of terminal septicaemia in mice expiring from fetal liver GvH 
disease suggests that bacterial infections are a decisive step in the sequence of patho-
logical events leading to death similar to the situation in GvH disease following bone 
marrow grafting. As it has been shown that the delayed GvH mortality after bone 
marrow transplantation is not due to direct immunological damage to organs and 
tissues but rather to complicating infections [Van Bekkum et al., 1974], it is suggested 
that the differences between bone marrow and fetal liver GvH mortality can be 
explained as a reduced susceptibility to infections due to minimized GvH reactions. 
It is to be expected that, similar to bone marrow grafting, the prevention of super-
imposed infections by inducing and maintaining the gnotobiotic state for the time 
of the immunosuppressive condition may prevent the mortality during that period. 
CHAPTER 7 
GENERAL DISCUSSION. 
IMPLICATIONS AND RECOMMENDATIONS FOR 
FETAL LIVER CELL TRANSPLANTATION IN HUMANS 
7.1 The position of fetal liver cell transplants 
Since methods have become available in recent years, which are effective in the 
prevention of acute GvH disease in allogeneic bone marrow transplantation [Dicke 
et al., 1968, 1970], it is the delayed GvH reaction that poses the major problem 
today. In order that haemopoietic cell transplantation may become a reliable treat-
ment regimen for patients with a defective stem cell compartment (aplasia, CID), 
attempts to prevent or control GvH disease are of primary importance. The GvH 
reaction is difficult to treat once it has become manifest; therefore, attention has been 
increasingly directed towards possible modes of prevention. In this connection, fetal 
liver cell transplants are of great interest, firstly, because they do not elicit acute GvH 
reactions and, secondly, because they have been shown to induce less severe delayed 
GvH reactions than allogeneic bone marrow cells. This procedure deserves special 
consideration, because the effect of measures which are being developed for the 
control of GvH disease following allogeneic bone marrow grafting is expected to be 
limited. 
In the first place, progress in donor selection is not likely to fulfil the needs of a 
generally preventive method because a. the approach of selecting the non-GvH 
inducing subclass among the histocompatible sibling donors, if successful, will tend 
to confine bone marrow therapy to an even more select group of patients; b. one 
cannot be very optimistic about the successful prevention of GvH disease by using 
MLC/HLA compatible donors outside the family. This latter opinion is based on the 
fact that even bone marrow grafts from siblings who are full-house identical for the 
major histocompatibility complex induce GvH reactions in as much as 50% of the 
cases in the treatment of aplasia [Storb et al., 1974]. It is anticipated therefore that 
progress in histocompatibility testing will at best provide only a partial solution to 
the problem of delayed GvH disease. 
Secondly, the procedure of bacteriological decontamination and isolation is not 
expected to completely solve the problem. This procedure was highly promising in 
mice in that delayed GvH mortality could be completely prevented while allowing 
restoration of the immune system [Van Bekkum et al., 1974]. Very recent data of 
Hendriks et al. [1974] in the monkey confirmed that decontamination significantly 
mitigated the lesions characteristic of delayed type GvH disease. However, this was 
associated with a prolonged state of immuno-deficiency during which the animals 
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died from overwhelming viral infections. Although the method had a satisfactory 
effect in postponing or preventing the onset of delayed GvH mortality following 
allogeneic bone marrow transplantation, it did not offer a complete solution. 
Other current approaches (e.g., immunological enhancement) aimed at the control 
of delayed GvH reactions cannot be considered for the time being because they are 
not at a stage of development which meets the conditions for practical application. 
Considering this, there are obvious needs for other methods to avoid severe 
delayed GvH disease. On the basis of the existing experimental and clinical evidence, 
it is envisaged that fetal liver cell grafts may, at least for a certain group of patients, 
satisfy these needs. Thus, for the time being, fetal liver cell grafts do seem to have 
practical applicability, although the category of potential recipients is as yet limited. 
7.2 Graft versus Host disease after fetal liver cell transplantation 
The experimental data collected in this study have shown that the moderate character 
of the delayed GvH reaction produced by fetal liver cells is due to special properties 
intrinsic to the embryonic HSC and not to numerical differences between the HSC 
in the fetal liver and bone marrow cell populations. It was demonstrated that stem 
cell purification of the fetal graft prior to transplantation (devised particularly for the 
elimination of acute Gv H reactive cells from the graft) did not modify the incidence of 
GvH mortality in the mouse. It is not certain that a similar conclusion applies to 
human fetal liver cell grafts, in view of the observations on the PHA reactivity of 
fetal liver cells (table 7.1). In our limited series, strongly positive PHA reactivity was 
found at a gestational age of 16 weeks or later. 
These findings, considered in connection with previous results of Dicke et al. 
Table 7.1 PHA responsiveness of humanfetalliver and fetal thymus cells 
fetal liver 
embryonic control 
age (wks) dpm 
8 288 
12 3182 
16 55 
16 783 
16 5431 
17 1756 
17 120 
18 780 
IS 2228 
18 15 
18 21 
18 82 
PHA response 
L'.dpm 
+ 25 
182 
+ 106 
+ 62 
+1619 
305 
+ 87 
- 80 
+ 826 
+ 2 
+ 334 
+ 196 
fetal thymus 
control 
dpm 
29 
22 
95 
11 
12 
10 
PHA response 
L'.dpm 
+ 1162 
+ 2806 
+ 14560 
+ 1028 
+ 530 
+ 1948 
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Table 7.2 PHA responsiveness of adult and fetal haemopoietic cell grafts in mouse and man 
bone marrow 
fetal liver 
* According to Dicke et al. [1969, 1970]. 
mouse man 
+* 
-or+ 
[1968, 1970], reveal a species difference between human beings and rodents as regards 
the proportion of PHA responsive lymphocytes in both fetal liver and bone marrow: 
these cells being considerably more abundant in the human tissues than in the anal-
ogous haemopoietic tissues of mice (table 7.2). Therefore, one should be aware of 
the possibility of inducing acute GvH disease with fetal liver cell transplantation 
in humans. This raises the question as to whether special preventive measures to avoid 
these complications should be taken (see paragraph 7.4). 
7.3 Considerations on the take of fetal liver cell grafts 
It was outlined in chapter 1 that failures of take represent a serious bottleneck in 
fetal liver cell transplantation in man. The uncertainty as to the source of the diffi-
culties prompted the present investigation into the biological basis of the take of 
fetal liver cell grafts. In the course of these studies, two factors were recognized to 
play a major role in determining takes following fetal liver cell allografting: a. the 
low number of stem cells in fetal liver; and b. the comparatively high susceptibility 
of the fraction of fetal liver HSC which initiate repopulation to allogeneic repression. 
Titration studies of purified and nonpurified grafts also established the fundamental 
rule that the takeability problem is relative, in that it can be overcome by increasing 
the number of HSC in the graft. This can be achieved in mice simply by the pooling 
of fetal livers from the same jnbred strain. In man, pooling is not practical, because it 
leads to a miscellaneous immunogenetic composition of the graft which suppresses 
the takeability and therefore counteracts the effect of increasing the number of stem 
cells [Van Bekkum, 1969a]. This led us to search for methods by which fetal liver HSC 
of a single immunogenetic make-up could be reproduced in larger numbers. In the 
culture system which was chosen for these studies, a net production of HSC has not 
been achieved so far, although self-replication of this cell population could be 
significantly augmented. Apparently, proliferation in this system was counteracted 
by a marked loss of HSC due to either death or differentiation. Further investigations, 
e.g., isolation of the so-called stem-cell-activating factor (SAF), should prove whether 
in vitro production of HSC by means of simple culture methods can be obtained. At 
the same time, this poses the question as to whether these HSC retain their normal 
proliferation capacities following in vitro multiplication. 
Another line of investigation concerned with the promotion of the take of the 
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haemopoietic cell transplant was the addition of fetal thymocytes to the liver cell 
graft. These cells did show a stimulating effect on early repopulation, which is in 
agreement with the findings of Bortin et al. [1973] that fetal thymus cells are capable 
of enhancing take. However, this course of action carries the risk of inducing a 
severe GvH reaction in man. At all fetal ages tested, strongly PHA positive responses 
were scored throughout our fetal thymus series, the earliest sample being from a 
fetus of 8 weeks gestation (table 7.1). The concern for possible GvH hazards following 
the application of these cells in humans is not contradicted by the experience that i.rn. 
implantation of small fragments of fetal thymus (up to 16 weeks of fetal age) does 
not induce GvH disease, because the introduction of GvH aggressive cells as organ 
pieces via the i.m. or s.c. route is far less efficient than the i.v. administration of cell 
suspensions [Van Bekkum, 1972]. If one accepts that the strict correlation between 
PHA responsiveness (in vitro) and GvH reactivity [Dicke et al., 1968; Dicke, 1970] 
also applies to human embryonic cell suspensions, one should either follow a very 
conservative policy as regards the use of fetal thymocytes in clinical practice, or employ 
irradiated thymus cells. However, no data on the effectivity if irradiated thymus 
cells in stimulating take of fetal liver cell allografts are available. It was shown in 
our experiments that irradiated adult thymocytes are similarly active as are non-
irradiated thymus cells in stimulating haemopoiesis in syngeneic spleen colonies. 
Whether irradiated thymocytes are also capable of promoting take in allogeneic 
conditions is not known. If so, it is probably feasible to employ irradiated human 
fetal thymocytes in attempts to promote the take of fetal liver cell grafts, because the 
human fetal thymocytes at the ages under consideration seem to have many of the 
characteristics of murine adult thymocytes (paragraph 4.2.5). 
Finally, it should be stated that in a re-evaluation of the past clinical experiences 
with fetal liver cell transplantation, it was concluded that grafting of an insufficient 
number of cells might have been the principal cause for the disappointing results. 
In this respect, two factors were considered to be involved in the failures of these cells 
to take: a. the use of frozen cells; and b. the administration of the graft by the i. p. 
route (paragraph 1.3.6). 
Our increased insight into the biology of fetal liver cell takeability provides a 
number of new possibilities for ensuring engraftment of fetal liver cells in human 
recipients. The following recommendations are made for future attempts at fetal 
liver cell transplantation. 
7.4 Recommendations for fetal liver cell transplantation 
Faced with the difficulty of engrafting fetal liver cells, the design of the transplanta-
tion protocol should place full emphasis on the take of the graft. In this respect, 
the strategy recommended for fetal liver cell grafting with its relatively low risks of 
acute GvH disease should differ from that for bone marrow grafting which is first of 
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all concerned with the prevention of GvH disease. With this in mind, a transplanta-
tion regimen is proposed which is deliberately centred on avoiding all possible factors 
which might in some way interfere with repopulation, such as freezing and gradient 
separation. The latter technical refinements may be added after sufficient experience 
with fetal liver cell takes has been gained, similar to the line of development seen in 
bone marrow transplantation. 
I. Selection of patients 
In view of the difficulties encountered in obtaining a take, it seems realistic to confine 
fetal liver cell grafting, for the present time, to ClD patients. They represent the 
most readily accepting group of recipients, so that relatively low numbers of HSC 
can be expected to produce takes. This has indeed been borne out by bone marrow 
transplantation in CID patients. Excellent results have been obtained with bone 
marrow cells from genotypically HLA-identical donors and this treatment has 
resulted in either a surprisingly mild Gv H disease or no Gv H reaction at all [Van 
Bekkum, 1972]. However, such donors are not available in the majority of the cases. 
It is for this category of patients that transplantation of fetal liver cells must be 
considered. 
Only when the problems of engraftment in CID patients can be regularly overcome 
and when it turns out that the GvH disease following transplantation of fetal liver 
cells, like in animals, is of a moderate type will it become useful to extend the fetal 
liver cell approach to the treatment of aplastic patients. Even then, the limited cell 
numbers obtained from one liver will preclude their therapeutic use in aplasia unless 
the present possibilities for in vitro multiplication are further developed. 
II. Cell dose and age of fetus 
In laboratory investigations concerned with transplantation of haemopoietic cells, 
no convenient model for CID recipients is available. For that reason, bone marrow 
transplantation research relies predominantly on experience in animals rendered 
aplastic by lethal irradiation. Such recipients need full repopulation, in contrast 
to CID recipients in which only the reconstitution of a single haemopoietic cell line 
(lymphocytic) is required. This explains why the CID patients require less cells for 
reconstitution than do aplastics. However, one may assume that the qualitative 
differences in repopulation properties between fetal liver and bone marrow cells, 
as observed in irradiated recipients, are essentially similar in CID hosts. 
Taking into account the factors which have been demonstrated in murine experi-
ments to have different effects on the repopulation by fetal and adult haemopoietic 
cells, and assuming that similar factors play a role in human recipients, the number of 
fetal liver cells needed to produce takes in histo-incompatible CID patients can be 
calculated from the number of bone marrow cells required. As immunocompetent 
lymphocytes syngeneic to the haemopoietic graft are known to markedly facilitate 
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the take in the allogeneic recipient [Van Bekkum and De Vries, 1967], the large 
numbers of lymphoid cells present in human bone marrow may significantly alter 
the analogy with the mouse. It seems more valid, therefore, to start the calculation 
from the number of cells of a purified human bone marrow graft needed for a take. 
This number is represented by the figure of 5 x 106 cells per kg of a HLA/MLC 
non-identical bone marrow stem cell concentrate [Van Bekkum and Dicke, 1972; 
Van Bekkum, 1972]. If we assume that the HSC population in the fraction is con-
centrated by a factor of 10 on the average [Dicke et al., 1968, 1970; Dicke, 1970] 
this figure is equivalent to 5 x 107 cells in terms of unfractionated bone marrow per 
kg. If we further assume (by analogy with the mouse) a 3-fold reduced stem cell 
concentration in fetal liver and a 2-fold allogeneic suppression of the efficiency of 
repopulation by embryonic HSC, the fetal liver cell number required for a take in an 
incompatible CID infant will be in the order of 3 x 108 cells per kg. This 6-fold larger 
cell dosage for fetal liver cell grafts is somewhat higher than the 4-fold difference 
between fetal liver and bone marrow cell numbers required to restore irradiated 
monkeys, which can be derived from the results published by VanPutten et al. [1968]. 
Therefore, we have adopted for our present recommendations a factor of 4-6 as the 
cell number difference between allogeneic fetal liver cell and bone marrow transplants. 
If we take the average body weight of a CID recipient to be 6 kg, a total cell number 
of 12-18 x 108 fetal liver cells would be required. According to data collected on 
human fetal liver cell yields (table 7.3), only livers of a gestational age of at least 16 
weeks will serve to provide these numbers. 
One should first a wait the results of the suggested animal experiments dealing with 
the question of the capacity of irradiated thymus cells to promote allogeneic fetal 
liver cell takes until deciding whether the additional i. v. injection of the thymocytes 
from the same embryo warrants application. 
Table 7.3 Cellularity and weight of developing humanfetalliver 
maturation cell yield 
age weight 
(wks) m. (gr) range 
8-12 3 1.5- 4.9 0.4-1.0 X 109 
16 2 4.3- 5.7 1.3 X 109 
17-18 7 5.0-10.8 1.3-3.6 X 109 
20 I 19 4x 109 
III. Fresh versus frozen cells 
Frozen cells offer three important advantages: 
a. the possibility of using all suitable embryos received; 
mean 
0.6 X 10~ 
1.3 X 109 
2.5 X 109 
4 X 109 
b. the opportunity to test the fetal liver cell graft on PHA activity before use; and 
c. the availability of fetal liver cell grafts at all times. 
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In spite of the development of a storage method which allows the complete preserva-
tion of HSC without a decrease in the concentration of viable HSC [Schaefer et al., 
1972a], one has to account for unavoidable losses of cells resulting from the extra 
steps included in the handling of the cell suspensions (e.g., repeated cell centrifugations). 
Because of the poor experience with frozen fetal liver cell transplants in the past 
[Soothill et al., 1971; Githens et al., 1973] and because of the necessity to eliminate 
all factors which might interfere with the results of fetal liver cell grafts in man, it is 
felt that preference should be given to the use of fresh fetal liver cells for the present 
time. 
IV. Intravenous versus intraperitoneal administration 
It is suggested that the cells be given by i.v. route, and not i.p., because of the marked 
increase in the chance of effective repopulation by i.v. administration [Schaefer et al., 
1972b]. When the liver tissue is processed according to the procedure described in 
Materials and Methods (paragraphs 2.2.3 and 2.2.4), tbe intravascular administration 
does not carry a significant risk for embolism; in at least 3 human patients and in 
10 monkeys treated so far, no complications due to the i.v. injection have been 
encountered. 
V. Additional measures aimed at the prevention of Gv H disease 
According to the results in rodents reported here (chapter 6) and elsewhere [Uphoff, 
1958, 1959; Urso et al., 1959; Lengerova, 1959; Crouch, 1959; Barnes et al., 1961], 
the amelioration of the GvH reaction by the use of fetal liver cells is not enough to 
assure complete survival. This may suggest the necessity for additional measures 
aimed at inhibition of delayed GvH disease in human fetal liver cell transplantation. 
In this respect it should be noted that one should avoid immunosuppressive treat-
ment for mitigation of the GvH reaction, if possible, because it interferes with the 
objective of the treatment in CID. 
The frequent occurrence of complicating bacterial infections during GvH disease 
in conjunction with only minor lesions directly attributable to the GvH reaction 
(paragraph 6.1) is a strong argument in support of the idea that the fetal liver GvH 
reaction, similar to the Gv H events after bone marrow transplantation [Van Bekkum 
et al., 1974], does not directly cause death, but plays a permissive role in the occurrence 
of fatal infections throughout the prolonged period of immune incompetency. Con-
sequently, it seems important to institute powerful prophylaxis to prevent infections. 
When applied throughout the major period of immune deficiency, the gnotobiotic 
state has proven to be an effective way of preventing endogenous as well as exogenous 
bacterial infections in rodents [Vander Waay et al., 1970; Van Bekkum et al., 1974]. 
Recent results of bone marrow research in the monkey indicate restricted benefit 
from this method in histo-incompatible bone marrow grafting in primates. However, 
it must be considered that, in the situation of the milder delayed GvH syndrome 
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following allogeneic fetal liver cell transplantation, the beneficial effect of germfree 
conditions may accordingly increase, as was seen in the comparatively mild bone 
marrow GvH disease encountered in rodents [Van Bekkum et al., 1974]. 
Because it is necessary to use donors older than 16 weeks for collecting sufficiently 
large fetal livers from a point of view of takeability (see above) and because 3 out of 
10 grafts in our series of fetal livers beyond this age manifested a clearly positive 
PHA response (table 7.1), the possibility must be considered that~ contrary to the 
rodent and monkey transplantation models- acute GvH disease may complicate the 
transplantation of fetal liver cells in man. Using the PHA reactivity as a specific 
indicator for acute GvH activity [Dicke et al., 1968, 1970; Dicke, 1970], a PHA 
assay could serve to test the cell suspensions prior to transplantation in order to dis-
card potentially hazardous fetal liver cell grafts. This underlines the great importance 
of a rapid PHA test measuring the response within a few hours [Van den Berg, 1974]. 
A very recently reported rapid MLC test (I h) may offer promise for the development 
of such an assay in the near future [Parsa and Kountz, 1974]. 
Another possibility is to subject the fetal liver cell grafts to cell separation [Dicke 
et al., 1968, 1970; Dicke, 1970] for removal of GvH reactive cells. However, both 
PHA testing and gradient separation require preservation of fetal liver cells, at 
present with the disadvantages mentioned above. Apart from the PHA monitoring, 
the gradient has the relative disadvantage in that certain losses of HSC will occur. 
It must be concluded, therefore, that, although purification of fetal liver stem cells is 
technically possible, this procedure should not be used until experience with whole 
fetal liver cell grafts has demonstrated the necessity for additional measures for 
preventing acute GvH complications. 
The present investigation has disclosed some of the special factors which are opera-
tive in the take of fetal liver cell grafts. No allowance has been made for these 
factors in fetal liver cell transplantation history. It is concluded that fetal liver cell 
transplantation has occurred under suboptimal conditions in the past and it is likely 
that this has had an important bearing on previous failures. Because of this, the 
restorative potencies of these grafts in man are still obscure. Taking these findings 
into account, a strategy for fetal liver cell transplantation in the human has been 
suggested. Due to the rare incidence of CID, however, it will take a long time before 
insight into the potentialities of fetal liver cell grafts will be gained. From a practical 
standpoint, it is therefore of great importance to conduct international cooperative 
trials. This is the only way to evaluate the usefulness of fetal liver cell grafts for the 
human being within a reasonable space of time. If, indeed, takes of fetal liver cell 
grafts can be repeatedly obtained in CID patients with the procedure proposed, it 
will become apparent whether the dissimilarity in GvH inducing properties of fetal 
and adult HSC, which has been found in the mouse, also applies to the human species. 

SUMMARY AND CONCLUSIONS 
Fetal liver cell transplantation deserves intensified interest because, according to 
previous experimental evidence, it may represent a useful approach to reduce or 
avoid severe Graft-versus-Host (GvH) reactions following treatment with allogeneic 
haemopoietic cell grafts. The application of fetal liver cells in man has not been very 
successful so far. The present investigation in the mouse was concerned with the 
practical issues of elucidating the causes for the repeated failures of fetal liver cell 
grafting in patients and of establishing the applicability and limitations of these 
grafts. This study also had interesting physiological aspects. It allowed us to investigate 
the specific growth properties of the embryonic haemopoietic stem cells (HSC) and 
to add information to our incomplete knowledge of factors controlling the differentia-
tion and proliferation of these cells. 
The study was introduced by a chapter(!) reviewing the present status of allogeneic 
bone marrow transplantation. After a discussion of some basic principles of haemo-
poietic cell transplantation and the stage of development of methods for the mitiga-
tion of GvH disease, specific consideration was given to fetal liver cell transplantation. 
A description of the ontogenetic development and the characteristics of fetal liver 
haemopoiesis was provided and this was followed by a review of the experiences with 
fetal liver cell transplants in animals and humans as reported in the literature. From 
this it was particularly evident that failures of engraftment have hitherto represented 
the most serious single barrier in the successful application of fetal liver cell grafts. 
The materials and methods employed in this study were described in chapter 2. 
Chapter 3 was concerned with defining the cellular constitution of the fetal liver 
cell transplant, with major reference to the HSC population. Using assays for estima-
tion of CFU-s numbers as well as the spleen colony forming efficiency of fetal liver 
stem cells made possible an enumeration of the HSC population in the fetal liver 
cell suspension. It was found that the HSC in the embryonic liver were present in 
approximately 3 x lower frequency than in the bone marrow tissue. The methodology 
of the assays was fully discussed. Discontinuous albumin density gradient centrifuga-
tion was employed to prepare fetal liver stem cell concentrates for transplantation 
purposes. Using this method it was confirmed that fetal liver HSC (1.057 gjcm3 ) 
were of lighter density than bone marrow HSC (1.064 gjcm3 ). 
The problems encountered in engrafting fetal liver cells prompted a study of the 
mechanism of take (chapter 4). Stem cell kinetics after haemopoietic cell transplanta-
tion were determined in direct relation to take. Several factors which determine 
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engraftment and which differently influence fetal liver and bone marrow cell descen-
dant repopulation were clarified: 
a. The transfusion of the large number of more differentiated cells together with the 
HSC in the fetal liver cell transplant was shown not to have a beneficial influence 
on engraftment. This supported the concept that the HSC in the fetal liver cell 
transplant represented the major part of the cellular basis for haemopoietic 
reconstitution. 
b. Under syngeneic transplantation conditions, fetal liver stem cells had the same 
repopulation proficiency as those from bone marrow. The 3 x higher nucleated 
cell numbers from fetal liver required for a successful take, as compared to bone 
marrow, correlated with the lower frequency of HSC in the embryonic liver 
tissue. 
c. The equivalent repopulation efficiency of both kinds of HSC was in good accord 
with the proliferation kinetics of fetal liver and bone marrow HSC: doubling of 
fetal liver CFU in the haem~poietic tissue of the host was more rapid but the 
fraction (f) of the total number of administered fetal liver CFU which initiated 
repopulation was smaller; in addition, the generation of differentiated progeny 
per injected fetal liver CFU was shown to be lower. 
d. From studies on fetal liver cell take in allogeneic recipients, it became apparent 
that the f-fraction of fetal-liver-derived CFU repopulation was repressed by a 
factor of 2 in allogeneic conditions which was in contrast to that of bone marrow; 
this accounted for a 2-fold difference in HSC numbers and a 6-fold difference in 
nucleated cell numbers needed for effective fetal liver cell versus bone marrow 
allotransplantation. 
e. The 5-10 times larger cell numbers needed for allografting of both kinds of grafts 
(as compared to isografting) was partly due to a reduction in the f-fraction of CFU 
and partly to inhibited differentiation but could not be fully accounted for. It was 
shown that impaired repopulation in allogeneic hosts in the first week following 
transplantation was mostly caused by so-called environmental resistance factors 
of the recipient to the donor type cells. Arguments were provided in support of 
the fact that at later stages immunological processes (cell mediated allograft 
rejection, GvH reaction) also interfered with reconstitution. 
f. The addition of thymocytes to the haemopoietic cell graft markedly enhanced 
haemopoietic repopulation in the host (as measured by spleen colony formation) 
which indicated the presence of allogeneic resistance and even syngeneic resistance 
(ontogenetic) to grafted fetal liver HSC. 
g. Attempts to promote take by employment of thymus cells in allotransplantation 
proved not convincing enough to warrant practical application (narrow effective 
dose range, risks for GvH disease, etc.). Some interesting possibilities for further 
exploration and development of this line of research were discussed, in particular, 
the employment of irradiated thymus cells. 
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Another possible approach to enhance fetal liver cell take was outlined in chapter 5. 
It was attempted to increase the number of stem cells in the transplant by multiplica-
tion of the number of HSC prior to grafting. For this purpose, a liquid culture system 
in which in vitro proliferation of HSC could be measured was devised; proliferation 
of HSC was determined by estimating the maintenance of CFU numbers and the 
cycling status of CFU at regular intervals. Various factors were tested for their effect 
on these two parameters of CFU in culture: serum from lethally irradiated mice, 
haemolysate, irradiated fibroblasts (i.e. the stimulating source of the so-called thin 
agar layer system (TALS) for myeloid colony growth in vitro). Evidence was obtained 
that self-replication of HSC in cultures containing fibroblasts or fibroblast-conditioned 
medium occurred and that it was dependent on the action of a stem cell activating 
factor (SAF). This factor was shown to be distinct from the colony stimulating factor 
(CSF) and from another product (haemolysate) which was able to sustain increased 
survival of HSC in culture. The experiments may offer promising possibilities for 
producing HSC in vitro for transplantation purposes. As yet, the method has not 
reached a sufficient stage of development to allow net production from limited 
numbers of HSC. 
As reported in the literature, fetal liver cell grafts compared favourably with bone 
marrow cells in that they elicited less severe delayed GvH reactions in our experiments. 
In specially designed experiments based on stem cell purification and quantitation of 
HSC numbers in the graft, the basis for the distinctly weak delayed GvH disease 
following fetal liver cell engraftment was traced back to intrinsic properties of the 
fetal liver HSC (chapter 6). According to the findings in this chapter, a somewhat 
modified classification of GvH disease was proposed which distinguished, apart 
from the acute GvH reaction which is directly caused by grafted immunocompetent 
cells, two other types: a severe delayed GvH reaction mediated by the lymphocytic 
progeny of adult HSC in the graft and a less severe delayed GvH disease mediated 
by lymphocytic descendant cells from transplanted fetal HSC. 
In chapter 7 the results of these investigations were put into the perspective of fetal 
liver cell transplantation in man; in this context, a strategy for attempts at fetal liver 
cell transplantation in patients suffering from severe combined immunodeficiency 
disease (CID) was proposed. 
SAMENVATTING/SUMMARY IN DUTCH 
De late Graft-versus-Host (GvH) reactie vormt hedentendage waarschijnlijk de be-
langrijkste hinderpaal voor uitgebreide toepassing van allogene beenmergtransplan-
tatie. Afgaande op dier-experimentele waarnemingen uit het verleden, mag de foetale 
leverceltransplantatie worden beschouwd als een alternatieve vorm van transplantatie 
van bloedvormende cellen die gepaard gaat met minder risico's van late GvH reacties. 
Hieraan ontleent de foetale leverceltransplantatie zijn betekenis. Opmerkelijk genoeg 
hebben pogingen van foetale leverceltransplantatie bij de mens echter tot op heden 
weinig effect gesorteerd; hierbij stonden moeilijkheden inzake het aanslaan van foetale 
levercellen centraal. De oorzaken hiervan waren grotendeels onbekend. Inzicht in de 
achtergrond van deze problemen is van rechtstreeks belang voor de ontwikkeling van 
foetale leverceltransplantatie tot een praktische methode voor transplantatie van 
haemopoietische cellen met rninder risico van GvH ziekte. De huidige studie, uitge-
voerd in de muis, was gericht op een opheldering van de oorzaken van de misluk-
kingen bij de mens en op het afbakenen van de mogelijkheden en beperkingen van 
foetale leverceltransplantatie. Daarbij waren de groeikarakteristieken van embryonate 
bloedvormende cellen en de factoren die de proliferatie en differentiatie van cellen 
van het haemopoietische systeem na transplantatie reguleren, belangrijke aspecten 
van onderzoek. Dit was met name mogelijk dank zij een aantal recente ontwikkelingen 
in inzichten en methodologie betreffende de haemopoiese en de beenmergtransplan-
tatie waardoor de rol van de pluripotente stamcel in het transplantatieproces (aan-
slaan, GvH reactie) in het onderzoek kon worden betrokken. 
In hoofdstuk I van deze studie werd een overzicht gegeven van de betekenis en de 
ontwikkeling van de beenmergtransplantatie. Nadat enkele basisprincipes van been-
mergtransplantatie waren beschreven, werd specifieke aandacht geschonken aan de 
foetale leverceltransplantatie zelf. Achtereenvolgens kwamen aan de orde: de onto-
genetische ontwikkeling en aard van de foetale lever haemopoiese en een evaluatie 
van de foetale leverceltransplantaties in proefdier en mens uit de literatuur. 
In hoofdstuk 2 werden de materialen en methoden beschreven, die in het onderzoek 
van dit proefschrift zijn gebruikt. 
In hoofdstuk 3 werd aan de hand van microscopisch onderzoek en functionele 
testen op een aantal specifieke celtypes, de cellulaire samenstelling van het foetale 
leverceltransplantaat gedefinieerd. De resultaten wezen op het opvallend erythro-
poietische karakter van de bloedcelvorming in de embryonale lever en het gebrek aan 
lymphopoietische en myelopoietische activiteit. Wat betreft de afwezigheid van deze 
laatste cellijn kon worden aangetoond dat ook de myeloide voorloper cellen (CFU-c) 
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numeriek in geringere mate aanwezig zijn. Ruime aandacht werd geschonken aan 
de populatie van de pluripotente haemopoietische stamcel (HSC) in foetale lever. 
Met behu1p van de miltknobbelproef en een methode ter bepaling van de efficientie 
waarmee deze test stamcellen detecteert in een intraveneus toegediende celsuspensie, 
was het mogelijk om het aantal stamcellen in de foetale levercelsuspensie bij bena-
dering vast te stellen. Het b1eek dat de HSC in de embryonate lever in een gemiddeld 
3 x lagere concentratie voorkomt dan in het beenmerg. De methodologie van deze 
bepaling werd uitvoerig ter discussie gesteld. 
Yoor het bereiden van stamcel-concentraten uit foetale lever werd de discontinue 
albumine dichtheid-gradient techniek toegepast. Daarmee konden gezuiverde stamcel 
suspensies worden verkregen die ontdaan waren van 80-90% van de rijpere cellen die 
naast de HSC in het transplantaat aanwezig zijn. Vergelijking van deze foetale levercel-
fracties met ongefractioneerde celsuspensies opende de mogelijkheid voor bet maken 
van een onderscheid tussen de rol van HSC en de meer gedifferentieerde cellen in de 
repopulatie en het ontstaan van GvH ziekte na transp1antatie (zie onder). Impliciet 
kon worden bevestigd dat de dichtheid van de foetale HSC (1 ,057 gjcm3) geringer is 
dan die van zijn vo1wassen tegenhanger (1 ,064 gjcm'). 
Het moeilijke aanslaan in dier-experimentele en humane foetale leverceltransplan-
taties vormde de aanleiding voor het onderzoek naar het mechanisme en de kinetiek 
van de repopulatie na transplantatie (hoofdstuk 4). In titratie-studies, waarin groepen 
letaal bestraalde muizen toenemende hoeveelheden stamcellen ontvingen, werd nage-
gaan wat de minimum benodigde hoevee1heid cellen was om 80% overleving op dag 
30 te bereiken (als maat voor protectie tegen sterfte aan het beenmerg-stralings-
syndroom). Voorts werd de stamcelproliferatie-activiteit van foetale lever en been-
merg rechtstreeks gemeten door bepaling van de aantallen HSC in beenmerg en milt 
met regelmatige tijdsintervallen na de transplantatie. Deze proeven, die werden uit-
gevoerd zowel in syngenetische als in allogenetische ontvangers, brachten de volgende 
gegevens aan het Iicht: 
a. de HSC in het transplantaat is voorname1ijk, zo niet geheel, verantwoorde1ijk 
voor repopulatie; de eliminatie van de rijpere cellen uit het transplantaat had geen 
effect op de overleving; 
b. in syngenetische transplantatie condities zijn foetale en volwassen stamcellen 
evengoed in staat om letaal bestraalde muizen te repopuleren; dit kon in verband 
worden gebracht met de repopulatie-kinetiek van beide soorten stamcellen: de 
pro1iferatiesnelheid van de foeta1e HSC was hoger t.o.v. die van de beenmerg 
HSC, maar de fractie (f) van de ingespoten partie stamcellen die de repopulatie 
initieerde was lager; voorts werden aanwijzingen verkregen dat de differentia tie 
van foetale levercellen geringer was op een per-ingespoten-stamcel basis. 
c. hoewel voor het aanslaan van het foetale leverceltransplantaat evenveel stam-
cellen dienden te worden toegediend, 1agen de tota1e celaantallen benodigd voor 
126 SAMENVATTING 
foetale leverceltransplantatie ongeveer 3 x hoger dan voor beenmerg, in verband 
met de lagere concentratie van HSC in dit weefsel. 
d. in allogene transplantatie waren zelfs 6 x zoveel foetale levercellen nodig voor aan-
slaan, vergeleken met beenmergtransplantatie; dit extra-verschil kwam overeen 
met een behoefte aan 2 x meer stamcellen voor foetale lever en kon worden toe-
geschreven aan een 2 x zo sterke suppressie van de proliferatieve fractie, f, van 
de ingespoten stamcellen in de allogene gastheer. 
e. aanwijzingen werde:a verkregen dat in de beginperiode na transplantatie vooral 
de zgn. microenvironment-factoren van de gastheer (allogeen) verantwoordelijk 
zijn voor de groeiremming; het was aannemelijk dat in een latere fase ook immuno-
logische reactiemechanismen de repopulatie verstoren. 
f. pogingen om de haemopoiese van foetale levercellen te stimuleren door toevoegen 
van een hoge dosis thymuscellen aan het transplantaat hadden een positief effect 
zowel in syngenetische als allogenetische condities. Deze bevindingen konden 
vvorden geinterpreteerd in term en van het bestaan van een syngenetische ( evt. 
ontogenetische), respectievelijk allogenetische barriere tegen getransplanteerde 
foetale lever haemopoiese die door de thymuscellen werd dom·broken. 
g. intussen stuitten pogingen om deze werking van thymuscellen toe te passen in 
een allogeen transplantatiesysteem ter bevordering van de kans op aanslaan 
vooralsnog op moeilijkheden, met name de inductie van acute Gv H reacties. 
Foetale thymuscellen i.p.v. volwassen thymocyten gaven geen GvH reactie, maar 
hadden het bezwaar in hun activiteit gebonden te zijn aan een smal dosisgebied 
van foetale levercellen. Tenslotte werden wegen voor verdere ontwikkeling van 
deze methodiek ten behoeve van praktische toepassing aangegeven, waarbij in 
het bijzonder het gebruik van bestraalde thymuscellen, die niet meer GvH reactief 
zijn, interessant leek. 
Het probleem van het aanslaan van foetale levercellen was relatief in die zin dat het 
kon worden overwonnen door de toediening van hogere aantallen stamcellen. Ben 
benaderingswijze die op dit uitgangspunt gebaseerd was, werd in hoofdstuk 5 ge-
exploreerd. Deze hield een poging in om een beperkte hoeveelheid beschikbare HSC 
te vermeerderen. Daartoe werd een in vitro kweeksysteem opgezet, dat was afgeleid 
van een eerder in dit laboratorium ontwikkelde techniek voor kolonievorming van 
haemopoietische cell en in agar. Doordat ons systeem een vloeibare basis had, kon de 
kinetiek van HSC in de aan wezigheid van een aantal stimuli technisch gemakkelijk 
worden onderzocht. Dit geschiedde aan de hand van twee parameters: de aantallen 
HSC in vitro en hun cyclusstatus. Uit het feit dat HSC in bepaalde condities in staat 
van actieve celdeling werden gebracht en in hogere aantallen uit de kweken werden 
verkregen, kon worden geconc1udeerd, dat in vitro proliferatie van HSC optrad. 
Replicatie van zowel beenmerg als foetale lever HSC kon worden opgewekt. De HSC 
delingsactiviteit bleek afhanke!ijk van de werking van een mediator die door fibro-
SAMENVATTING 127 
blasten wordt afgegeven. Met grote waarschijnlijkheid kon worden aangetoond dat 
de stamcel activerende factor (SAF) een andere is dan de kolonie stimulerende factor 
(CSF), die myeloide precursor cellen activeert. Helaas is de methode vooralsnog 
niet bruikbaar als preparatieve techniek ten behoeve van een netto produktie van 
stamcellen voor transplantatiedoeleinden. 
In hoofdstuk 6 werd bevestigd dat na allogenetische foetale leverceltransplantatie 
een relatief milde GvH reactie van het vertraagde type optreedt die met minder sterfte 
gepaard gaat. In experimenten die gebaseerd waren op stamcelzuivering en kwantifi-
cering van HSC in het transplantaat, kon worden aangetoond dat het mildere type 
GvH reactie berust op specifieke eigenschappen van de embryonale stamcel. Dit 
leidde tot een gemodificeerde formulering van de gebruikelijke indeling van GvH 
reacties: a. een acute GvH reactie die rechtstreeks afkomstig is van lymphocyten in 
het transplantaat, b. een ernstige vertraagde GvH reactie die wordt veroorzaakt door 
de lymphocyten-nakomelingschap van de beenmerg HSC in het transplantaat, en 
c. de minder ernstige late GvH reactie die berust op de activiteit van lymphocyten 
afstammend van de embryonale lever HSC. 
In hoofdstuk 7 werden de gegevens die in het onderhavige onderzoek werden ver-
kregen en de implicaties daarvan getoetst aan de foetale leverceltransplantatie bij de 
mens. Via extrapolatie van deze bevindingen konden de veelvuldige mislukkingen 
van het aanslaan van deze transplantaten bij de mens worden verklaard, nl. uit het 
niet voldoen aan de kwantitatieve voorwaarden van celaantallen die nodig zijn voor 
aanslaan. Deze nieuwe gegevens leidden onder meer tot het formuleren van aan-
bevelingen voor toekomstige toepassing van foetale levercel-therapie in de kliniek, 
voorlopig voor het behandelen van kinderen met ernstige gecombineerde immuun-
deficienties (CID). 

cAMP 
BSA 
CFC 
CFU-c 
CFU-s 
CID 
Con A 
CSF 
DMSO 
DNA 
dpm 
f-factor 
FCM 
GvH 
HBSS 
HLA 
HSC 
3 HTdR 
i.m. 
i.v. 
i.p. 
LPS 
MEM 
MLC 
n.d. 
PHA 
SAF 
S.C. 
S.D. 
S.E. 
TALS 
To 
TdR 
ABBREVIATIONS 
adenosine cyclic monophosphate 
bovine serum albumin 
colony forming cells - represents the whole class of cells which share the 
capacity of giving rise to colonies in vivo (a proportion of the same popula-
tion in an oculum produce spleen colonies) 
colony forming units in culture 
colony forming units spleen - refers to the single cells in a haemopoietic 
suspension which actually produce spleen colonies 
(severe) combined immunodeficiency disease 
concanavalin A 
colony stimulating factor 
dimethylsulfoxide 
deoxyribonucleic acid 
desintegrations per minute 
fraction of injected CFU that form macroscopic colonies on the surface 
of the spleen following injection into lethally irradiated mice (- spleen 
colony forming efficiency- CFU/CFC ratio) 
fibroblast conditioned medium 
graft versus host 
Hanks' balanced salt solution 
human leucocyte antigens (major histocompatibility complex in man) 
pluripotent haemopoietic stem cell(s) 
tritiated thymidine 
intramuscular 
intravenous 
intraperitoneal 
E.coli lipopolysaccharide 
minimum essential medium 
mixed lymphocyte culture 
not done 
phytohaemagglutinin 
stem cell activating factor 
subcutaneous 
standard deviation 
standard error 
thin agar layer system 
(mean) population doubling time 
unlabelled thymidine 
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